REGISTER RAKA ZA SLOVENIJO CANCER REGISTRY OF SLOVENIA EPIDEMIOLOGIJA IN REGISTER RAKA EPIDEMIOLOGY AND CANCER REGISTRY Poročilo RR št. 44 Report No. 44 LJUBLJANA 2005 INCIDENCA RAKA V SLOVENIJI CANCER INCIDENCE IN SLOVENIA ISSN 1318-2471 REGISTER RAKA ZA SLOVENIJO CANCER REGISTRY OF SLOVENIA EPIDEMIOLOGIJA IN REGISTER RAKA EPIDEMIOLOGY AND CANCER REGISTRY Poročilo RR št. 44 Report No. 44 LJUBLJANA 2005 INCIDENCA RAKA V SLOVENIJI CANCER INCIDENCE IN SLOVENIA ISSN 1318-2471 Uredniški odbor / Editorial Board Maja Primic Žakelj, glavna urednica / editor-in-chief Matej Bračko Marko Hočevar Vera Pompe–Kirn Primož Strojan Vesna Zadnik Branko Zakotnik Tina Žagar Osebje Registra raka / Staff of the Cancer Registry Maja Primic Žakelj, vodja / head Mojca Brus Andrej Kirn Neža Milčič Nataša Robek Fani Škrlec Nataša Šturm Tina Žagar, mlada raziskovalka / junior researcher Računalniška obdelava / EDP analysis Jurij Modic Vesna Zadnik Tina Žagar Oblikovanje / Design Monika Fink-Serša Studio N, studio za oblikovanje in grafično pripravo Priprava za tisk in tisk / Typesetting and printing Studio N, studio za oblikovanje in grafično pripravo Izdal / Published by Onkološki inštitut Ljubljana / Insitute of Oncology Ljubljana, Slovenia Direktor / Director Zvonimir Rudolf Naslov / Correspondence to Maja Primic Žakelj Onkološki inštitut / Institute of Oncology Zaloška c. 2, 1001 Ljubljana, p.p. 2217, Slovenia Telefon / Phone: + 386 (1) 5879 563 E-pošta / E-mail: register@onko-i.si Spletna stran / Web site: http://www2.arnes.si/~m01vzadnik http://www.onko-i.si/ Nasvet za citiranje / Recommended reference Incidenca raka v Sloveniji 2002. Ljubljana: Onkološki inštitut, Register raka za Slovenijo, 2005. Cancer incidence in Slovenia 2002. Ljubljana: Onkološki inštitut, Register raka za Slovenijo, 2005. Vse pravice pridržane. All rights reserved. VSEBINSKO KAZALO / CONTENTS Stran / Page Uvod in pojasnila Introduction and Comments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 Tabela A Breme raka - Slovenija 2002 Table A Cancer burden - Slovenia 2002 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14 Tabela B Prevalenca glede na obdobje opazovanja - Slovenija, 31. 12. 2002 Table B Prevalence by period of observation - Slovenia, December 31, 2002 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14 Tabela C Stabilnost podatkov - število in odstotek novih primerov raka, prijavljenih po izdaji letnega poročila, po obdobju - Slovenija, 1965-2001 Table C Data stability - number and percentage of new cases reported after the publication of annual reports, by time period - Slovenia, 1965-2001 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14 Tabela D Opazovana in napovedana incidenca raka v Sloveniji v obdobju 1993-2005 Table D Observed and predicted cancer incidence in Slovenia in the period 1993-2005 . . . . . . . . . . . . . . . . . . . . . . . 15 Slike / Figures 1 Najpogostejše rakave bolezni po spolu - Slovenija 2002 The leading cancer sites by sex - Slovenia 2002 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16 2 Odstotni delež vseh rakov po starostnih skupinah in spolu - Slovenija 2002 Percentage distribution of all cancer sites by age groups and sex - Slovenia 2002 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17 3 Odstotni odklon grobe incidenčne stopnje raka po statističnih regijah od povprečne slovenske - Slovenija 2002 Percentage deviation of crude cancer incidence rate in statistical regions from average - Slovenia 2002 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17 4 Groba in kumulativna letna incidenca vseh rakov po spolu - Slovenija 1950-2002 Crude and cumulative annual cancer incidence; all sites by sex - Slovenia 1950-2002 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18 5 Groba letna incidenca izbranih rakov po spolu - Slovenija 1950-2002 Crude annual cancer incidence by selected primary sites and sex - Slovenia 1950-2002 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19 6 Pljuča - moški Lung - males . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20 7 Pljuča - ženske Lung - females . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21 8 Debelo črevo - moški Colon - males . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22 9 Debelo črevo - ženske Colon - females . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23 10 Danka - moškI Rectum - males . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24 11 Danka - ženske Rectum - females . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25 12 Dojka - ženske Breast - females . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26 13 Maternični vrat Cervix uteri . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27 Cancer Incidence in Slovenia 2002 3 Institute of Oncology Ljubljana, Cancer Registry of Slovenia Tabele / Tables 1 Prebivalstvo Slovenije po starosti in spolu na dan 30. 6. 2002 Population of Slovenia by age and sex on June 30, 2002 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28 2 Prebivalstvo Slovenije po statističnih regijah po spolu na dan 30. 6. 2002 Population of Slovenia by statistical regions by sex on June 30, 2002 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29 3 Število novih primerov raka ter število in odstotek primerov, registriranih samo iz zdravniških poročil o vzroku smrti, po lokaciji in spolu - Slovenija 2002 Total number of new cancer cases, number and percentage of cases registered from death certificates only, by site and sex - Slovenia 2002 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30 4a Število novih primerov raka po lokaciji (MKB-10), spolu in starosti - Slovenija 2002 Number of new cancer cases by primary site (ICD-10), sex, and age - Slovenia 2002 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36 4b Število novih primerov raka po lokaciji (MKB-8), spolu in starosti - Slovenija 2002 Number of new cancer cases by primary site (ICD-8), sex, and age - Slovenia 2002 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40 5 Incidenca raka na 100.000 prebivalcev po spolu in starosti ter kumulativna stopnja (KS) po lokaciji - Slovenija 2002 Cancer incidence per 100.000 population by sex and age, and cumulative rate (CR) by site - Slovenia 2002 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43 6a Število novih primerov raka po statističnih regijah, po najpogostejših lokacijah in spolu - Slovenija 2002 Number of new cancer cases by statistical regions, by most frequent sites and sex - Slovenia 2002 . . . . . . . . . . . . . . . 50 6b Starostno standardizirana incidenca raka po statističnih regijah, po najpogostejših lokacijah in spolu - Slovenija Age standardised cancer incidence rate by statistical regions, by most frequent sites and sex - Slovenia 2002 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51 7 Število novih primerov raka, ugotovljenih v bolnišnicah, ter število in odstotek mikroskopsko potrjenih primerov, po lokaciji in spolu - Slovenija 2002 Total number of new cancer cases diagnosed in hospitals and number and percentage of microscopically confirmed cases - by site and sex - Slovenia 2002 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 52 8 Število histološko (in citološko) potrjenih novih primerov raka po histološki vrsti in lokaciji - Slovenija 2002 Number of histologically (and cytologically) confirmed new cancer cases by histologic type and site - Slovenia 2002 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58 9 Število primerov ne-Hodgkinovih limfomov po lokaciji, spolu in starosti - Slovenija 2002 Total number of non-Hodgkin's malignant lymphomas by site, sex, and age - Slovenia 2002 . . . . . . . . . . . . . . . . . . . . . . . . . 67 10 Število novih primerov raka po bolnišnicah ugotovitve diagnoze ter število in odstotek primerov, napotenih na Onkološki inštitut Ljubljana (OI) - Slovenija 2002 Number of new cancer cases diagnosed by reporting hospitals, and number and percentage of cases referred to the Institute of Oncology Ljubljana (IO) - Slovenia 2002 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 68 11 Število in odstotek novih primerov raka, ugotovljenih v bolnišnicah, po stadiju, lokaciji in spolu - Slovenija 2002 Number and percentage of new cancer cases reported by hospitals by stage, site and sex - Slovenia 2002 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 70 12 Število umrlih za rakom po lokaciji, spolu in starosti - Slovenija 2002 Number of cancer deaths by site, sex and age - Slovenia 2002 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 74 13 Število vseh živih bolnikov z rakom po spolu in izbrani primarni lokaciji - Slovenija, 31. 12. 2002 Prevalence of cancer patients by sex and selected primary site - Slovenia, December 31, 2002 . . . . . . . . . . . . . . . . . . . 79 Izbor publikacij / Selected publications . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 80 4 Incidenca raka v Sloveniji 2002 Onkološki inštitut Ljubljana, Register raka za Slovenijo Institute of Oncology Ljubljana, Cancer Registry of Slovenia Cancer Incidence in Slovenia 2002 5 UVOD Register raka za Slovenijo (Register) je eden najstarejših populacijski registrov v Evropi. Usta- novljen je bil leta 1950 na Onkološkem inštitutu v Ljubljani kot posebna služba za zbiranje in obdelavo podatkov o incidenci raka in preži- vetju bolnikov z rakom. Pred letom 1950 so bili populacijski registri raka le v Hamburgu, na Danskem in v Veliki Britaniji. Od ustanovitve do leta 1975 je Register vodila pokojna profesorica dr. Božena Ravnihar, dologoletna direktorica Onkološkega inštituta. Njeno delo je nato pre- vzela profesorica dr. Vera Pompe Kirn, ki je do leta 2003 skrbela za nadaljnjo uveljavljanje Registra v domačem in mednarodnem merilu. Tega leta je Onkološki inštitut dobil nov statut, ki je združil Register z Enoto za epidemiologijo v enotno službo Epidemiologija in registri raka. V njej so poleg Registra še bolnišnični register Onkološkega inštituta, oddelek za epidemiolo- gijo, kjer tečejo epidemiološke raziskave, in na novo ustanovljeni Register organiziranega pre- sejanja za raka materničnega vratu (ZORA), kjer je tudi koordinacija državnega programa presejanja za raka materničnega vratu. Prijavljanje raka je že od ustanovitve Registra v Republiki Sloveniji obvezno in zakonsko predpi- sano (Ur. l. SRS, št. 10/50, št. 29/50, št. 14/65, št. 1/80, št. 45/82, št. 42/85; Ur. l. RS, št. 9/92 in št. 65/00). Zbrani podatki so podlaga za ocenjevanje bre- mena rakavih bolezni v državi, za načrtovanje in ocenjevanje onkološkega varstva na področju primarne in sekundarne preventive, diagnostike, zdravljenja in rehabilitacije, za načrtovanje zmogljivosti in sredstev, ki so potrebni za obvla- dovanje rakavih bolezni (osebje, medicinska oprema, posteljne zmogljivosti), ter za klinične in epidemiološke raziskave v Sloveniji in v sklopu širših mednarodnih raziskav. Populacijski register raka opravičuje svoj obstoj, če se zbrani podatki tudi redno obdelujejo, objavljajo in uporabljajo. Ena izmed stalnih oblik vračanja obdelanih informacij so letna poročila. Ker je virov informacij več, je čas, potreben za dokončanje zbirke, povezavo in objavo podat- kov pri nas in po svetu daljši, običajno 2 leti do 3. Sedanje poročilo prikazuje podatke o novih pri- merih, registriranih v letu 2002. Za osnovno infor- macijo o tem, kakšno incidenco pričakujemo leta 2005, dodajamo s posebno statistično metodo ocenjeno napoved za leto 2005. INTRODUCTION The Cancer Registry of Slovenia (Registry) is one of the oldest population-based registries in Europe. It was founded in 1950 at the Institute of Oncology in Ljubljana as a special service for collecting and processing data on cancer incidence and cancer patients’ survival. Before 1950, popula- tion-based registries existed only in Hamburg, Denmark and in Great Britain. From its foundation and until 1975, the Registry was headed by the late Professor Božena Ravnihar who was also director general of the Institute of Oncology for almost 20 years. At the Registry, she was succeeded by Professor Vera Pompe-Kirn who successfully car- ried on her work until 2003 and contributed a lot to the further development of the Registry as well as to its promotion and recognition at the national and international level. In 2003, a new Statute was adopted by the Institute that enacted the merging of the Registry and Epidemiology Unit in a single service, Epidemiology and Cancer Registry. The new service comprises, besides Cancer Registry of Slovenia, also the hospital-based Cancer Registry of the Institute of Oncology, Epidemiology Unit for epidemiologic studies and the newly esta- blished Cancer Screening Registry, a unit that is in charge of coordinating the nationally organised cervical cancer screening programme. Notification of cancer has been compulsory in Slovenia since the foundation of the Registry and is prescribed by law (Official Gazette of SRS, No. 10/50, No. 29/50, No. 14/65, No. 1/80, No. 45/82, No. 42/85; Official Gazette of RS, No. 9/92 and No. 65/00). The data collected serve as the basis for assessing the cancer burden in the country, for programming and evaluating primary prevention, diagnosis, treatment and rehabilitation, planning facilities and funding needed for cancer control (personnel, equipment and hospital capacities) as well as for clinical and epidemiological research in Slovenia and in international multicentric studies. The existence of a population-based cancer registry is justified only by regular processing, publishing and using the data collected. The Registry’s Annual Reports are one of the regular ways of dissemi- nating information. Because of a variety of data sources, data collection, their linking and publica- tion is rather time consuming (with us and else- where), and usually takes two to three years. As preliminary information on expected incidence in 2005, predicted numbers and rates are pre- sented in this report. Onkološki inštitut Ljubljana, Register raka za Slovenijo 6 Incidenca raka v Sloveniji 2002 Register je prva letna poročila izdajal že v letih 1953-57 za leta 1951-55. Prva analiza podatkov za leto 1950 je bila objavljena v Zdravstvenem vestniku leta 1951. Podatki za leta 1957-71 so bili objavljani v periodičnih publikacijah Svetovne zdravstvene organizacije Epidemiological and Vital Statistics in v World Health Statistics Report. Od leta 1965 so bili podatki spet redno objavljani v posebnih letnih poročilih z naslovom Rak v Sloveniji (1965-77) in Incidenca raka v Sloveniji (1978-2001), in sicer v slovenskem in angleškem jeziku. Za vsebino publikacije skrbi uredniški odbor, v katerem smo zbrani specialisti raznih vej onkologije. Glede na želje in pripombe uporab- nikov letna poročila iz leta v leto dopolnjujemo, vendar skrbimo tudi za to, da so objavljeni podatki iz leta v leto primerljivi. Incidenca raka je po svetu zelo različna, za raz- iskovanje teh razlik pa so ključni kakovostni podatki. Prav zato so bili in so naši podatki o incidenci raka zanimivi tudi za svet. Leta 1957 je izšlo prvo obsežnejše poročilo za leta 1950-55 v angleščini. Podatke za leta 1956-60, 1961-65, 1968-72, 1973-76, 1978-81, 1982-87, 1988-92 in 1993-97 so objavili tudi v vseh osmih zvezkih knji- ge Cancer Incidence in Five Continents, ki jo izdaja Mednarodna agencija za raziskovanje raka. Podatki o incidenci in umrljivosti za rakom so vključeni tudi v mednarodne podatkovne baze EUROCIM, GLOBOCAN, ACCIS, preživetje slovenskih bolnikov pa je obdelano v medna- rodnih študijah EUROCARE II in EUROCARE III. Zbrane podatke v Registru obdelujemo in pojas- njujemo v skladu s trenutno perečo problema- tiko v Sloveniji, z lastnim raziskovalnim programom in s predlogi uporabnikov. Izsledke objavljamo v člankih v domačem in tujem strokovnem in poljudnem tisku. Med najpomembnejšimi so tri knjige: Zemljevidi incidence raka v Sloveniji 1978-1987, Preživetje bolnikov z rakom v Sloveniji 1963-1990 in Preživetje bolnikov z rakom v Sloveniji 1983-1997. Seznam drugih pomembnej- ših del, objavljenih v zadnjih petih letih, je v dodatku na koncu poročila. Letošnje poročilo je v celoti dostopno v elek- tronski obliki na začasni spletni strani http://www2.arnes.si/~m01vzadnik/, v kratkem pa bo tudi na prenovljeni spletni strani Onkološkega inštituta http://www.onko-i.si. The first annual reports of the Registry for the period 1951-55 were issued during the years 1953-57. The first data analysis for the year 1950 was published in Zdravstveni vestnik in 1951. The data for the period 1957-71 were appearing in the periodicals Epidemiological and Vital Statistics Report and World Health Statistics Report, both edited by World Health Organization. From 1965 onwards, the data have been appearing regularly in special bilingual (Slovene-English) annual reports, first entitled Cancer in Slovenia (1965-77), and then Cancer Incidence in Slovenia (1978-2000). The editorial board, responsible for the contents of the report, consists of experts of different specialties in oncology. Our endeavours have always been directed towards further improvement of these publications, by taking into account as much the requests and comments of the users as the comparability of the data from year to year. There are great differences in cancer incidence among different populations and to evaluate them, good quality data are needed from dif- ferent parts of the world. That is why our data on cancer incidence have always been interesting also for professional public abroad. In 1957, the first comprehensive report, covering the period 1950-55, was issued in English under the title Cancer in Slovenia 1955. The data for the periods 1956-60, 1961-65, 1968-72, 1973-76, 1978-81, 1982-87, 1988-92 and 1993-97 were published in all eight volumes of the Cancer Incidence in Five Continents issued by International Agency for Research on Cancer. The data on cancer incidence and mor- tality for the years 1983-99 were also included in international databases EUROCIM, GLOBOCAN, ACCIS. The survival of Slovenian cancer patients is included into and analysed by the interna- tional studies EUROCARE II and EUROCARE III. The data collected have been processed in accor- dance with the current problems in Slovenia, as well as with respect to our research program and suggestions from our users. These data are published in national and foreign medical litera- ture and as publications for lay readers. Among the most important are three special publica- tions: Atlas of Cancer Incidence in Slovenia 1978-1987, Cancer Patients’ Survival in Slovenia 1963-1990 and Cancer Patients’ Survival in Slovenia 1983-1997. The list of other relevant publications is at the end of this report. The current annual report is available in pdf format on the temporary website http://www2.arnes.si/~m01vzadnik/, but soon it will be available on the renewed website of the Institute of Oncology: http://www.onko-i.si. Institute of Oncology Ljubljana, Cancer Registry of Slovenia Cancer Incidence in Slovenia 2002 7 GRADIVO IN METODE Osnovni vir podatkov so prijavnice rakave bolez- ni. Registru jih pošiljajo iz vseh bolnišnic in diagno- stičnih centrov v Sloveniji, iz ordinacij osnovnega zdravstvenega varstva pa le izjemoma, če bolnik ni napoten na nadaljnje preiskave in/ali zdravljenje. Dodatni vir podatkov so zdravniška poročila o vzroku smrti in obdukcijski zapisniki z diagnozo maligne bolezni. Zbiranje podatkov za to letno poročilo smo zaključili 28. februarja 2005. Zanesljivost podatkov osvetljujeta dva kazalca: odstotni delež raka, registriranega samo iz zdravniških poročil o vzroku smrti (tabela 3), in odstotni delež mikroskopsko (histološko ali cito- loško) potrjenih primerov (tabela 7). Majhen delež primerov, prijavljenih po izdaji letnega poročila v raznih časovnih obdobjih, kaže, da do izdaje poročila registriramo večino novih pri- merov raka. Ta delež je stabilen in kaže na popolnost podatkov (tabela C). Od leta 1993 je obvezno prijavljanje sprememb materničnega vratu, označenih kot CIN III (šifra 219 po 8. reviziji MKB), dotlej pa so se registrirale le spremembe, označene v tabelah s šifro 234.0 (karcinom in situ). Primerjava s podatki za obdobje 1961-92 tako ni možna. Po 10. reviziji MKB so vse intraepiteljiske spremembe mater- ničnega vratu uvrščene v šifro D06. Od leta 1995 registriramo tudi prijavljene intraepitelijske karci- nome mehurja in maligne melanome Clark I. Za razvrščanje neoplazem po lokacijah Register od leta 1997 uporablja 10. revizijo Mednarodne klasifikacije bolezni, poškodb in vzrokov smrti, do takrat pa je uporabljal osmo. Za vse, ki želijo primerjati podatke iz prejšnjih poročil, je dodana tabela 4b. Klasifikaciji različno uvrščata bolezni med maligne, zato število novih primerov raka po obeh klasifikacijah ni enako. Prav pri uvrščanju med maligne bolezni je treba opozoriti še na klasifikacijo za morfologijo neo- plazem, za katero uporabljamo morfološki del Mednarodne klasifikacije bolezni za onkologijo, od poročila za leto 2001 tretjo izdajo. V tej izdaji je spet nekaj sprememb, tudi katere histološke vrste sodijo med maligne. Po tretji reviziji so med maligne uvrščene kronične mieloproliferativne bolezni in mielodisplastični sindromi (sedaj v topografski šifri C96.7). V skladu z novimi pravili tudi mejno malignih ovarijskih tumorjev ne uvr- ščamo več v kategorijo C56, pač pa v D39.1. MATERIAL AND METHODS The main sources of data are notifications gath- ered from all hospitals and diagnostic centres in Slovenia, exceptionally also from primary health care centres in case the patient was not referred for further diagnostic investigations. This information is completed by death certificates and autopsy protocols stating cancer diagnosis. The collection of data for the current report was completed on February 28, 2005. The reliability of information can be assessed by two parameters: the percentage of cancer cases registered solely on the basis of death certificates (Table 3), and by the percentage of microscopi- cally (histologically or cytologically) confirmed cases (Table 7). The small and stable proportion of cases registered after the publication of annual reports shows that the majority of cases are reported to the Registry by the time of the publication of annual reports and that the registration is com- plete (Table C). In 1993, compulsory registration of all cervical intraepithelial dysplasias classified as CIN III was introduced (code 219 according to ICD-8). Till then, only carcinoma in situ (code 234.0) was registered. Thus, the comparison with the data for the peri- od 1961-92 is not possible. According to ICD-10, all cervical intraepithelial neoplasms (in situ and CIN III) are coded as D06. Since 1995, the number of all reported intraepithelial carcinomas of the bladder and all malignant melanomas Clark I have been registered. Since 1997, cancer sites are coded according to the 10th revision of the International Statistical Classification of Diseases and Related health Problems (ICD-10); before, the 8th revision was used (ICD-8). As in earlier reports, Table 4b contains also the data coded according to the 8th revision in order to allow the comparison with the earlier reports. There are differences in coding neoplasms as malignant or benign according to both classi- fications, so, according to the two classifications, the number of new cancer cases is not equal. When classifying tumours as malignant, the beha- viour digit of the morphology code of the third edi- tion of International Classification of Diseases for Oncology is used in the current annual report. In this edition, some changes were introduced in terms of morphology and behaviour code. According to this classification, chronic myeloproliferative Onkološki inštitut Ljubljana, Register raka za Slovenijo 8 Incidenca raka v Sloveniji 2002 Opozarjamo še, da so v tabeli 8 histološke vrste razvrščene po tretji reviziji morfološkega dela Mednarodne klasifikacije bolezni za onkologijo in združene v drugačne skupine kot v poročilih za leto 2000 in leta pred njim. V tabeli 6 smo doslej prikazovali podatke po devetih zdravstvenih regijah. V skladu z Uredbo o standardni klasifikaciji teritorialnih enot - SKTE, ki predpisuje sistematiko členitve ozemlja Slovenije na enajstih ravneh, smo se odločili, da v tej tabeli in zemljevidih uporabimo raven SKTE-3, 12 statističnih regij. Po potrebi pa podatke lahko še vedno posredujemo do ravni upravnih enot. Za napoved incidence v letu 2005 je uporabljena metoda po Dybi in Hakulinenu, ki je primerna za oceno incidence v krajšem časovnem obdo- bju, saj upošteva samo obdobje diagnoze in starost; pri napovedih za daljša časovna obdo- bja je treba upoštevati tudi vpliv rojstne kohorte. DEFINICIJE Incidenca pomeni število vseh v enem koledar- skem letu na novo ugotovljenih primerov raka v točno določeni populaciji. V incidenco ne šte- jemo novih primarnih rakov parnega organa iste lokacije, če je bila histološka vrsta obeh rakov, npr. leve in desne dojke, enaka. Prav tako v incidenco ne štejemo novega pojava raka iste histološke vrste na istem organu, npr. multi- ple lezije v debelem črevesu. V incidenco so vključeni primeri bolezni bolnikov s stalnim biva- liščem na območju Republike Slovenije, ne glede na to, kje so bili ti bolniki zdravljeni. Prevalenca je število vseh živih bolnikov z rakom na določen datum ne glede na leto diagnoze. Groba incidenčna stopnja je število novih pri- merov na 100.000 oseb opazovane populacije, starostno specifična stopnja pove to relativno število v posamezni petletni starostni skupini. Če analiziramo incidenco v daljšem časovnem obdobju (če se starostna struktura prebivalstva v času spreminja) ali če primerjamo incidenco med populacijami z drugačno starostno struk- turo, je treba uporabiti eno od metod starostne standardizacije. Starostno standardizirana stopnja je teoretična incidenčna stopnja, pri kateri predpostavimo, da je starostna struktura opazovane populacije enaka starostni strukturi v standardni populaciji. V tabeli 6b je za primer- disorders and myelodisplastic syndromes are classified as malignant (topography code C96.7), while ovarian tumours of borderline malignancy are currently coded as D39.1 (and not C56). It should be noted that in Table 8 the morphology codes are grouped in new categories and are adapted to the third revision of morphology part of International Classification of Diseases for Oncology. Till this report, the data in Table 6 have been pre- sented by 9 health regions. The new law on regional division of Slovenia introduced the system of eleven levels, and health regions are not official units. So, 12 statistical regions have been chosen to present the data in Table 6 and on the maps. The method by Dyba and Hakulinen was used for predictions. It is suitable for predictions in shorter time period, taking into account period of diagnosis and age structure of population. For long-term predictions the cohort effect should be included also. DEFINITIONS Incidence is the number of newly diagnosed cancer cases in a defined population, reported to the Registry for a given calendar year. New primary cancers of the same histology in paired organs, e.g. of the left and right breast, are not comprised in the incidence figures, neither are any new cancers of the same histology appearing in the same organ, e.g. multiple lesions of the colon. The incidence includes only the data on patients with permanent residence in Slovenia, regardless of the place of treatment. Prevalence is the number of all surviving cancer patients, irrespective of the year of diagnosis. Crude incidence rate is the number of new cases per 100,000 population, while the age specific rate expresses relative number in an individual five-year age group. When analysing the incidence rate within longer time period (if the age structure of population changes) or comparing the incidence between populations with different age structure, age standardisation is needed to adjust the rate for the effect of age. The age-standardised rate is a theoretical incidence rate assuming that the age structure in the observed population is the same as in the standard population. In Table 6b, Institute of Oncology Ljubljana, Cancer Registry of Slovenia Cancer Incidence in Slovenia 2002 9 javo incidenčnih stopenj med slovenskimi stati- stičnimi regijami uporabljena neposredna metoda starostne standardizacije; standard je starostna struktura prebivalcev Slovenije ob popisu leta 2002. Kumulativna incidenčna stopnja (v zadnjem stolpcu tabele 5) je petkratna vsota starostno specifičnih incidenc na 100 prebivalcev posa- meznih petletnih starostnih skupin do 74. leta starosti. Je neposredna, na dejansko populacijo posamezne petletne starostne skupine standar- dizirana incidenca ali približek kumulativnemu tveganju. Kumulativno tveganje je verjetnost posameznika, da zboli za rakom v izbranem starostnem obdobju, npr. do 74. leta starosti (če, seveda, ne umre prej zaradi drugih vzrokov). Kumulativno stopnjo računamo na 100 prebi- valcev in jo izražamo v odstotkih. Kumulativna stopnja (0-74) raka dojk pri ženskah 7/100 pome- ni, npr., da bo verjetno 7 % deklic, rojenih leta 2002 (ali ena od 14) do 75. leta starosti zbolelo za rakom dojk. Kumulativno incidenčno stopnjo smo uporabili za prikaz časovnega trenda incidence, kot je za Slovenijo prikazan na spodnjem delu slike 4. Primerjava oblike krivulj grobih in kumulativnih stopenj na sliki 4 kaže, da povečevanja inci- dence raka ne moremo pripisati le staranju prebivalstva RS, ampak da k temu prispevajo še drugi nevarnostni dejavniki. Kumulativne stopnje smo uporabili tudi pri zemljevidih. POJASNILA Tabeli A in B in slika 1 prikazujejo osnovne podatke o bremenu raka v Sloveniji: število vseh zbolelih in umrlih za rakom v letu 2002, prevalen- co in najpogostejše rakave bolezni po spolu. Slika 2 opozarja na različno breme raka v raz- nih življenjskih obdobjih; rak je skoraj izjema pri mladih do 19 let. Manj kot 3 % vseh rakov je med 20. in 34. letom starosti, ko je pri moških naj- pogostejši rak mod, pri ženskah pa rak mater- ničnega vratu. Pljučni rak pri moških in rak dojk pri ženskah sta na prvem mestu od 35. leta sta- rosti, več kot tri četrtine vseh rakov pa je pri bol- nikih, starejših od 50 let. Na sliki 3 je prikazan odstotni delež, za katere- ga posamezne statistične regije odstopajo od slovenskega povprečja. Med najbolj obremenje- direct age standardisation with Slovenian pop- ulation from the 2002 census as standard is used for the comparison of incidence rates between health regions, controlling for differences in their age composition. The cumulative incidence rate (the last column in Table 5) is five times the sum of the age-specific incidence rates per 100 population, calculated over five-year age groups up to the age of 74 years. It is a directly age-standardized rate with the same population size in each age group, or as an approximation to the cumulative risk. The cumulative risk is the risk an individual would have of developing the disease in question during a certain age period if no other causes of death were in operation. The cumulative rate is expressed per hundred (per cent). Thus, the cumulative rate (0-74) of 7/100 for breast cancer in females means that 7% of women (every l4th woman) are expect- ed to develop breast cancer by their age of 75. The cumulative rate was used to present the incidence time trend in the lower part of Figure 4. The comparison of the curves of crude incidence per 100,000 population and cumulative incidence rates in Figure 4 indicates that the increasing cancer incidence rate in both sexes cannot be attributed only to the aging of population, but also to additional risk factors. Cumulative rate is used also in cancer maps. COMMENTS Tables A and B and Figure 1 present the data on cancer burden in Slovenia: the number of new, deceased and prevalent cancer patients in 2002 and the most frequent cancer sites by sex. Figure 2 points to the different proportion of cancer in different age groups; up to the age of 19, cancer is more an exception. Less than 3% of all cancers develop in the age group of 20-34 years, in which the most frequent is testicular cancer in males and cervical cancer in females. The lung in males and the breast in females are the most frequent cancer sites after the age of 35; more than three quarters of all cancers develop after the age of 50. In Figure 3, the percentage deviation of crude incidence rate in 12 statistical regions from Slovenian average incidence rate is presented. The highest incidence rates are in the Osrednjeslovenska, Onkološki inštitut Ljubljana, Register raka za Slovenijo 10 Incidenca raka v Sloveniji 2002 nimi izstopajo Osrednjeslovenska, Gorenjska in Obalno-kraška statistična regija. Ti podatki so pomembni za načrtovanje zdravstvenih zmog- ljivosti. Starostno standardizirane incidenčne stopnje (tabela 6b) pa kažejo, da je pretežni del razlik med regijami posledica različne sta- rostne strukture njihovih prebivalcev. Sliki 4 in 5 kažeta trende incidence vseh in izbra- nih rakov po spolu. Pri grafičnih prikazih so v eno skupino združeni rak debelega črevesa in danke in v drugo rak ust, žrela in grla (glava in vrat). Na slikah 6 do 10 začenjamo prvi krog objav zemljevidov incidence raka po statističnih regi- jah. Tokrat poleg zemljevidov grobe in kumula- tivne incidenčne stopnje po spolu za pljučnega raka, raka debelega črevesa, danke, dojke pri ženskah in materničnega vratu v letih 1997-2002 prikazujemo še trend incidence po stadijih ob diagnozi in starostno specifično incidenco. Tabele prikazujejo podatke o prebivalcih in inci- denci raka v Sloveniji leta 2002 po spolu, starosti, lokaciji, histološki vrsti in stadiju bolezni ob diagnozi, o incidenci po statističnih regijah ter podatke o številu novih primerov raka, ugotovljenih v tem letu po posameznih bolnišnicah, število smrti za rakom po spolu, starosti in lokaciji ter prevalenco najpogostejših rakov. Iz tabel 3, 4a, 7 in 8 je mogoče povzeti, da je bilo leta 2002 na novo registriranih 9.356 primerov raka, 134 (1 %) samo na osnovi zdravniškega poročila o vzroku smrti (tabela 3). Ta delež, ki je že več let podoben, kaže bolnike, ki verjetno zaradi starosti ali napredovale bolezni niso bili zdravljeni v bolnišnici. Od 9.222 bolnikov, ki so jim diagnozo postavili v bolnišnicah ali diagnostič- nih centrih, je bila pri 8.597 (93 %) bolezen potr- jena mikroskopsko (tabela 7). Kakšna je bila morfološka slika malignomov, kaže tabela 8. V njej so posebej primeri, ki so potrjeni histološko (91 %), in tisti, ki so bili potrjeni samo citološko (9 %). Po 8. reviziji MKB, po kateri so raki razvrščeni v tabeli 4b, je novih primerov raka 9.294. Razlika za 62 primerov je posledica novega razvrščanja neo- plazem glede na tretjo izdajo morfološkega dela Mednarodne klasifikacije bolezni za onkologijo. Tabela 5 prikazuje grobo in starostno specifično incidenčno stopnjo na 100.000 prebivalcev ter kumulativno stopnjo na 100. Število vseh novih primerov raka iz leta 2002 je preračunano na število prebivalcev R Slovenije na dan 30. junija 2002. Gorenjska and Obalno-kraška statistical region. While these data are important for planning health care facilities, the age standardised rates in Table 6b indicate that the majority of these dif- ferences are due to different age structure of population in these regions. Figures 4 and 5 show the incidence trends for all and selected cancers by sex. In graphical presentations, colon and rectal cancers are grouped in one category as colorectal, as well as oral, pharyngeal and laryngeal cancers as head and neck cancers. In Figures 6-10, the first cycle of new maps on can- cer incidence by statistical regions is presented. Along with the maps on crude and cumulative rates of lung, colon, rectal, breast in females and cervical cancer in the years 1998-2002, trends in incidence by stage, and age specific rates are presented. Tables show the data on population and on cancer incidence in Slovenia in 2002 by sex, age, primary site, histology, stage of the disease at diagnosis, on the incidence in the individual statistical regions, and on new cancer cases diagnosed in the current year in different hospi- tals in Slovenia, on deaths and on prevalence of most frequent cancer sites. Tables 3, 4a, 7 and 8 show that, in the year 2002, 9,356 new cancer cases were registered, 134 (1%) from death certificates only (Table 3). This percentage has been similar for several years and represents those patients that, due to advanced age or diseas, have not been treated in the hospital. From 9,222 cases, diagnosed in hospitals or diagnostic centres, 8,597 (93%) diag- noses were confirmed microscopically (Table 7). The morphology of tumours is presented in Table 8, where histologically verified cases (91%) are presented separately from those con- firmed by cytology only (9%). In Table 4b, the diagnoses are coded according to the 8th revision of International Classification of Diseases. According to this classification, 9,294 new cancer cases were detected. The dif- ference of 62 cases is due to new morphology classification of the third revision of International Classification of Diseases for Oncology. Table 5 shows crude and age specific incidence rate per 100,000 population and cumulative rate per 100. For calculation of crude rate, the Slovenian population census on June 30, 2002 was used. Institute of Oncology Ljubljana, Cancer Registry of Slovenia Cancer Incidence in Slovenia 2002 11 V tabeli 6a je število novih primerov vseh in izbranih rakov prikazano po statističnih regijah. Te številke so pomembne za načrtovanje zdravstvenih zmogljivosti. V tabeli 6b starostno standardizirana incidenca kaže, da so razlike med regijami tudi posledica različnega deleža starejših. Tabela 9 kaže starostno porazdelitev ekstrano- dalnih in nodalnih lokacij ne-Hodgkinovih malig- nih limfomov. Ker je število ekstranodalnih lokacij majhno, so prikazane le absolutne številke. Iz tabele 10 je razvidno, kje vse bolnikom posta- vijo diagnozo. Tako kot že vrsto let, polovica od vseh bolnikov z rakom, ki jim diagnozo postavijo v slovenskih bolnišnicah ali jih tam tudi začnejo zdraviti, v nadaljnjem poteku bolezni pride na posvet ali na zdravljenje na Onkološki inštitut. Tabela 11 prikazuje porazdelitev bolnikov po stadiju, v katerem je bila bolezen odkrita. Upo- rabljena je poenostavljena opredelitev stadijev, ki upošteva vse preiskovalne metode, vključno operacijo; če bolnik ni bil poprej zdravljen, tudi obdukcijo. Uporabljamo in navajamo jo zato, ker so podatki o stadiju bolezni po klasifikaciji TNM na prijavnicah pogosto pomanjkljivi. Poenostavljena opredelitev stadijev pri solidnih tumorjih praviloma sledi klasifikaciji TNM. V omejeni stadij je razvrščena bolezen, kjer je tumor označen kot T1 in T2 (razen pri dojki, malignem melanomu in ščitnici, kjer so vključeni tudi tumorji T3, in materničnem vratu, telesu in pri sarkomih, kjer so vključeni le tumorji T1) in pri kateri niso prizadete regionarne bezgavke in ni zasevkov v oddaljenih organih (N0, M0). V stadi- ju regionarne razširitve je bolezen, kjer je tumor opredeljen kot T3 in T4 (razen v omenjenih izje- mah) in/ali so prizadete tudi regionarne bez- gavke (N1), zasevkov v oddaljenih bezgavkah in organih pa ni (M0). V stadiju oddaljene raz- širitve pa je tista bolezen, pri kateri so zasevki že v oddaljenih bezgavkah ali organih (M1). Maligni limfomi so opredeljeni po klasifikaciji Ann-Arbor. V tabeli 12 so uradni podatki o umrljivosti za rakom. Tabelo so pripravili na Inštitutu za varo- vanje zdravja RS. Tabela 13 prikazuje prevalenco vseh in pogo- stejših rakov na dan 31. 12. 2002. In Table 6a, the number of new cases of all and selected cancer sites by statistical regions is presented. These numbers are important for planning health care facilities. The age stan- dardised rates in Table 6b indicate that the majority of differences are due to different age structure of population in these regions. Age distribution of extranodal and nodal sites of non-Hodgkin malignant lymphomas is present- ed in Table 9. Owing to a small number of extra- nodal sites, only the absolute numbers are given. From Table 10 it is evident in which hospitals cancer cases are diagnosed. Observations of many years show that half of the patients diag- nosed or initially treated in regional hospitals are later on referred to the Institute of Oncology Ljubljana. A simplified definition of stages at diagnosis is presented in Table 11. The simplified definition is based on all investigation methods, including surgery. In case the patient was not treated before death, the autopsy record is considered as well. The simplified stage definition is used because, in cancer notification forms, the data on stage according to TNM Classification System are often lacking. However, in solid tumours, the simplified stage definition often follows the TNM Classification. Localised stage includes all can- cers where the tumour has been classified as T1 and T2 (except in breast, malignant melanoma and thyroid cancer, where T3 is also included, and uterine cervix, uterine corpus and sarco- mas, where T1 only is included), where neither regional node involvement nor distant metas- tases are found (N0, MO). The regional stage includes tumours classified as T3 and T4 (excep- tions already mentioned) and/or regional node metastases (N1), if no metastases in distant lymph nodes or organs (MO) are found. The disease with metastases in distant nodes or organs is classi- fied as the remote stage (M1). Malignant lym- phomas are classified according to AnnArbor System. Official data on cancer mortality are given in Table 12. The table has been prepared at the Institute of Public Health of the Republic of Slovenia. Data on prevalence of all and most frequent cancers are presented in Table 13. Onkološki inštitut Ljubljana, Register raka za Slovenijo 12 Incidenca raka v Sloveniji 2002 ZAHVALA Zdravniki, medicinske sestre in administrativno osebje iz slovenskih bolnišnic in drugih zdrav- stvenih ustanov so Registru pošiljali prijavnice s podatki o novih bolnikih z rakom in o njihovi nadaljnji usodi ter nam pomagali dopolnjevati prijave z manjkajočimi informacijami. Vsaj polovico podatkov, obdelanih v tem poro- čilu, sta prispevali sodelavki Bolnišničnega regi- stra Onkološkega inštituta v Ljubljani Ana Dotzauer in Maruška Ferjančič. Naše delo bi bilo bistveno težje brez dolgolet- nega sodelovanja s Centralnim registrom pre- bivalstva RS, z Inštitutom za varovanje zdravja RS in Statističnim uradom RS. Vsem imenovanim in tudi drugim, ki so kakorkoli prispevali, da smo lahko prikazali rezultate naše- ga dela v tem poročilu, se najlepše zahvalju- jemo. Uredniški odbor ACKNOWLEDGEMENT Physicians, nurses, and administrative staff from Slovenian hospitals and other health institutions have provided the data on new cancer patients and their medical history as well as helped us in obtaining additional information when needed. Our co-workers at the Hospital Registry of the Institute of Oncology, Mrs. Ana Dotzauer and Maruška Ferjančič, have contributed at least a half of the information presented in this report. The long-term collaboration with the Population Registry of the Republic of Slovenia, the Institute of Public Health of the Republic of Slovenia and the Statistical Office of the Republic of Slovenia is indispensable for our work. We thank all of them as well as all others who have helped to present the results of our work in this report. Editors Cancer Incidence in Slovenia 2002 13 Institute of Oncology Ljubljana, Cancer Registry of Slovenia REFERENCE / References - Ravnihar B, Gruden I. Statističen pregled in kratka analiza prijavljenih rakovnih obolenj iz področja LRS za leto 1950. Zdrav Vestn 1951; 20: 264-77. - Epidemiological and Vital Statistics Report. Geneva: World Health Organization, 1961-1966. - World Health Statistics Report. Geneva: World Health Organization, 1970-1974. - Rak v Sloveniji (1965-77). Ljubljana: Onkološki inštitut, Register raka za Slovenijo, 1967-1980. - Incidenca raka v Sloveniji (1978-2001). Ljubljana: Onkološki inštitut, Register raka za Slovenijo, 1981-2004. - Doll R, Payne P, Waterhouse J, eds. Cancer inciden- ce in five continents. Vol 1. Berlin: Springer, 1966. - Doll R, Muir C, Waterhouse J, eds. Cancer incidence in five continents. Vol 2. Lyon: International Agency for Research on Cancer, 1970. - Waterhouse J, Muir C, Correa C, Powell J, eds. Cancer incidence in five continents. Vol 3. Lyon: International Agency for Research on Cancer, 1976 (IARC Sci Publ 15). - Waterhouse J, Muir C, Shanmugaratnam K, Powell J, eds. Cancer incidence in five continents. Vol 4. Lyon: International Agency for Research on Cancer, 1982 (IARC Sci Publ 42). - Muir C, Waterhouse J, Mack T, Powell J, Whelan S, eds. Cancer incidence in five continents. Vol 5. Lyon: International Agency for Research on Cancer, 1987 (IARC Sci Publ 88). - Parkin DM, Muir C, Whelan S, Gao Y, Ferlay J, Powell J, eds. Cancer incidence in five continents. Vol 6. Lyon: International Agency for Research on Cancer, 1992 (IARC Sci Publ 120). - Parkin DM, Whelan S, Ferlay J, Raymond L, Young J, eds. Cancer incidence in five continents. Vol 7. Lyon: International Agency for Research on Cancer, 1997 (IARC Sci Publ 143). - Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB, eds. Cancer incidence in five continents. Vol 8. Lyon: International Agency for Research on Cancer, 2002 (IARC Sci Publ 155). - European Network of Cancer Registries. EUROCIM version 4.0. European incidence database V2.4, ICD-10 dictionary (2003), Lyon 2001. - Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002. Cancer incidence, mortality and prevalence worldwide. IARC CancerBase No. 5, version 2.0. Lyon: IARC Press, 2004. - Šteliarova-Foucher E, Berrino F, Coebergh JW et al. ACCISpass 1.01 software for analysis and presen- tation of data on incidence and survival of chil- dren and adolescents in Europe. Lyon: ENCR, 2002. - Berrino F, Capocaccia R, Esteve J et al, eds. Survival of cancer patients in Europe: the EUROCARE-2 study. Lyon: International Agency for Research on Cancer, 1999. - Berrino F, Capocaccia R, Gatta G et al, eds. Survival of cancer patients in Europe: the EURO- CARE-3 study. Ann Oncol 2003: 14 (Suppl 5). - Pompe-Kirn V, Primic Žakelj M, Ferligoj A, Škrk J. Zemljevidi incidence raka v Sloveniji 1978-1987 (Atlas of Cancer Incidence in Slovenia 1978-1987). Ljubljana: Onkološki inštitut, Register raka za Slovenijo, 1992. - Pompe-Kirn V, Zakotnik B, Benulič T, Volk N, Škrk J. Preživetje bolnikov z rakom v Sloveniji 1963-1990 (Cancer Patients’ Survival in Slovenia 1963-1990). Ljubljana: Onkološki inštitut, Register raka za Slovenijo, 1995. - Pompe-Kirn V, Zakotnik B, Zadnik V. Preživetje bolni- kov z rakom v Sloveniji 1983-1997 (Cancer Patients’ Survival in Slovenia 1983-1997). Ljubljana: Onkološki inštitut, Register raka za Slovenijo, 2003. - Savezni zavod za zdravstvenu zaštitu. Međunarodna klasifikacija bolesti, povreda i uzroka smrti. 8. revizija. Novi sad: Savezni zavod za zdravstvenu zaštitu, 1970. - Inštitut za varovanje zdravja RS. Mednarodna kla- sifikacija bolezni in sorodnih zdravstvenih proble- mov za statistične namene. 10. revizija (International Statistical Classification of Diseases and Related Health Problems). Ljubljana: Inštitut za varovanje zdravja, 1995. - World Health Organisation. International Calssification of Diseases for Oncology. Geneva: World Health Organisation, 2000. - Uredba o standardni klasifikaciji teritorialnih enot – SKTE. Ur. l. RS št. 28/2000. - Moller B, Fekjaer H, Hakulinen T et al. Prediction of cancer incidence in the Nordic countries: empiri- cal comparison of different approaches. Stat Med 2003; 15: 2751-66. - Jensen OM, Parkin M, Maclennan R et al, eds. Cancer registration principles and methods. Lyon: International Agency for Research on Cancer, 1991 (IARC Sci Publ 95). - Statistični letopis Republike Slovenije 2003. Ljubljana: Statistični urad Republike Slovenije, 2004. Onkološki inštitut Ljubljana, Register raka za Slovenijo 14 Incidenca raka v Sloveniji 2002 Tabela A. Breme raka - Slovenija 2002 Table A. Cancer burden - Slovenia 2002 Tabela B. Prevalenca glede na obdobje opazovanja - Slovenija, 31. 12. 2002 Table B. Prevalence by period of observation - Slovenia, December 31, 2002 Skupaj Moški Ženske Total Males Females Incidenca 9356 4689 4667Incidence Umrljivost 4978 2809 2169Mortality Prevalenca 53858 20846 33012Prevalence Od tega izgubljenih Lost to follow-up Obdobje Število bolnikov Število Odstotek Period Number of patients Number Percentage 1950-2002 53858 2428 4,5 1963-2002 52356 1388 2,7 1973-2002 50419 955 1,9 1983-2002 45734 403 0,9 1993-2002 35234 99 0,3 Tabela C. Stabilnost podatkov - število in odstotek novih primerov raka, prijavljenih po izdaji letnega poročila, po obdobju - Slovenija, 1965-2001 Table C. Data stability - number and percentage of new cases reported after the publication of annual reports, by time period - Slovenia, 1965 -2001 Naknadno prijavljeni Subsequently registered Obdobje Letno poročilo 28. 2. 2005 Število Odstotek Period Annual report February 28, 2005 Number Percentage 1965-68 14696 14849 153 1,0 1969-72 15719 16171 452 2,9 1973-76 17711 18275 564 3,2 1977-80 19176 19896 720 3,8 1981-84 20701 21417 716 3,5 1985-88 22715 23374 659 2,9 1989-92 25973 26683 710 2,7 1993-96 29141 30333 1192 4,1 1997-00 33859 35068 1209 3,6 2001 9058 9378 320 3,5 Institute of Oncology Ljubljana, Cancer Registry of Slovenia Cancer Incidence in Slovenia 2002 15 Tabela D. Opazovana in napovedana incidenca raka v Sloveniji v obdobju 1993-2005 Table D. Observed and predicted cancer incidence in Slovenia in the period 1993-2005 Šifra Primarna Povprečne opazovane Povprečne opazovane Napovedane vrednosti MKB lokacija vrednosti 1993-1997 vrednosti 1998-2002 za 2005 Spol Število Incidenčna Število Incidenčna Število Incidenčna stopnja stopnja stopnja na 100.000 na 100.000 na 100.000 ICD Primary Sex Average observed Average observed Predicted values code site values 1993-1997 values 1998-2002 for 2005 Number Incidence rate Number Incidence rate Number Incidence rate per 100,000 per 100,000 per 100,000 Skupaj 7750 390,4 9020 453,7 9706 486,1 C00 Vse lokacije Total – Moški 3936 409,2 4563 471,6 4939 505,5 C96 All sites MaleŽenske 3813 372,8 4457 436,8 4767 467,4Female C00 Usta in žrelo M 271 28,0 260 26,8 267 27,3 -C14 Mouth and pharynx Ž 41 4,0 55 5,5 59 5,7 C15 Požiralnik M 78 8,1 73 7,6 81 8,2Oesophagus Ž 13 1,3 19 1,8 20 1,9 C16 Želodec M 299 31,1 290 30,0 305 31,2Stomach Ž 203 19,9 185 18,2 194 19,0 C18 Debelo črevo M 229 23,8 326 33,7 357 36,5Colon Ž 232 22,6 273 26,7 301 29,5 Rektum in rektosigmoidna C19 zveza M 239 24,8 280 29,0 307 31,4 -C20 Rectum and Ž 195 19,1 206 20,2 229 22,4 rectosigmoid junction C22 Jetra in intrahepatični vodi M 60 6,3 80 8,2 87 8,9Liver and intrahepatic bile ducts Ž 38 3,7 34 3,3 38 3,7 C23 Žolčnik in žolčevodi M 41 4,3 49 5,0 54 5,5 -C24 Gallbladder and billiary tract Ž 74 7,3 81 8,0 87 8,5 C25 Trebušna slinavka M 91 9,5 110 11,4 130 13,3Pancreas Ž 102 10,0 117 11,5 132 12,9 C32 Grlo M 96 10,0 102 10,5 113 11,6Larynx Ž 10 0,9 12 1,2 14 1,4 C33 Sapnik, sapnici in pljuča M 819 85,2 800 82,7 848 86,7 -C34 Trachea, bronchus and lung Ž 176 17,2 240 23,5 269 26,4 C43 Maligni melanom kože M 85 8,8 115 11,9 126 12,9Malignant melanoma of skin Ž 99 9,7 135 13,2 141 13,8 C44 Druge maligne neoplazme kože M 377 39,1 560 57,9 625 64,0Skin, other malignomas Ž 441 43,1 631 61,8 704 69,0 C48 Vezivno in mehko tkivo M 19 2,0 26 2,7 30 3,0 -C49 Connective and soft tissue Ž 23 2,3 26 2,6 27 2,7 C50 Dojka M 8 0,8 9 0,9 11 1,1Breast Ž 809 79,1 977 95,8 1020 100,0 C53 Maternični vrat M – – – – – –Cervix uteri Ž 202 19,7 201 19,7 201 19,7 C54 Maternično telo M – – – – – –Corpus uteri Ž 247 24,1 279 27,3 296 29,1 C56 Jajčnik M – – – – – –Ovary Ž 172 16,8 178 17,5 185 18,1 C61 Prostata M 355 36,9 518 53,5 595 60,8Prostate Ž – – – – – – C62 Modo M 65 6,8 82 8,5 88 9,0Testis Ž – – – – – – C64 Ledvica z ledvičnim mehom M 110 11,5 132 13,6 138 14,1 -C65 Kidney with renal pelvis Ž 79 7,7 76 7,4 74 7,2 C67 Sečni mehur M 143 14,9 147 15,2 162 16,5Bladder Ž 54 5,2 48 4,7 56 5,5 C70 Centralni in avtonomni živčni sistem M 54 5,6 68 6,9 70 7,2 -C72 Central and autonomic Ž 47 4,6 54 5,3 62 6,1 nervous system C73 Ščitnica M 16 1,6 23 2,4 26 2,6Thyroid gland Ž 51 5,0 68 6,6 68 6,7 C81 Hodgkinova bolezen M 22 2,3 19 2,0 21 2,1Hodgkin's disease Ž 19 1,8 22 2,2 23 2,2 C82 ne-Hodgkinovi limfomi M 89 9,2 107 11,0 119 12,1 -C85 non-Hodgkin's lymphoma Ž 94 9,2 110 10,7 125 12,2 Difuzni plazmocitom in maligne neoplazme plazmocitov M 30 3,2 34 3,5 33 3,4C90 Multiple myeloma and Ž 36 3,6 44 4,3 47 4,6 malignant plasma cell neoplasms C91 Levkemije M 98 10,2 98 10,2 105 10,7 -C95 Leukaemias Ž 74 7,2 85 8,3 51 5,0 Onkološki inštitut Ljubljana, Register raka za Slovenijo 16 Incidenca raka v Sloveniji 2002 MOŠKI - MALES 0 5 10 15 20 25 % Pljuča Debelo črevo in danka* Prostata Glava in vrat* Želodec Mehur Maligni melanom Ostalo L NHL* edvica Koža, drugo Lung Colorectum* Prostate Head and neck* Stomach Bladder Melanoma Other Kidney NHL* Skin, other 16,8 20,4 14,2 2,5 2,5 13,0 11,5 7,6 5,8 2,9 2,8 Slika 1. Najpogostejše rakave bolezni po spolu - Slovenija 2002 Figure 1. The leading cancer sites by sex - Slovenia 2002 ŽENSKE - FEMALES 0 5 10 15 20 25 % Dojka Koža, drugo Debelo črevo in danka* Maternično telo Pljuča Maternični vrat Želodec Jajčnik Maligni melanom Ostalo Trebušna slinavka Breast Skin, other Colorectum* Corpus uteri Lung Stomach Ovary Melanoma Other C P ervix uteri ancreas 22,0 22,4 15,3 3,3 2,8 10,9 6,4 5,6 4,0 3,7 3,6 * Pojasnilo – Explantion Debelo črevo in danka – Colorectum: C18-C20 Glava in vrat – Head and neck: C00-C14, C30-C32 NHL: ne-Hodgkinovi limfomi – NHL: non-Hodkgin's lymphoma: C82-C85 Institute of Oncology Ljubljana, Cancer Registry of Slovenia Cancer Incidence in Slovenia 2002 17 Slika 3. Odstotni odklon grobe incidenčne stopnje raka po statističnih regijah od povprečne slovenske - Slovenija 2002 Figure 3. Percentage deviation of crude cancer incidence rate in statistical regions from average - Slovenia 2002 POMURSKA 0-5 5 20 25-20-25 %% 10 15-10-15 MOŠKI - MALES ŽENSKE - FEMALES PODRAVSKA KOROŠKA SAVINJSKA ZASAVSKA SPODNJEPOSAVSKA JV SLOVENIJA OSREDNJESLOVENSKA GORENJSKA NOTRANJSKO-KRAŠKA GORIŠKA OBALNO-KRAŠKA 18,3 0,3 9,8 12,4 6,4 20,9 22,9 14,6 6,2 2,3 1,9 10,7 5,5 12,9 10,3 14,3 12,4 11,9 5,0 6,8 8,4 6,6 13,7 11,8 Slika 2. Odstotni delež vseh rakov po starostnih skupinah in spolu - Slovenija 2002 Figure 2. Percentage distribution of all cancer sites by age groups and sex - Slovenia 2002 Onkološki inštitut Ljubljana, Register raka za Slovenijo 18 Incidenca raka v Sloveniji 2002 Slika 4. Groba in kumulativna letna incidenca vseh rakov po spolu - Slovenija 1950-2002 Figure 4. Crude and cumulative annual cancer incidence; all sites by sex - Slovenia 1950-2002 Moški - Males Ženske - Females 19 50 19 52 19 54 19 56 19 58 19 60 19 62 19 64 19 66 19 68 19 70 19 72 19 74 19 76 19 78 19 80 19 82 19 84 19 86 19 88 19 90 19 92 19 94 19 96 19 98 20 00 Leto / Year 20 02 50 40 30 20 10 0 Moški - Males Ženske - Females Leto / Year 19 50 19 52 19 54 19 56 19 58 19 60 19 62 19 64 19 66 19 68 19 70 19 72 19 74 19 76 19 78 19 80 19 82 19 84 19 86 19 88 19 90 19 92 19 94 19 96 19 98 20 00 20 02 500 400 300 200 100 0 Institute of Oncology Ljubljana, Cancer Registry of Slovenia Cancer Incidence in Slovenia 2002 19 Slika 5. Groba letna incidenca izbranih rakov po spolu - Slovenija 1950-2002 Figure 5. Crude annual cancer incidence by selected primary sites and sex - Slovenia 1950-2002 Debelo črevo in danka - Colorectum (C18-C20) Želodec - Stomach Koža, drugo - Skin, other Pljuča - Lung Maligni melanom - Melanoma Maternično telo - Corpus uteri Maternični vrat - Cervix uteri Dojka - Breast Leto / Year 19 50 19 52 19 54 19 56 19 58 19 60 19 62 19 64 19 66 19 68 19 70 19 72 19 74 19 76 19 78 19 80 19 82 19 84 19 86 19 88 19 90 19 92 19 94 19 96 19 98 20 00 20 02 1 01 Kožni melanom - Melanoma of skin Glava in vrat - Head and neck (C00-C14, C30-C32) Pljuča - Lung Koža, drugo - Skin, other Želodec - Stomach Mehur - BladderProstata - Prostate Leto / Year Debelo črevo in danka - Colorectum (C18-C20) 19 50 19 52 19 54 19 56 19 58 19 60 19 62 19 64 19 66 19 68 19 70 19 72 19 74 19 76 19 78 19 80 19 82 19 84 19 86 19 88 19 90 19 92 19 94 19 96 19 98 20 00 20 02 1 01 MOŠKI – MALES ŽENSKE – FEMALES Onkološki inštitut Ljubljana, Register raka za Slovenijo 20 Incidenca raka v Sloveniji 2002 Povprečne letne kumulativne incidenčne stopnje 1998–2002 Pljuča - moški Lung - males MKB-10/ICD-10 : C33, C34 Povprečne letne grobe incidenčne stopnje 1998–2002 Povprečne letne starostno specifične incidenčne stopnje 1998-2002 Slike 6 - Figures 6 600 500 400 300 200 100 0 1973-1977 1978-1982 1983-1987 1988-1992 1993-1997 1998-2002 30 35 40 45 25 20 15 10 5 0 % Omejen Razširjen Razsejan Neznan Slovenija 7,4 /100 6,38 – 6,92 6,93 – 7,46 7,47 – 7,99 8,00 – 8,53 8,54 – 9,07 Delež bolnikov odkritih po posameznih stadijih, 1973-2002 Slovenija 82,65 /100.000 71,06 – 80,32 80,33 – 89,57 89,58 – 98,83 98,84 –108,08 108,09 – 117,34 Institute of Oncology Ljubljana, Cancer Registry of Slovenia Cancer Incidence in Slovenia 2002 21 Average annual cumulative incidence rates 1998–2002 Pljuča - ženske Lung - females MKB-10/ICD-10 : C33, C34 Average annual crude incidence rates 1998–2002 Average annual age specific incidence rates 1998-2002 Slike 7 - Figures 7 In ci d e nc e ra te p e r 1 00 ,0 00 A g e 1973-1977 1978-1982 1983-1987 1988-1992 1993-1997 1998-2002 30 35 40 45 50 25 20 15 10 5 0 100 80 60 40 20 0 Omejen Razširjen Razsejan Neznan Year % Slovenia 1.6 /100 1.04 – 1.33 1.34 – 1.62 1.63 – 1.90 1.91 – 2.19 2.20 – 2.48 Slovenia 23.55 /100,000 17.29 – 20.23 20.24 – 23.18 23.19 – 26.12 26.13 – 29.07 29.08 – 32.01 Percentage of patients by stage at diagnosis, 1973-2002 Onkološki inštitut Ljubljana, Register raka za Slovenijo Povprečne letne kumulativne incidenčne stopnje 1998–2002 22 Incidenca raka v Sloveniji 2002 Debelo črevo - moški Colon - males MKB-10/ICD-10 : C18 Povprečne letne grobe incidenčne stopnje 1998–2002 Povprečne letne starostno specifične incidenčne stopnje 1998-2002 Slike 8 - Figures 8 100 120 140 160 80 60 40 20 0 1973-1977 1978-1982 1983-1987 1988-1992 1993-1997 1998-2002 30 40 50 60 70 20 10 0 Omejen Razširjen Razsejan Neznan % Slovenija 2,9 /100 1,88 – 2,16 2,17 – 2,44 2,45 – 2,72 2,73 – 3,00 3,01 – 3,28 Delež bolnikov odkritih po posameznih stadijih, 1973-2002 Slovenija 33,63 /100.000 23,35 – 26,74 26,75 – 30,13 30,14 – 33,53 33,54 – 36,92 36,93 – 40,31 Institute of Oncology Ljubljana, Cancer Registry of Slovenia Cancer Incidence in Slovenia 2002 23 Average annual cumulative incidence rates 1998–2002 Debelo črevo - ženske Colon- females MKB-10/ICD-10 : C18 Average annual crude incidence rates 1998–2002 Average annual age specific incidence rates 1998-2002 Slike 9 - Figures 9 A g e 100 120 140 160 80 60 40 20 0 In ci d e nc e ra te p e r 1 00 ,0 00 1973-1977 1978-1982 1983-1987 1988-1992 1993-1997 1998-2002 30 35 40 45 50 25 20 15 10 5 0 Omejen Razširjen Razsejan Neznan Year % Slovenia 1.5 /100 1.06 – 1.20 1.21 – 1.34 1.35 – 1.47 1.48 – 1.61 1.62 – 1.75 Slovenia 26.75 /100,000 18.81 – 21.28 21.29 – 23.75 23.76 – 26.23 26.24 – 28.70 28.71 – 31.17 Percentage of patients by stage at diagnosis, 1973-2002 Onkološki inštitut Ljubljana, Register raka za Slovenijo 24 Incidenca raka v Sloveniji 2002 Povprečne letne kumulativne incidenčne stopnje 1998–2002 Danka - moški Rectum - males MKB-10/ICD-10 : C19, C20 Povprečne letne grobe incidenčne stopnje 1998–2002 Povprečne letne starostno specifične incidenčne stopnje 1998-2002 Slike 10 - Figures 10 Omejen 1973-1977 1978-1982 1983-1987 1988-1992 1993-1997 1998-2002 Razširjen Razsejan Neznan 60 50 40 30 20 10 00 250 200 150 100 50 % Slovenija 2,5 /100 1,93 – 2,17 2,18 – 2,40 2,41 – 2,64 2,65 – 2,87 2,88 – 3,11 Delež bolnikov odkritih po posameznih stadijih, 1973-2002 Slovenija 28,96 /100.000 25,11 – 27,08 27,09 – 29,06 29,07 – 31,03 31,04 – 33,01 33,02 – 34,98 Institute of Oncology Ljubljana, Cancer Registry of Slovenia Cancer Incidence in Slovenia 2002 25 Average annual cumulative incidence rates 1998–2002 Danka - ženske Rectum - females MKB-10/ICD-10 : C19, C20 Average annual crude incidence rates 1998–2002 Average annual age specific incidence rates 1998-2002 Slike 11 - Figures 11 0 In ci d e nc e ra te p e r 1 00 ,0 00 1973-1977 1978-1982 1983-1987 1988-1992 1993-1997 1998-2002 60 50 40 30 20 10 0 120 100 80 60 40 20 Omejen Razširjen Razsejan Neznan % A g e Year Slovenia 1.2 /100 0.72 – 0.97 0.98 – 1.22 1.23 – 1.48 1.49 – 1.73 1.74 – 1.98 Slovenia 20.20 /100,000 15.72 – 18.60 18.61 – 21.48 21.49 – 24.36 24.37 – 27.24 27.25 – 31.12 Percentage of patients by stage at diagnosis, 1973-2002 Onkološki inštitut Ljubljana, Register raka za Slovenijo 26 Incidenca raka v Sloveniji 2002 Povprečne letne kumulativne incidenčne stopnje 1998–2002 Dojka - ženske Breast - females MKB-10/ICD-10 : C50 Povprečne letne grobe incidenčne stopnje 1998–2002 Povprečne letne starostno specifične incidenčne stopnje 1998-2002 Slike 12 - Figures 12 300 250 200 150 100 50 0 1973-1977 1978-1982 1983-1987 1988-1992 1993-1997 1998-2002 60 50 40 30 20 10 0 Omejen Razširjen Razsejan Neznan % Slovenija 6,6 /100 4,68 – 5,37 5,38 – 6,05 6,06 – 6,74 6,75 – 7,42 7,43 – 8,11 Delež bolnic odkritih po posameznih stadijih, 1973-2002 Slovenija 95,81 /100.000 67,18 – 78,00 78,01 – 88,82 88,83 – 99,65 99,66 –110,47 110,48 –121,29 Institute of Oncology Ljubljana, Cancer Registry of Slovenia Cancer Incidence in Slovenia 2002 27 Average annual cumulative incidence rates 1998–2002 Maternični vrat Cervix uteri MKB-10/ICD-10 : C53 Average annual crude incidence rates 1998–2002 Average annual age specific incidence rates 1998-2002 Slike 13 - Figures 13 30 35 40 45 25 20 15 10 5 0 A g e In ci d e nc e ra te p e r 1 00 .0 00 30 40 50 60 70 20 10 0 1973-1977 1978-1982 1983-1987 1988-1992 1993-1997 1998-2002 Omejen Razširjen Razsejan Neznan Year % Slovenia 1.4 /100 0.72 – 0.96 0.97 – 1.20 1.21 – 1.45 1.46 – 1.69 1.70 – 1.93 Slovenia 19.75 /100,000 10.11 – 13.32 13.33 – 16.53 16.54 – 19.74 19.75 – 22.95 22.96 – 26.16 Percentage of patients by stage at diagnosis, 1973-2002 Tabela 1. Prebivalstvo Slovenije po starosti in spolu na dan 30. 6. 2002* Table 1. Population of Slovenia by age and sex on June 30, 2002* Starost Skupaj Moški Ženske Age Total Males Females 0 - 4 89594 46273 43321 5 - 9 97659 50122 47537 10 - 14 115567 59361 56206 15 - 19 131064 66891 64173 20 - 24 150370 77760 72610 25 - 29 149560 77113 72447 30 - 34 143490 73051 70439 35 - 39 156206 78911 77295 40 - 44 154587 78649 75938 45 - 49 161434 83644 77790 50 - 54 142723 73275 69448 55 - 59 106855 52550 54305 60 - 64 104575 49825 54750 65 - 69 95874 42335 53539 70 - 74 84095 33552 50543 75 - 79 60252 19045 41207 80+ 51813 13754 38059 Vse starosti Total 1995718 976111 1019607 *Vir: Statistični urad Republike Slovenije Source: Statistical Office of the Republic of Slovenia 28 Incidenca raka v Sloveniji 2002 Onkološki inštitut Ljubljana, Register raka za Slovenijo Tabela 2. Prebivalstvo Slovenije po statističnih regijah po spolu na dan 30. 6. 2002* Table 2. Population of Slovenia by statistical regions by sex on June 30, 2002* Statitična regija Skupaj Moški Ženske Health region Total Males Females Pomurska 123776 59980 63796 Podravska 319941 156172 163769 Koroška 73994 36853 37141 Savinjska 257629 126638 130991 Zasavska 46104 22472 23632 Spodnjeposavska 70064 34695 35369 Jugovzhodna Slovenija 138414 68403 70011 Osrednjeslovenska 492951 238740 254211 Gorenjska 197487 96333 101154 Notranjsko-kraška 50825 25135 25690 Goriška 120073 59191 60882 Obalno-kraška 104460 51499 52961 Slovenija Skupaj 1995718 976111 1019607 Total *Vir: Statistični urad Republike Slovenije Source: Statistical Office of the Republic of Slovenia Institute of Oncology Ljubljana, Cancer Registry of Slovenia Cancer Incidence in Slovenia 2002 29 30 Incidenca raka v Sloveniji 2002 Onkološki inštitut Ljubljana, Register raka za Slovenijo nadaljevanje / cont’d ➝ Tabela 3. Število novih primerov raka ter število in odstotek primerov, registriranih samo iz zdravniških poročil o vzroku smrti, po lokaciji in spolu - Slovenija 2002 Table 3. Total number of new cancer cases, number and percentage of cases registered from death certificates only, by site and sex - Slovenia 2002 Šifra Število novih Registrirani samo iz MKB* Primarna lokacija Spol primerov zdravniških poročil o vzroku smrti Število Odstotek** ICD Number of Registered from death code* Primary site Sex new cases certificates only Number Per cent** C00 Vse lokacije M+Ž 9356 134 1 – M 4689 72 2 C96 All sites Ž 4667 62 1 C00 Ustnica M 21 – – Lip Ž 12 – C01 Baza jezika M 15 – – Base of tongue Ž – – C02 Jezik, drugi deli M 25 – – Tongue, other & unspecified parts Ž 3 – C03 Dlesen M 4 – Gum Ž 5 – C04 Ustno dno M 33 – – Floor of mouth Ž 5 – C05 Nebo M 10 – Palate Ž 3 – C06 Usta, drugi deli M 14 – Mouth, other & unspecified parts Ž 6 – C07 Parotidna žleza M 7 – Parotid gland Ž 5 – C08 Druge in neopredeljene velike žleze slinavke M – – Other & unspecified major salivary glands Ž 2 – C09 Tonzila M 30 – – Tonsil Ž 5 – C10 Orofarinks M 35 1 3 Oropharynx Ž 4 – C11 Nazofarinks M 5 – Nasopharynx Ž 8 – C12 Piriformni sinus M 25 – – Pyriform sinus Ž 2 – C13 Hipofarinks M 25 1 4 Hypopharynx Ž 2 1 C14 Druga in slabo opredeljena mesta na ustnici, v ustni votlini in farinksu M 1 1 Other and ill-defined sites in the lip, oral cavity and pharynx Ž – – Institute of Oncology Ljubljana, Cancer Registry of Slovenia nadaljevanje / cont’d ➝ Tabela 3. – Table 3. Nadaljevanje – Continued Šifra Število novih Registrirani samo iz MKB* Primarna lokacija Spol primerov zdravniških poročil o vzroku smrti Število Odstotek** ICD Number of Registered from death code* Primary site Sex new cases certificates only Number Per cent** C15 Požiralnik M 77 1 1 Oesophagus Ž 23 1 4 C16 Želodec M 270 7 3 Stomach Ž 173 5 3 C17 Tanko črevo M 11 – Small intestine Ž 5 – C18 Debelo črevo M 355 10 3 Colon Ž 295 4 1 C19 Rektosigmoidna zveza M 62 – – Rectosigmoid junction Ž 38 1 3 C20 Rektum M 251 2 1 Rectum Ž 175 5 3 C21 Anus in analni kanal M 3 – Anus and anal canal Ž 9 1 C22 Jetra in intrahepatični vodi M 96 3 3 Liver and intrahepatic bile ducts Ž 38 4 11 C23 Žolčnik M 13 1 Gallbladder Ž 44 – – C24 Drugi in neopredeljeni deli biliarnega trakta M 35 – – Billiary tract, other and unspecified parts Ž 41 1 2 C25 Trebušna slinavka M 110 1 1 Pancreas Ž 131 2 2 C26 Druga in slabo opredeljena mesta v prebavnih organih M 1 1 Other and ill-defined digestive organs Ž 8 3 C30 Nosna votlina in srednje uho M 2 – Nasal cavity and middle ear Ž 3 – C31 Obnosni sinusi M 5 – Accessory sinuses Ž 4 – C32 Grlo M 98 1 1 Larynx Ž 11 – C33 Sapnik M 3 – Trachea Ž 2 – C34 Sapnica in pljuča M 787 12 2 Bronchus and lung Ž 258 3 1 C37 Timus M 1 – Thymus Ž – – C38 Srce, mediastinum, plevra M 2 – Heart, mediastinum, pleura Ž 1 – Cancer Incidence in Slovenia 2002 31 32 Incidenca raka v Sloveniji 2002 Onkološki inštitut Ljubljana, Register raka za Slovenijo nadaljevanje / cont’d ➝ Tabela 3. – Table 3. Nadaljevanje – Continued Šifra Število novih Registrirani samo iz MKB* Primarna lokacija Spol primerov zdravniških poročil o vzroku smrti Število Odstotek** ICD Number of Registered from death code* Primary site Sex new cases certificates only Number Per cent** C39 Druga in slabo opredeljena mesta v dihalih in prsnih organih M 1 1 Other and ill-defined sites in the respiratory Ž – – system and intrathoracic organs C40 Kosti, sklepni hrustanec udov M 4 – Bone and articular cartilage of limbs Ž 5 – C41 Kosti, sklepni hrustanec, drugje M 5 – Bone and articular cartilage of other and unspecified parts Ž 3 – C43 Maligni melanom kože M 116 1 1 Malignant melanoma of skin Ž 154 – – C44 Druge maligne neoplazme kože M 610 – – Skin, other malignomas Ž 715 1 – C45 Mezoteliom M 22 – – Mesothelioma Ž 9 – C46 Kaposijev sarkom M – – Kaposi's sarcoma Ž – – C47 Periferni živci in avtonomno živčevje M 4 – Peripheral nerves and autonomic nervous system Ž 1 – C48 Retroperitonej in peritonej M 11 – Retroperitoneum and peritoneum Ž 3 – C49 Drugo vezivno in mehko tkivo M 21 – – Other connective and soft tissue Ž 20 – – C50 Dojka M 14 – Breast Ž 1026 10 1 C51 Žensko zunanje spolovilo M – – Vulva Ž 43 2 5 C52 Nožnica M – – Vagina Ž 17 – – C53 Maternični vrat M – – Cervix uteri Ž 187 – – C54 Maternično telo M – – Corpus uteri Ž 299 – – C55 Maternica, neopredeljeno M – – Uterus, unspecified part Ž 10 3 C56 Jajčnik M – – Ovary Ž 169 2 1 C57 Drugi in neopredeljeni ženski spolni organi M – – Other & unspecified parts of female genital organs Ž 12 1 Institute of Oncology Ljubljana, Cancer Registry of Slovenia nadaljevanje / cont’d ➝ Tabela 3. – Table 3. Nadaljevanje – Continued Šifra Število novih Registrirani samo iz MKB* Primarna lokacija Spol primerov zdravniških poročil o vzroku smrti Število Odstotek** ICD Number of Registered from death code* Primary site Sex new cases certificates only Number Per cent** C58 Posteljica M – – Placenta Ž – – C60 Penis M 4 – Penis Ž – – C61 Prostata M 541 17 3 Prostate Ž – – C62 Modo M 78 – – Testis Ž – – C63 Drugi in neopredeljeni moški spolni organi M 3 – Other and unspecified male genital organs Ž – – C64 Ledvica razen meha M 131 – – Kidney, except renal pelvis Ž 50 – – C65 Ledvični meh M 9 – Renal pelvis Ž 5 – C66 Sečevod M 4 – Ureter Ž – – C67 Sečni mehur M 136 2 1 Bladder Ž 50 1 2 C68 Drugi in neopredeljeni sečni organi M 1 – Other and unspecified urinary organs Ž – – C69 Oko in očesni adneksi M 9 – Eye and adnexa Ž 8 – C70 Meninge M 1 – Meninges Ž 5 – C71 Možgani M 67 1 1 Brain Ž 60 – – C72 Hrbtni mozeg, možganski živci in drugi deli CŽS M 1 – Spinal cord, cranial nerves and other parts of CNS Ž 1 – C73 Ščitnica M 22 – – Thyroid gland Ž 75 – – C74 Nadledvična žleza M 2 – Adrenal gland Ž 4 – C75 Druge endokrine žleze in sorodne strukture M 2 – Other endocrine glands and related structures Ž – – C76 Druga in slabo opredeljena mesta M 6 – Other and ill-defined sites Ž 14 – C77 Metastaza in neopredeljena maligna neoplazma bezgavk M 29 – – Metastasis and unspecified Ž 18 – – malignant neoplasm of lymph nodes Cancer Incidence in Slovenia 2002 33 34 Incidenca raka v Sloveniji 2002 Onkološki inštitut Ljubljana, Register raka za Slovenijo nadaljevanje / cont’d ➝ Tabela 3. – Table 3. Nadaljevanje – Continued Šifra Število novih Registrirani samo iz MKB* Primarna lokacija Spol primerov zdravniških poročil o vzroku smrti Število Odstotek** ICD Number of Registered from death code* Primary site Sex new cases certificates only Number Per cent** C78 Metastaze dihal in prebavil M 65 3 5 Metastases of respiratory and digestive organs Ž 58 3 5 C79 Metastaze, drugje M 16 – – Metastases of other sites Ž 17 2 12 C80 Maligna neoplazma brez opredeljenega mesta M 42 5 12 Malignant neoplasm without specification of site Ž 33 2 6 C81 Hodgkinova bolezen M 18 – – Hodgkin's disease Ž 25 – – C82 Folikularni ne-Hodgkinov limfom M 21 – – Follicular non-Hodgkin's lymphoma Ž 15 – – C83 Difuzni ne-Hodgkinov limfom M 68 – – Diffuse non-Hodgkin's lymphoma Ž 55 – – C84 Limfomi celic T in kožni limfom celic T M 10 – Peripheral and cutaneous T-cell lymphomas Ž 7 – C85 Druge in neopredeljene vrste ne-Hodgkinovega limfoma M 18 – – Other and unspecified types of non-Hodgkin's lymphoma Ž 19 1 5 C88 Maligne imunoproliferativne bolezni M 1 – Malignant immunoproliferative diseases Ž – – C90 Difuzni plazmocitom in maligne neoplazme plazmocitov M 27 – – Multiple myeloma and malignant plasma cell neoplasms Ž 35 2 6 C91.0– Limfatična levkemija, akutna M 9 – Lymphoblastic leukaemia, acute Ž 12 – C91.1 – Limfatična levkemija, druga M 35 – – C91.9 Lymphoid leukaemia, other Ž 30 1 3 C92 Mieloična levkemija M 35 – – Myeloid leukaemia Ž 32 – – C93 Monocitna levkemija M 3 – Monocytic leukaemia Ž 1 – C94 Druge opredeljene levkemije M 1 – Other leukaemias of specified cells Ž – – C95 Levkemija z neopredeljenim celičnim tipom M 2 – Leukaemia, unspecified cell type Ž 3 – C96 Druge in neopredeljene maligne neoplazme limfatičnega, krvotvornega in sorodnega tkiva M 32 – – Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue Ž 41 – – Tabela 3. – Table 3. Nadaljevanje – Continued Šifra Število novih Registrirani samo iz MKB* Primarna lokacija Spol primerov zdravniških poročil o vzroku smrti Število Odstotek** ICD Number of Registered from death code* Primary site Sex new cases certificates only Number Per cent** Zgoraj neupoštevani Not included above D03 Melanom, in situ M 15 – – Melanoma, in situ Ž 9 – D05 Dojka, in situ M – – Breast, in situ Ž 71 – – D06 Maternični vrat, in situ (CIN III) M – – Cervix uteri, in situ (CIN III) Ž 901 – – D09.0 Karcinom in situ mehurja M 56 – – Bladder, in situ Ž 9 – D32.0 Meninge, benigna neoplazma M 15 – – Benign neoplasm of meninges Ž 52 – – D33.0 Možgani, benigna neoplazma M – – - D33.2 Benign neopasm of brain Ž 1 – D39.1 Jajčnik, neopl. negotovega značaja M – – Ovary, neopl. of uncertain behavior Ž 31 – – D43.0 Možgani, neopredeljeno M 4 – - D43.2 Brain, uncertain or unknown Ž 9 – * MKB - Mednarodna klasifikacija bolezni, deseta revizija, 1995 ICD - International Classification of Diseases, Tenth Revision, 1995 ** Odstotki niso računani pri številih pod 15 Percentages are not calculated for less than 15 cases Institute of Oncology Ljubljana, Cancer Registry of Slovenia Cancer Incidence in Slovenia 2002 35 36 Incidenca raka v Sloveniji 2002 Onkološki inštitut Ljubljana, Register raka za Slovenijo nadaljevanje / cont’d ➝ Tabela 4a. Število novih primerov raka po lokaciji (MKB-10), spolu in starosti - Slovenija 2002 Table 4a. Number of new cancer cases by primary site (ICD-10), sex, and age - Slovenia 2002 Šifra Primarna Vse S t a r o s t i MKB lokacija Spol starosti A g e ICD Primary Sex All code site ages 0– 5– 10– 15– 20– 25– 30– 35– 40– 45– 50– 55– 60– 65– 70– 75– 80+ Skupaj 9356 23 10 13 34 48 75 106 181 290 536 764 799 1106 1460 1530 1209 1172 C00 Vse lokacije Total – Moški 4689 11 7 3 18 29 37 44 59 101 238 404 451 620 873 788 562 444 C96 All sites Male Ženske 4667 12 3 10 16 19 38 62 122 189 298 360 348 486 587 742 647 728 Female C00 Ustnica M 21 – – – – – – – – 1 3 – 1 3 2 7 3 1Lip Ž 12 – – – – – – – – 1 1 – – – 1 3 3 3 C01 Baza jezika M 15 – – – – – – – – – 1 3 3 2 1 3 1 1Base of tongue Ž – – – – – – – – – – – – – – – – – – C02 Jezik, drugi deli M 25 – – – – – – – – – 8 4 2 1 3 5 2 –Tongue, other & Ž 3 – – – – – – – – – – – – – 2 – 1 –unspecified parts C03 Dlesen M 4 – – – – – – – – 1 1 1 – – – – 1 –Gum Ž 5 – – – – – – – – – – 1 – – 3 – – 1 C04 Ustno dno M 33 – – – – – – – 1 2 3 4 10 5 4 2 2 –Floor of mouth Ž 5 – – – – – – – 1 – 1 1 1 1 – – – – C05 Nebo M 10 – – – – – – – – – 1 3 1 3 2 – – –Palate Ž 3 – – – – – – – – – 1 – – – 2 – – – C06 Usta, drugi deli M 14 – – – – – – – – – 2 6 3 1 – 1 1 –Mouth, other & Ž 6 – – – – – – – – – 1 – – 1 1 3 – –unspecified parts C07 Parotidna žleza M 7 – – – – – – – 1 1 – – 1 2 1 1 – –Parotid gland Ž 5 – – – – – – – – 1 2 – 1 – – – 1 – C08 Druge in neopredeljene M – – – – – – – – – – – – – – – – – –velike žleze slinavke Other & unspecified Ž 2 – – – – – – – – – – – – 1 1 – – – major salivary glands C09 Tonzila M 30 – – – – – – – – 1 2 9 3 6 7 – 2 –Tonsil Ž 5 – – – – – – – – – 1 – – 1 1 1 – 1 C10 Orofarinks M 35 – – – – – – – – 3 6 9 4 2 8 1 2 –Oropharynx Ž 4 – – – – – – – – – 1 1 – – – – 1 1 C11 Nazofarinks M 5 – – – 1 – – – 1 – 1 2 – – – – – –Nasopharynx Ž 8 – – – – – – 1 – 1 – 1 1 2 2 – – – C12 Piriformni sinus M 25 – – – – – – – – – 2 6 2 5 6 2 1 1Pyriform sinus Ž 2 – – – – – – – – – – – 1 – 1 – – – C13 Hipofarinks M 25 – – – – – – – – – 3 7 5 2 3 4 – 1Hypopharynx Ž 2 – – – – – – – – – – – – 1 – – – 1 C14 Druga in slabo oprede- ljena mesta na ustnici, v ustni votlini in farinksu M 1 – – – – – – – – – – 1 – – – – – – Other and ill-defined sites Ž – – – – – – – – – – – – – – – – – – in the lip, oral cavity and pharynx C15 Požiralnik M 77 – – – – – – 1 – 2 6 10 13 11 12 10 7 5Oesophagus Ž 23 – – – – – – 1 – – 1 – – 1 5 4 1 10 C16 Želodec M 270 – – – – – – 2 1 9 8 20 22 42 41 53 41 31Stomach Ž 173 – – – – – 1 2 2 3 5 8 9 9 29 36 26 43 C17 Tanko črevo M 11 – – – – – – – – – 2 2 – – 2 1 2 2Small intestine Ž 5 – – – – – – – – 1 – – – – 1 – 2 1 C18 Debelo črevo M 355 – – – – 1 1 – 2 5 20 23 31 38 85 61 40 48Colon Ž 295 – – – – 1 1 1 4 5 7 18 17 28 39 50 57 67 C19 Rektosigmoidna zveza M 62 – – – – – – – – 2 7 3 3 15 14 3 8 7Rectosigmoid junction Ž 38 – – – – – – – – 3 2 1 1 4 9 6 6 6 C20 Rektum M 251 – – – – – – – 2 2 8 20 21 44 57 48 27 22Rectum Ž 175 – – – – – – – 1 2 5 11 8 18 31 31 32 36 C21 Anus in analni kanal M 3 – – – – – – – – – 1 – – – 1 – 1 –Anus and anal canal Ž 9 – – – – – – – – – 1 – – 2 1 1 1 3 C22 Jetra in intrahepatični vodi M 96 – – – – – 1 – 1 2 4 5 8 13 20 20 14 8Liver and intrahepatic Ž 38 – – – – – – – – 1 1 – 5 3 3 9 9 7bile ducts C23 Žolčnik M 13 – – – – – – – – 1 – – 2 1 2 2 5 –Gallbladder Ž 44 – – – – – – – – – 1 – 1 5 3 8 11 15 C24 Drugi in neopredeljeni deli biliarnega trakta M 35 – – – – – – – – 1 2 4 5 3 6 6 1 7 Billiary tract, other and Ž 41 – – – – – – – – – – 1 1 9 3 6 7 14 unspecified parts C25 Trebušna slinavka M 110 – – – – – – – 2 2 5 11 11 13 19 21 12 14Pancreas Ž 131 – – – – – – – 2 5 6 2 6 10 17 25 25 33 Institute of Oncology Ljubljana, Cancer Registry of Slovenia nadaljevanje / cont’d ➝ Tabela 4a. – Table 4a. Nadaljevanje – Continued Šifra Primarna Vse S t a r o s t i MKB lokacija Spol starosti A g e ICD Primary Sex All code site ages 0– 5– 10– 15– 20– 25– 30– 35– 40– 45– 50– 55– 60– 65– 70– 75– 80+ Druga in slabo opredeljena mesta v prebavnih organih M 1 – – – – – – – – – – 1 – – – – – –C26 Other and ill-defined Ž 8 – – – – – – – – – – – – 1 2 – 1 4 digestive organs C30 Nosna votlina in srednje uho M 2 – – – – – – – – – – – – – – 2 – – Nasal cavity and Ž 3 – – – – – – – – – – – – 2 – – 1 – middle ear C31 Obnosni sinusi M 5 – – – – – – – – 2 – 1 – – – 2 – –Accessory sinuses Ž 4 – – – – – – – – – – 1 – – 1 2 – – C32 Grlo M 98 – – – – – – – 2 4 10 8 17 15 24 7 7 4Larynx Ž 11 – – – – – – – – 1 3 1 1 1 1 1 2 – C33 Sapnik M 3 – – – – – – – – – – 1 – 1 1 – – –Trachea Ž 2 – – – – – – – – – – – – – – 1 – 1 C34 Sapnica in pljuča M 787 – – – – – – – 2 8 26 81 100 133 150 155 97 35Bronchus and lung Ž 258 – – – – – – 1 1 10 16 23 29 26 41 51 32 28 C37 Timus M 1 – – – – – – – – – – – – 1 – – – –Thymus Ž – – – – – – – – – – – – – – – – – – C38 Srce, mediastinum, plevra M 2 – – – – 1 – – – – – – – – – 1 – –Heart, mediastinum, pleura Ž 1 – – – – – – – – – – – – – – – – 1 Druga in slabo oprede- ljena mesta v dihalih C39 in prsnih organih M 1 – – – – – – – – – – – – – – 1 – –Other and ill-defined sites Ž – – – – – – – – – – – – – – – – – – in the respiratory system and intrathoracic organs C40 Kosti, sklepni hrustanec udov M 4 – – – 1 – – 2 – – 1 – – – – – – –Bone and articular Ž 5 – 1 1 2 – – – – – – – – – – – 1 –cartilage of limbs Kosti, sklepni hrustanec, drugje C41 Bone and articular M 5 – – – 1 – – – – 2 1 – – – – 1 – – cartilage of other and Ž 3 – – – 1 – – – – – – – – 1 – – 1 – unspecified parts C43 Maligni melanom kože M 116 – – – 1 2 4 3 3 7 8 16 13 16 12 12 6 13Malignant melanoma Ž 154 – – 1 – – 6 5 13 12 20 13 10 17 16 17 11 13of skin Druge maligne C44 neoplazme kože M 610 – – – 1 3 6 5 9 15 24 42 57 68 116 103 83 78 Skin, other malignomas Ž 715 – – 1 2 – 3 3 8 15 26 34 47 59 92 130 117 178 C45 Mezoteliom M 22 – – – – – – – – – 3 3 2 5 4 1 1 3Mesothelioma Ž 9 – – – – – – – – – 1 – 2 3 1 – 1 1 C46 Kaposijev sarkom M – – – – – – – – – – – – – – – – – –Kaposi's sarcoma Ž – – – – – – – – – – – – – – – – – – C47 Periferni živci in avtonomno živčevje M 4 2 – – – – 2 – – – – – – – – – – – Peripheral nerves and Ž 1 – – – – – – – 1 – – – – – – – – – autonomic nervous system C48 Retro- in peritonej M 11 – – – – 1 – 1 – – – – 1 3 1 1 2 1Retro- and peritoneum Ž 3 – – – – – – – – – – 1 – – – 1 – 1 Drugo vezivno in C49 mehko tkivo M 21 – – – – 1 1 – 2 2 1 3 3 1 2 3 1 1Other connective Ž 20 – – – 2 – – – 2 – 1 3 3 – 3 2 – 4 and soft tissue C50 Dojka M 14 – – – – – – – – – 1 1 1 4 2 1 3 1Breast Ž 1026 – – – – – 5 9 35 71 103 119 103 129 126 139 105 82 C51 Žensko zunanje spolovilo M – – – – – – – – – – – – – – – – – –Vulva Ž 43 – – – – – – – – 2 2 1 4 6 3 6 11 8 C52 Nožnica M – – – – – – – – – – – – – – – – – –Vagina Ž 17 – – – – – – – – – 1 2 – 4 2 1 4 3 C53 Maternični vrat M – – – – – – – – – – – – – – – – – –Cervix uteri Ž 187 – – – 1 4 4 21 24 21 29 20 15 12 8 11 7 10 C54 Maternično telo M – – – – – – – – – – – – – – – – – –Corpus uteri Ž 299 – – – – – – 1 2 7 16 32 32 50 38 60 35 26 C55 Maternica, neopredeljeno M – – – – – – – – – – – – – – – – – –Uterus, unspecified Ž 10 – – – – – – – – – 2 1 – – – 4 2 1 C56 Jajčnik M – – – – – – – – – – – – – – – – – –Ovary Ž 169 – – – – 2 1 4 5 8 13 10 17 28 25 30 11 15 Cancer Incidence in Slovenia 2002 37 38 Incidenca raka v Sloveniji 2002 Onkološki inštitut Ljubljana, Register raka za Slovenijo nadaljevanje / cont’d ➝ Tabela 4a. – Table 4a. Nadaljevanje – Continued Šifra Primarna Vse S t a r o s t i MKB lokacija Spol starosti A g e ICD Primary Sex All code site ages 0– 5– 10– 15– 20– 25– 30– 35– 40– 45– 50– 55– 60– 65– 70– 75– 80+ Drugi in neopredeljeni ženski spolni organi M – – – – – – – – – – – – – – – – – – C57 Other and unspecified parts Ž 12 – – – – – – – – 1 – 1 – 2 1 2 1 4 of female genital organs C58 Posteljica M – – – – – – – – – – – – – – – – – –Placenta Ž – – – – – – – – – – – – – – – – – – C60 Penis M 4 – – – – – – – – – – 1 – – 1 1 1 –Penis Ž – – – – – – – – – – – – – – – – – – C61 Prostata M 541 – – – – – – – – – 5 17 33 73 138 111 86 78Prostate Ž – – – – – – – – – – – – – – – – – – C62 Modo M 78 – – – 3 11 15 18 13 7 5 3 2 1 – – – –Testis Ž – – – – – – – – – – – – – – – – – – C63 Drugi in neopredeljeni moški spolni organi M 3 – 1 – – – – – – – – – – 1 – 1 – – Other and unspecified Ž – – – – – – – – – – – – – – – – – – male genital organs C64 Ledvica razen meha M 131 – 2 – – – – – 1 4 7 20 16 17 22 18 17 7Kidney, except renal pelvis Ž 50 2 – – – – – 1 1 2 3 1 6 5 6 5 11 7 C65 Ledvični meh M 9 – – – – – – – – – 2 – – – – 3 2 2Renal pelvis Ž 5 – – – – – – – – – – – 1 – 3 1 – – C66 Sečevod M 4 – – – – – – – – – – 1 – 1 – 1 1 –Ureter Ž – – – – – – – – – – – – – – – – – – C67 Sečni mehur M 136 – – – – – – 1 1 1 9 7 7 14 33 25 24 14Bladder Ž 50 – – – – – – – – 3 – 1 1 2 4 11 13 15 Drugi in neopredeljeni sečni organi M 1 – – – – – – – – – – – – – 1 – – – C68 Other and unspecified Ž – – – – – – – – – – – – – – – – – – urinary organs C69 Oko in očesni adneksi M 9 – – – – – – – – 1 1 1 2 1 2 1 – –Eye and adnexa Ž 8 – – – – – – 1 – – – 1 – – 1 1 2 2 C70 Meninge M 1 – – – – – – – – – – – – – – 1 – –Meninges Ž 5 – – – – – – – – – 1 2 – 1 1 – – – C71 Možgani M 67 3 – 2 2 – 1 1 3 3 8 7 11 7 9 6 2 2Brain Ž 60 3 1 – 1 1 3 1 4 1 2 9 3 7 7 8 7 2 Hrbtni mozeg, možganski živci in drugi deli CŽS M 1 – – – – – – – – – – – – 1 – – – – C72 Spinal cord, cranial nerves Ž 1 – – – – – – – – – – – – – 1 – – – and other parts of CNS C73 Ščitnica M 22 – – – – 1 1 2 2 3 – 3 1 2 2 2 2 1Thyroid gland Ž 75 – – 2 2 4 5 4 5 5 6 13 4 6 7 7 4 1 C74 Nadledvična žleza M 2 – – – – – – – – – – – 1 – – 1 – –Adrenal gland Ž 4 1 – – – – – – – 1 – – – – – 2 – – C75 Druge endokrine žleze in sorodne strukture M 2 – – – – 1 – – – 1 – – – – – – – – Other endocrine glands Ž – – – – – – – – – – – – – – – – – – and related structures Druga in slabo opredeljena mesta M 6 1 – – 1 – – – – – – – – – – 1 – 3C76 Other and ill-defined sites Ž 14 – – – – – – – – – – 1 – 3 – 2 6 2 C77 Metastaza in neoprede- ljena maligna neoplazma bezgavk M 29 – – – – – – – – – 3 5 5 1 7 5 2 1 Metastasis and unspecified Ž 18 – – – – – – – 1 – – 3 1 1 3 – 3 6 malignant neoplasm of lymph nodes Metastaze dihal in prebavil M 65 – – – – – – – – – 1 3 3 8 9 19 8 14 C78 Metastases of respiratory Ž 58 – – – – – – – – 2 1 2 2 1 5 10 15 20 and digestive organs C79 Metastaze, drugje M 16 – – – – – – – – – 1 4 1 4 1 2 2 1Metastases of other sites Ž 17 – – – – – – – – – 1 – – 2 – 4 5 5 Maligna neoplazma brez opredeljenega mesta M 42 – – – – – – – – 1 – 3 3 6 5 11 8 5C80 Malignant neoplasm Ž 33 – – – – – – – – – 1 2 2 2 3 6 9 8 without specification of site C81 Hodgkinova bolezen M 18 – 2 1 3 3 2 1 1 – 1 – 2 1 – – 1 –Hodgkin's disease Ž 25 – – 2 3 6 4 1 3 – 1 – – 1 1 1 1 1 Folikularni ne-Hodgkinov limfom M 21 – – – – – – – 1 – 6 3 2 2 – 4 1 2C82 Follicular non-Hodgkin's Ž 15 – – – – – 1 – 1 – – 3 3 2 – 2 1 2 lymphoma Institute of Oncology Ljubljana, Cancer Registry of Slovenia Tabela 4a. – Table 4a. Nadaljevanje – Continued Šifra Primarna Vse S t a r o s t i MKB lokacija Spol starosti A g e ICD Primary Sex All code site ages 0– 5– 10– 15– 20– 25– 30– 35– 40– 45– 50– 55– 60– 65– 70– 75– 80+ Difuzni ne-Hodgkinov limfom M 68 1 – – – 3 1 1 1 2 7 4 9 9 9 3 12 6C83 Diffuse non-Hodgkin's Ž 55 – – 1 – – 1 – 1 1 3 4 3 4 8 11 11 7 lymphoma C84 Limfomi celic T in kožni limfom celic T M 10 – 1 – – – – 2 1 1 1 – 1 – 1 1 1 – Peripheral and cutaneous Ž 7 – – 1 1 – – – 1 – 1 1 – – 2 – – – T-cell lymphomas Druge in neopredeljene vrste ne-Hodgkinovega limfoma M 18 – 1 – 1 – – – – – – 2 – 1 1 6 3 3C85 Other and unspecified types Ž 19 – – – – – – – – – – – 1 – 2 7 2 7 of non-Hodgkin's lymphoma C88 Maligne imunoprolife- rativne bolezni M 1 – – – – – – – – – – – 1 – – – – – Malignant immunopro- Ž – – – – – – – – – – – – – – – – – – liferative diseases Difuzni plazmocitom in maligne neoplazme plazmocitov M 27 – – – – – – – 1 – 2 2 2 2 7 4 3 4C90 Multiple myeloma and Ž 35 – – – – – – – – – 1 3 2 3 3 8 11 4 malignant plasma cell neoplasms C91.0 Limfatična levkemija, akutna M 9 4 – – 1 – – 1 – – 2 – – 1 – – – – Lymphoblastic Ž 12 6 1 – – – 1 1 – – – – – 2 1 – – – leukaemia, acute C91.1 - Limfatična levkemija, druga M 35 – – – – – – – 1 1 1 1 1 2 7 9 3 9 C91.9 Lymphoid leukaemia, other Ž 30 – – – – – 1 – – 1 1 1 2 3 4 4 5 8 C92 Mieloična levkemija M 35 – – – 2 – 1 2 3 – 4 3 2 2 6 4 3 3Myeloid leukaemia Ž 32 – – 1 1 – – 2 1 – 4 2 1 4 6 3 4 3 C93 Monocitna levkemija M 3 – – – – 1 – – – 1 – – – 1 – – – –Monocytic leukaemia Ž 1 – – – – – – – – – 1 – – – – – – – C94 Druge opredeljene levkemije M 1 – – – – – – – – – – 1 – – – – – – Other leukaemias Ž – – – – – – – – – – – – – – – – – – of specified cells Levkemija z neoprede- ljenim celičnim tipom M 2 – – – – – – – 1 – – – – – – – – 1C95 Leukaemia, unspecified Ž 3 – – – – – – 1 – – – – – – 1 – – 1 cell type Druge in neopredeljene maligne neoplazme limfatičnega, krvotvornega C96 in sorodnega tkiva M 32 – – – – – 1 1 – – 1 3 1 3 4 7 7 4Other and unspecified Ž 41 – – – – 1 1 1 3 2 1 4 1 – 3 8 11 5 malignant neoplasms of lymphoid, haematopoietic and related tissue Zgoraj neupoštevani Not included above D03 Melanom, in situ M 15 – – – – – 1 – – 2 2 1 2 1 2 3 1 –Melanoma, in situ Ž 9 – – – – – 1 – – – – 3 – – – 3 2 – D05 Dojka, in situ M – – – – – – – – – – – – – – – – – –Breast, in situ Ž 71 – – – – – – 1 1 5 20 10 10 9 6 6 1 2 D06 Maternični vrat, in situ (CIN III) M – – – – – – – – – – – – – – – – – –Cervix uteri, in situ (CIN III) Ž 901 – – – 2 47 179 194 196 127 92 29 11 8 8 5 1 2 D09.0 Karcinom in situ mehurja M 56 – – – – 1 1 1 – 1 3 6 6 5 9 14 6 3Bladder, in situ Ž 9 – – – – – – – – – 1 1 1 1 1 – 3 1 Meninge, benigna neoplazma M 15 – – – – 2 1 – 1 1 – 1 1 4 2 2 – –D32.0 Benign neoplasm of Ž 52 – – – – – 2 – 5 4 4 6 5 5 7 7 5 2 meninges D33.0 Možgani, benigna neoplazma M – – – – – – – – – – – – – – – – – –- D33.2 Benign neopasm of brain Ž 1 – – – – – – – – – – – 1 – – – – – Jajčnik, neopl. negotovega značaja M – – – – – – – – – – – – – – – – – –D39.1 Ovary, neopl. of Ž 31 – – – – 1 – 1 3 1 5 4 1 6 6 1 – 2 uncertain behavior D43.0 Možgani, neopredeljeno M 4 – – – – – – – – – – 2 – 1 – 1 – – - D43.2 Brain, uncertain or unknown Ž 9 – – 1 – – – – – – – – – 1 1 1 1 4 Cancer Incidence in Slovenia 2002 39 40 Incidenca raka v Sloveniji 2002 Onkološki inštitut Ljubljana, Register raka za Slovenijo nadaljevanje / cont’d ➝ Tabela 4b. Število novih primerov raka po lokaciji (MKB-8), spolu in starosti - Slovenija 2002 Table 4b. Number of new cancer cases by primary site (ICD-8), sex, and age - Slovenia 2002 Šifra Primarna Vse S t a r o s t i MKB lokacija Spol starosti A g e ICD Primary Sex All code site ages 0– 5– 10– 15– 20– 25– 30– 35– 40– 45– 50– 55– 60– 65– 70– 75– 80+ Skupaj 9294 23 10 13 34 47 73 104 178 288 534 760 796 1103 1454 1519 1194 1164 140 Vse lokacije Total – Moški 4661 11 7 3 18 29 36 43 59 101 237 403 449 617 870 783 555 440 209 All sites Male Ženske 4633 12 3 10 16 18 37 61 119 187 297 357 347 486 584 736 639 724 Female 140 Ustnica M 21 – – – – – – – – 1 3 – 1 3 2 7 3 1Lip Ž 12 – – – – – – – – 1 1 – – – 1 3 3 3 141 Jezik M 40 – – – – – – – – – 9 7 5 3 4 8 3 1Tongue Ž 3 – – – – – – – – – – – – – 2 – 1 – 142 Slinavke M 9 – – – – – – – 1 1 1 – 1 2 1 1 1 –Salivary glands Ž 10 – – – – – – – – 1 2 – 3 2 1 – 1 – 143 Dlesni M 4 – – – – – – – – 1 1 1 – – – – 1 –Gum Ž 6 – – – – – – – – – – 1 – – 3 – – 2 144 Ustno dno M 33 – – – – – – – 1 2 3 4 10 5 4 2 2 –Floor of mouth Ž 5 – – – – – – – 1 – 1 1 1 1 – – – – 145 Usta, drugo M 24 – – – – – – – – – 3 9 4 4 2 1 1 –Mouth, other parts Ž 10 – – – – – – – – – 2 – – 1 3 3 – 1 146 Orofarinks M 70 – – – – – – – – 4 9 18 8 9 16 1 5 –Oropharynx Ž 11 – – – – – – – – – 2 1 – 1 1 1 2 3 147 Epifarinks M 7 – – – 1 – – 1 1 – 1 2 – 1 – – – –Epipharynx Ž 8 – – – – – – 1 – 1 – 1 1 2 2 – – – 148 Hipofarinks M 50 – – – – – – – – – 5 13 7 7 9 6 1 2Hypopharynx Ž 4 – – – – – – – – – – – 1 1 1 – – 1 149 Žrelo, neoznačeno M 1 – – – – – – – – – – 1 – – – – – –Pharynx, not specified Ž – – – – – – – – – – – – – – – – – – 150 Požiralnik M 77 – – – – – – 1 – 2 6 10 13 11 12 10 7 5Oesophagus Ž 23 – – – – – – 1 – – 1 – – 1 5 4 1 10 151 Želodec M 285 – – – – – – 2 1 9 10 22 24 44 42 54 44 33Stomach Ž 184 – – – – – 1 2 2 3 5 8 10 10 29 43 27 44 152 Tanko črevo M 14 – – – – – – – 1 – 3 2 1 – 2 1 2 2Small intestine Ž 6 – – – – – – – – 1 – – – – 1 – 3 1 153 Debelo črevo M 357 – – – – 1 1 – 2 5 20 23 31 38 86 61 40 49Colon Ž 299 – – – – 1 1 1 4 5 7 18 17 28 41 50 57 69 154 Rektum M 316 – – – – – – – 2 4 16 23 24 59 72 51 36 29Rectum Ž 222 – – – – – – – 1 5 8 12 9 24 41 38 39 45 155 Jetra M 79 – – – – – 1 – 1 2 4 5 6 12 16 19 7 6Liver Ž 29 – – – – – – – – 1 1 – 5 3 2 7 6 4 156 Žolčnik, žolčni vodi M 48 – – – – – – – – 2 2 4 7 4 8 8 6 7Gallbladder, bile ducts Ž 84 – – – – – – – – – 1 1 2 14 6 14 18 28 157 Trebušna slinavka M 110 – – – – – – – 2 2 5 11 11 13 19 21 12 14Pancreas Ž 131 – – – – – – – 2 5 6 2 6 10 17 25 25 33 158 Retro- in peritonej M 14 – – – – 1 – 1 – – – – 1 4 1 1 3 2Retro- and peritoneum Ž 4 – – – – – – – – – – 1 – – – 1 – 2 159 Prebavila, drugo M 2 – – – – – – – – – – 1 – 1 – – – –Digestive organs, other Ž 6 – – – – – – – – – – – – 1 1 – 1 3 160 Nos, obnosne votline,drugo M 8 – – – – – – – – 2 – 1 1 – – 4 – –Nose, sinuses, etc. Ž 7 – – – – – – – – – – 1 – 2 1 2 1 – 161 Grlo M 98 – – – – – – – 2 4 10 8 17 15 24 7 7 4Larynx Ž 11 – – – – – – – – 1 3 1 1 1 1 1 2 – 162 Sapnik, sapnica, pljuča M 791 – 1 – – – – – 2 8 26 82 100 134 151 155 97 35Trachea, bronchus, lung Ž 260 – – – – – – 1 1 10 16 23 29 26 41 52 32 29 163 Plevra, mediastinum, drugo M 22 – – – – 1 – – – – 3 3 2 4 4 3 – 2Pleura, mediastinum, etc. Ž 9 – – – – – – – – – 1 – 2 3 1 – 1 1 170 Kosti M 10 – – – 2 1 – 2 – 2 2 – – – – 1 – –Bone Ž 10 – 1 1 3 – – – – – – 1 – 1 – – 2 1 171 Mehka tkiva M 23 – 1 – – 1 1 – 2 2 1 3 3 1 2 3 2 1Soft tissues Ž 20 – – – 2 – – – 2 – 1 3 3 – 3 2 – 4 172 Koža, maligni melanom M 116 – – – 1 2 4 3 3 7 8 16 13 16 12 12 6 13Skin, malignant melanoma Ž 154 – – 1 – – 6 5 13 12 20 13 10 17 16 17 11 13 173 Koža, drugi malignomi M 613 – – – 1 3 6 5 9 15 25 42 57 69 116 104 83 78Skin, other malignancies Ž 718 – – 1 2 – 3 3 8 15 26 35 47 59 94 130 117 178 174 Dojka M 14 – – – – – – – – – 1 1 1 4 2 1 3 1Breast Ž 1030 – – – – – 5 9 35 71 103 119 104 130 127 140 105 82 Institute of Oncology Ljubljana, Cancer Registry of Slovenia nadaljevanje / cont’d ➝ Tabela 4b. – Table 4b. Nadaljevanje – Continued Šifra Primarna Vse S t a r o s t i MKB lokacija Spol starosti A g e ICD Primary Sex All code site ages 0– 5– 10– 15– 20– 25– 30– 35– 40– 45– 50– 55– 60– 65– 70– 75– 80+ 180 Maternica, vrat M – – – – – – – – – – – – – – – – – –Uterus, cervix Ž 187 – – – 1 4 4 21 24 21 29 20 15 12 8 11 7 10 181 Horioepiteliom M – – – – – – – – – – – – – – – – – –Chorioepithelioma Ž – – – – – – – – – – – – – – – – – – 182 Maternica, telo, drugo M – – – – – – – – – – – – – – – – – –Uterus, corpus, etc. Ž 309 – – – – – – 1 2 7 18 33 32 50 38 64 37 27 183 Jajčnik, jajcevod, drugo M – – – – – – – – – – – – – – – – – –Ovary, Fallopian tube, other Ž 174 – – – – 2 1 4 5 9 13 10 17 28 26 31 12 16 184 Nožnica, vulva, drugo M – – – – – – – – – – – – – – – – – –Vagina, vulva, etc. Ž 67 – – – – – – – – 2 3 4 4 12 5 8 15 14 185 Prostata M 541 – – – – – – – – – 5 17 33 73 138 111 86 78Prostate Ž – – – – – – – – – – – – – – – – – – 186 Modo M 78 – – – 3 11 15 18 13 7 5 3 2 1 – – – –Testis Ž – – – – – – – – – – – – – – – – – – 187 Penis, obmodek, drugo M 5 – – – – – – – – – – 1 – – 1 2 1 –Penis, epididymis, etc. Ž – – – – – – – – – – – – – – – – – – 188 Sečni mehur M 136 – – – – – – 1 1 1 9 7 7 14 33 25 24 14Bladder Ž 50 – – – – – – – – 3 – 1 1 2 4 11 13 15 189 Ledvica, sečevod, drugo M 146 – 2 – – – – – 1 4 10 21 16 18 23 22 20 9Kidney, ureter, etc. Ž 55 2 – – – – – 1 1 2 3 1 7 5 9 6 11 7 190 Oko M 11 – – – – – – – – 1 2 1 2 1 2 2 – –Eye Ž 8 – – – – – – 1 – – – 1 – – 1 1 2 2 191 Možgani M 70 3 1 2 2 – 1 1 3 3 8 7 12 8 9 6 2 2Brain Ž 64 3 1 – 1 1 3 1 4 1 2 9 4 7 7 10 8 2 192 Živčevje, drugo M 6 2 – – – – 2 – – – – – – 1 – 1 – –Nervous system, other Ž 8 1 – – – – – – 1 – 1 2 – 1 2 – – – 193 Ščitnica M 22 – – – – 1 1 2 2 3 – 3 1 2 2 2 2 1Thyroid Ž 76 – – 2 2 4 5 4 5 5 6 13 4 6 7 8 4 1 194 Endokrine žleze, druge M 5 – – – – 1 – – – 1 – – 1 1 – 1 – –Endocrine glands, other Ž 3 – – – – – – – – 1 – – – – – 2 – – 195 Slabo opredeljene lokacije M 6 1 – – 1 – – – – – – – – – – 1 – 3Ill-defined site Ž 15 – – – – – – – – – – 1 – 3 – 2 6 3 196 Metastaze v bezgavkah M 29 – – – – – – – – – 3 5 5 1 7 5 2 1Lymph node metastases Ž 18 – – – – – – – 1 – – 3 1 1 3 – 3 6 197 Metastaze v dihalih, prebavilih M 85 – – – – – – – – 1 1 3 5 9 13 21 16 16 Respirative, digestive Ž 67 – – – – – – – – 2 1 2 2 1 6 12 18 23 tract metastases 198 Metastaze, drugje M 16 – – – – – – – – – 1 4 1 4 1 2 2 1Metastases, other Ž 17 – – – – – – – – – 1 – – 2 – 4 5 5 199 Malignomi, neopredeljeni M 42 – – – – – – – – 1 – 3 3 6 5 11 8 5Malignancies, unspecified Ž 33 – – – – – – – – – 1 2 2 2 3 6 9 8 200 + Ne-Hodgkinovi limfomi M 75 1 – – 1 2 1 2 2 2 6 7 7 7 8 10 11 8 202 Non-Hodgkin's lymphoma Ž 62 – – 2 1 – 2 – 3 1 4 6 2 3 8 10 10 10 201 Hodgkinov limfom M 18 – 2 1 3 3 2 1 1 – 1 – 2 1 – – 1 –Hodgkin's disease Ž 25 – – 2 3 6 4 1 3 – 1 – – 1 1 1 1 1 203 Plazmocitom M 24 – – – – – – – 1 – 2 2 1 1 7 4 2 4Plasmocytoma Ž 35 – – – – – – – – – 1 3 2 3 3 8 11 4 204.0 Levkemija, limfatična, akutna M 10 4 – – 1 – – 1 1 – 2 – – 1 – – – – Leukaemia, lymphatic, Ž 12 6 1 – – – 1 1 – – – – – 2 1 – – – acute Levkemija, limfatična, 204.1 drugo M 32 – – – – – – – – 1 1 1 1 1 7 9 2 9 - 204.9 Leukaemia, lymphatic, Ž 28 – – – – – 1 – – 1 1 1 1 3 4 3 5 8 other 205 Levkemija, mieloična M 30 – – – 1 – 1 2 3 – 4 3 1 1 6 4 1 3Leukaemia, myeloic Ž 26 – – 1 1 – – 1 1 – 4 2 – 4 4 2 4 2 206 Levkemija, monocitna M 8 – – – 1 1 – – – 1 – – 1 2 – – 2 –Leukaemia, monocytic Ž 7 – – – – – – 1 – – 1 – 1 – 2 1 – 1 207 Levkemije, druge M 5 – – – – – – – 1 – – 1 – 1 – – 1 1Leukaemias, other Ž 5 – – – – – – 1 – – – – 1 – 1 1 – 1 208 Policitemija, prava M 2 – – – – – – – – – – 1 – – – 1 – –Polycithemia vera Ž 2 – – – – – – – – – – – – – – 1 1 – 209 Mielofibroza M 3 – – – – – – – – – – 1 – – 1 1 – –Myelofibrosis Ž 4 – – – – – – – – – – 1 – – – – 2 1 Cancer Incidence in Slovenia 2002 41 42 Incidenca raka v Sloveniji 2002 Onkološki inštitut Ljubljana, Register raka za Slovenijo Tabela 4b. – Table 4b. Nadaljevanje – Continued Šifra Primarna Vse S t a r o s t i MKB lokacija Spol starosti A g e ICD Primary Sex All code site ages 0– 5– 10– 15– 20– 25– 30– 35– 40– 45– 50– 55– 60– 65– 70– 75– 80+ Zgoraj neupoštevani Not included above 219 Maternični vrat, in situ (CIN III) M – – – – – – – – – – – – – – – – – – + 234 Cervix uteri, in situ (CIN III) Ž 901 – – – 2 47 179 194 196 127 92 29 11 8 8 5 1 2 225.0 Možgani, benigni tumor M 15 – – – – 2 1 – 1 1 – 1 1 4 2 2 – – + 225.2 Brain, benign tumor Ž 53 – – – – – 2 – 5 4 4 6 6 5 7 7 5 2 232.2 Maligni melanom, in situ M 14 – – – – – 1 – – 2 1 1 2 1 2 3 1 –Malignant melanoma, in situ Ž 9 – – – – – 1 – – – – 3 – – – 3 2 – 233 Dojka, in situ M – – – – – – – – – – – – – – – – – –Breast, in situ Ž 71 – – – – – – 1 1 5 20 10 10 9 6 6 1 2 Jajčnik, neopl. negotovega značaja M – – – – – – – – – – – – – – – – – –235 Ovary, neopl. Ž 31 – – – – 1 – 1 3 1 5 4 1 6 6 1 – 2 of uncertain behavior 237.6 Sečni mehur, in situ M 56 – – – – 1 1 1 – 1 3 6 6 5 9 14 6 3Urinary bladder, in situ Ž 9 – – – – – – – – – 1 1 1 1 1 – 3 1 238.1 Možgani, neopredeljeno M 4 – – – – – – – – – – 2 – 1 – 1 – –Brain, unspecified Ž 9 – – 1 – – – – – – – – – 1 1 1 1 4 nadaljevanje / cont’d ➝ Tabela 5. Incidenca raka na 100.000 prebivalcev po spolu in starosti ter kumulativna stopnja (KS) po lokaciji - Slovenija 2002 Table 5. Cancer incidence per 100,000 population by sex and age, and cumulative rate (CR) by site - Slovenia 2002 Šifra Primarna Vse S t a r o s t i KS MKB lokacija Spol starosti A g e CR ICD Primary Sex All code site ages 0 – 5 – 10 – 15 – 20 – 25 – 30 – 35 – 40 – 45 – 50 – 55 – 60 – 65 – 70 – 75 – 80 + 0 – 74 Skupaj 468,8 25,7 10,2 11,2 25,9 31,9 50,1 73,9 115,9 187,6 332,0 535,3 747,7 1057,6 1522,8 1819,4 2006,6 2262,0 32,7 C00 Vse lokacije Total – Moški 480,4 23,8 14,0 5,1 26,9 37,3 48,0 60,2 74,8 128,4 284,5 551,3 858,2 1244,4 2062,1 2348,6 2950,9 3228,2 38,8 C96 All sites Male Ženske 457,7 27,7 6,3 17,8 24,9 26,2 52,5 88,0 157,8 248,9 383,1 518,4 640,8 887,7 1096,4 1468,1 1570,1 1912,8 28,2 Female C00 Ustnica M 2,2 – – – – – – – – 1,3 3,6 – 1,9 6,0 4,7 20,9 15,8 7,3 0,2 Lip Ž 1,2 – – – – – – – – 1,3 1,3 – – – 1,9 5,9 7,3 7,9 0,1 C01 Baza jezika M 1,5 – – – – – – – – – 1,2 4,1 5,7 4,0 2,4 8,9 5,3 7,3 0,1 Base of tongue Ž – – – – – – – – – – – – – – – – – – – C02 Jezik, drugi deli M 2,6 – – – – – – – – – 9,6 5,5 3,8 2,0 7,1 14,9 10,5 – 0,2 Tongue, other & Ž 0,3 – – – – – – – – – – – – – 3,7 – 2,4 – 0,0 unspecified parts C03 Dlesen M 0,4 – – – – – – – – 1,3 1,2 1,4 – – – – 5,3 – 0,0 Gum Ž 0,5 – – – – – – – – – – 1,4 – – 5,6 – – 2,6 0,0 C04 Ustno dno M 3,4 – – – – – – – 1,3 2,5 3,6 5,5 19,0 10,0 9,4 6,0 10,5 – 0,3 Floor of mouth Ž 0,5 – – – – – – – 1,3 – 1,3 1,4 1,8 1,8 – – – – 0,0 C05 Nebo M 1,0 – – – – – – – – – 1,2 4,1 1,9 6,0 4,7 – – – 0,1 Palate Ž 0,3 – – – – – – – – – 1,3 – – – 3,7 – – – 0,0 C06 Usta, drugi deli M 1,4 – – – – – – – – – 2,4 8,2 5,7 2,0 – 3,0 5,3 – 0,1 Mouth, other & Ž 0,6 – – – – – – – – – 1,3 – – 1,8 1,9 5,9 – – 0,1 unspecified parts C07 Parotidna žleza M 0,7 – – – – – – – 1,3 1,3 – – 1,9 4,0 2,4 3,0 – – 0,1 Parotid gland Ž 0,5 – – – – – – – – 1,3 2,6 – 1,8 – – – 2,4 – 0,0 C08 Druge in neopredeljene velike žleze slinavke M – – – – – – – – – – – – – – – – – – – Other & unspecified Ž 0,2 – – – – – – – – – – – – 1,8 1,9 – – – 0,0 major salivary glands C09 Tonzila M 3,1 – – – – – – – – 1,3 2,4 12,3 5,7 12,0 16,5 – 10,5 – 0,3 Tonsil Ž 0,5 – – – – – – – – – 1,3 – – 1,8 1,9 2,0 – 2,6 0,0 C10 Orofarinks M 3,6 – – – – – – – – 3,8 7,2 12,3 7,6 4,0 18,9 3,0 10,5 – 0,3 Oropharynx Ž 0,4 – – – – – – – – – 1,3 1,4 – – – – 2,4 2,6 0,0 C11 Nazofarinks M 0,5 – – – 1,5 – – – 1,3 – 1,2 2,7 – – – – – – 0,0 Nasopharynx Ž 0,8 – – – – – – 1,4 – 1,3 – 1,4 1,8 3,7 3,7 – – – 0,1 C a ncer Incid ence in Slovenia 2002 43 Institute of O ncolog y Ljub lja na , C a ncer Reg istry of Slovenia nadaljevanje / cont’d ➝ Tabela 5. – Table 5. Nadaljevanje – Continued Šifra Primarna Vse S t a r o s t i KS MKB lokacija Spol starosti A g e CR ICD Primary Sex All code site ages 0 – 5 – 10 – 15 – 20 – 25 – 30 – 35 – 40 – 45 – 50 – 55 – 60 – 65 – 70 – 75 – 80 + 0 – 74 C12 Piriformni sinus M 2,6 – – – – – – – – – 2,4 8,2 3,8 10,0 14,2 6,0 5,3 7,3 0,2 Pyriform sinus Ž 0,2 – – – – – – – – – – – 1,8 – 1,9 – – – 0,0 C13 Hipofarinks M 2,6 – – – – – – – – – 3,6 9,6 9,5 4,0 7,1 11,9 – 7,3 0,2 Hypopharynx Ž 0,2 – – – – – – – – – – – – 1,8 – – – 2,6 0,0 Druga in slabo opredeljena mesta na ustnici, C14 v ustni votlini in farinksu M 0,1 – – – – – – – – – – 1,4 – – – – – – 0,0 Other and ill-defined sites in Ž – – – – – – – – – – – – – – – – – – – the lip, oral cavity and pharynx C15 Požiralnik M 7,9 – – – – – – 1,4 – 2,5 7,2 13,6 24,7 22,1 28,3 29,8 36,8 36,4 0,6 Oesophagus Ž 2,3 – – – – – – 1,4 – – 1,3 – – 1,8 9,3 7,9 2,4 26,3 0,1 C16 Želodec M 27,7 – – – – – – 2,7 1,3 11,4 9,6 27,3 41,9 84,3 96,8 158,0 215,3 225,4 2,2 Stomach Ž 17,0 – – – – – 1,4 2,8 2,6 4,0 6,4 11,5 16,6 16,4 54,2 71,2 63,1 113,0 0,9 C17 Tanko črevo M 1,1 – – – – – – – – – 2,4 2,7 – – 4,7 3,0 10,5 14,5 0,1 Small intestine Ž 0,5 – – – – – – – – 1,3 – – – – 1,9 – 4,9 2,6 0,0 C18 Debelo črevo M 36,4 – – – – 1,3 1,3 – 2,5 6,4 23,9 31,4 59,0 76,3 200,8 181,8 210 349,0 2,9 Colon Ž 28,9 – – – – 1,4 1,4 1,4 5,2 6,6 9,0 25,9 31,3 51,1 72,8 98,9 138,3 176,0 1,5 C19 Rektosigmoidna zveza M 6,4 – – – – – – – – 2,5 8,4 4,1 5,7 30,1 33,1 8,9 42,0 50,9 0,5 Rectosigmoid junction Ž 3,7 – – – – – – – – 4,0 2,6 1,4 1,8 7,3 16,8 11,9 14,6 15,8 0,2 C20 Rektum M 25,7 – – – – – – – 2,5 2,5 9,6 27,3 40,0 88,3 134,6 143,1 141,8 160,0 2,2 Rectum Ž 17,2 – – – – – – – 1,3 2,6 6,4 15,8 14,7 32,9 57,9 61,3 77,7 94,6 1,0 C21 Anus in analni kanal M 0,3 – – – – – – – – – 1,2 – – – 2,4 – 5,3 – 0,0 Anus and anal canal Ž 0,9 – – – – – – – – – 1,3 – – 3,7 1,9 2,0 2,4 7,9 0,0 C22 Jetra in intrahepatični vodi M 9,8 – – – – – 1,3 – 1,3 2,5 4,8 6,8 15,2 26,1 47,2 59,6 73,5 58,2 0,8 Liver and intrahepatic bile ducts Ž 3,7 – – – – – – – – 1,3 1,3 – 9,2 5,5 5,6 17,8 21,8 18,4 0,2 C23 Žolčnik M 1,3 – – – – – – – – 1,3 – – 3,8 2,0 4,7 6,0 26,3 – 0,1 Gallbladder Ž 4,3 – – – – – – – – – 1,3 – 1,8 9,1 5,6 15,8 26,7 39,4 0,2 Drugi in neopredeljeni deli biliarnega trakta M 3,6 – – – – – – – – 1,3 2,4 5,5 9,5 6,0 14,2 17,9 5,3 50,9 0,3C24 Billiary tract, other and Ž 4,0 – – – – – – – – – – 1,4 1,8 16,4 5,6 11,9 17,0 36,8 0,2 unspecified parts C25 Trebušna slinavka M 11,3 – – – – – – – 2,5 2,5 6,0 15,0 20,9 26,1 44,9 62,6 63,0 101,8 0,9 Pancreas Ž 12,8 – – – – – – – 2,6 6,6 7,7 2,9 11,0 18,3 31,8 49,5 60,7 86,7 0,7 Druga in slabo opredeljena mesta C26 v prebavnih organih M 0,1 – – – – – – – – – – 1,4 – – – – – – 0,0 Other and ill-defined Ž 0,8 – – – – – – – – – – – – 1,8 3,7 – 2,4 10,5 0,0 digestive organs 44 Incid enca ra ka v Sloveniji 2002 O nkološki inštitut Ljub lja na , Reg ister ra ka za Slovenijo nadaljevanje / cont’d ➝ Tabela 5. – Table 5. Nadaljevanje – Continued Šifra Primarna Vse S t a r o s t i KS MKB lokacija Spol starosti A g e CR ICD Primary Sex All code site ages 0 – 5 – 10 – 15 – 20 – 25 – 30 – 35 – 40 – 45 – 50 – 55 – 60 – 65 – 70 – 75 – 80 + 0 – 74 Nosna votlina in srednje uho M 0,2 – – – – – – – – – – – – – – 6,0 – – 0,0C30 Nasal cavity and middle ear Ž 0,3 – – – – – – – – – – – – 3,7 – – 2,4 – 0,0 C31 Obnosni sinusi M 0,5 – – – – – – – – 2,5 – 1,4 – – – 6,0 – – 0,0 Accessory sinuses Ž 0,4 – – – – – – – – – – 1,4 – – 1,9 4,0 – – 0,0 C32 Grlo M 10,0 – – – – – – – 2,5 5,1 12,0 10,9 32,4 30,1 56,7 20,9 36,8 29,1 0,9 Larynx Ž 1,1 – – – – – – – – 1,3 3,9 1,4 1,8 1,8 1,9 2,0 4,9 – 0,1 C33 Sapnik M 0,3 – – – – – – – – – – 1,4 – 2,0 2,4 – – – 0,0 Trachea Ž 0,2 – – – – – – – – – – – – – – 2,0 – 2,6 0,0 C34 Sapnica in pljuča M 80,6 – – – – – – – 2,5 10,2 31,1 110,5 190,3 266,9 354,3 462,0 509,3 254,5 7,1 Bronchus and lung Ž 25,3 – – – – – – 1,4 1,3 13,2 20,6 33,1 53,4 48,5 76,6 100,9 77,7 73,6 1,7 C37 Timus M 0,1 – – – – – – – – – – – – 2,0 – – – – 0,0 Thymus Ž – – – – – – – – – – – – – – – – – – – C38 Srce, mediastinum, plevra M 0,2 – – – – 1,3 – – – – – – – – – 3,0 – – 0,0 Heart, mediastinum, pleura Ž 0,1 – – – – – – – – – – – – – – – – 2,6 0,0 C39 Druga in slabo opredeljena mesta v dihalih in prsnih organih M 0,1 – – – – – – – – – – – – – – 3,0 – – 0,0 Other and ill-defined sites Ž – – – – – – – – – – – – – – – – – – – in the respiratory system and intrathoracic organs Kosti, sklepni hrustanec udov M 0,4 – – – 1,5 – – 2,7 – – 1,2 – – – – – – – 0,0 C40 Bone and articular Ž 0,5 – 2,1 1,8 3,1 – – – – – – – – – – – 2,4 – 0,0 cartilage of limbs C41 Kosti, sklepni hrustanec, drugje M 0,5 – – – 1,5 – – – – 2,5 1,2 – – – – 3,0 – – 0,0 Bone and articular cartilage Ž 0,3 – – – 1,6 – – – – – – – – 1,8 – – 2,4 – 0,0 of other and unspecified parts C43 Maligni melanom kože M 11,9 – – – 1,5 2,6 5,2 4,1 3,8 8,9 9,6 21,8 24,7 32,1 28,3 35,8 31,5 94,5 0,9 Malignant melanoma of skin Ž 15,1 – – 1,8 – – 8,3 7,1 16,8 15,8 25,7 18,7 18,4 31,1 29,9 33,6 26,7 34,2 1,0 C44 Druge maligne neoplazme kože M 62,5 – – – 1,5 3,9 7,8 6,8 11,4 19,1 28,7 57,3 108,5 136,5 274,0 307,0 435,8 567,1 4,8 Skin, other malignomas Ž 70,1 – – 1,8 3,1 – 4,1 4,3 10,3 19,8 33,4 49,0 86,5 107,8 171,8 257,2 283,9 467,7 3,7 C45 Mezoteliom M 2,3 – – – – – – – – – 3,6 4,1 3,8 10,0 9,4 3,0 5,3 21,8 0,2 Mesothelioma Ž 0,9 – – – – – – – – – 1,3 – 3,7 5,5 1,9 – 2,4 2,6 0,1 C46 Kaposijev sarkom M – – – – – – – – – – – – – – – – – – – Kaposi's sarcoma Ž – – – – – – – – – – – – – – – – – – – C a ncer Incid ence in Slovenia 2002 45 Institute of O ncolog y Ljub lja na , C a ncer Reg istry of Slovenia nadaljevanje / cont’d ➝ Tabela 5. – Table 5. Nadaljevanje – Continued Šifra Primarna Vse S t a r o s t i KS MKB lokacija Spol starosti A g e CR ICD Primary Sex All code site ages 0 – 5 – 10 – 15 – 20 – 25 – 30 – 35 – 40 – 45 – 50 – 55 – 60 – 65 – 70 – 75 – 80 + 0 – 74 Periferni živci in avtonomno živčevje M 0,4 4,3 – – – – 2,6 – – – – – – – – – – – 0,0 C47 Peripheral nerves and Ž 0,1 – – – – – – – 1,3 – – – – – – – – – 0,0 autonomic nervous system C48 Retro- in peritonej M 1,1 – – – – 1,3 – 1,4 – – – – 1,9 6,0 2,4 3,0 10,5 7,3 0,1Retro- and peritoneum Ž 0,3 – – – – – – – – – – 1,4 – – – 2,0 – 2,6 0,0 Drugo vezivno in mehko tkivo M 2,2 – – – – 1,3 1,3 – 2,5 2,5 1,2 4,1 5,7 2,0 4,7 8,9 5,3 7,3 0,2C49 Other connective and Ž 2,0 – – – 3,1 – – – 2,6 – 1,3 4,3 5,5 – 5,6 4,0 – 10,5 0,1 soft tissue C50 Dojka M 1,4 – – – – – – – – – 1,2 1,4 1,9 8,0 4,7 3,0 15,8 7,3 0,1Breast Ž 100,6 – – – – – 6,9 12,8 45,3 93,5 132,4 171,4 189,7 234,6 235,3 275,0 254,8 215,5 7,0 C51 Žensko zunanje spolovilo M – – – – – – – – – – – – – – – – – – –Vulva Ž 4,2 – – – – – – – – 2,6 2,6 1,4 7,4 11,0 5,6 11,9 26,7 21,0 0,2 C52 Nožnica M – – – – – – – – – – – – – – – – – – –Vagina Ž 1,7 – – – – – – – – – 1,3 2,9 – 7,3 3,7 2,0 9,7 7,9 0,1 C53 Maternični vrat M – – – – – – – – – – – – – – – – – – –Cervix uteri Ž 18,3 – – – 1,6 5,5 5,5 29,8 31,0 27,7 37,3 28,8 27,6 21,9 14,9 21,8 17,0 26,3 1,3 C54 Maternično telo M – – – – – – – – – – – – – – – – – – –Corpus uteri Ž 29,3 – – – – – – 1,4 2,6 9,2 20,6 46,1 58,9 91,3 71,0 118,7 84,9 68,3 2,1 C55 Maternica, neopredeljeno M – – – – – – – – – – – – – – – – – – –Uterus, unspecified Ž 1,0 – – – – – – – – – 2,6 1,4 – – – 7,9 4,9 2,6 0,1 C56 Jajčnik M – – – – – – – – – – – – – – – – – – –Ovary Ž 16,6 – – – – 2,8 1,4 5,7 6,5 10,5 16,7 14,4 31,3 51,1 46,7 59,4 26,7 39,4 1,2 Drugi in neopredeljeni ženski spolni organi M – – – – – – – – – – – – – – – – – – –C57 Other and unspecified parts Ž 1,2 – – – – – – – – 1,3 – 1,4 – 3,7 1,9 4,0 2,4 10,5 0,1 of female genital organs C58 Posteljica M – – – – – – – – – – – – – – – – – – –Placenta Ž – – – – – – – – – – – – – – – – – – – C60 Penis M 0,4 – – – – – – – – – – 1,4 – – 2,4 3,0 5,3 – 0,0Penis Ž – – – – – – – – – – – – – – – – – – – C61 Prostata M 55,4 – – – – – – – – – 6,0 23,2 62,8 146,5 326,0 330,8 451,6 567,1 4,5Prostate Ž – – – – – – – – – – – – – – – – – – – C62 Modo M 8,0 – – – 4,5 14,1 19,5 24,6 16,5 8,9 6,0 4,1 3,8 2,0 – – – – 0,5Testis Ž – – – – – – – – – – – – – – – – – – – C63 Drugi in neopredeljeni moški spolni organi M 0,3 – 2,0 – – – – – – – – – – 2,0 – 3,0 – – 0,0 Other and unspecified Ž – – – – – – – – – – – – – – – – – – – male genital organs 46 Incid enca ra ka v Sloveniji 2002 O nkološki inštitut Ljub lja na , Reg ister ra ka za Slovenijo nadaljevanje / cont’d ➝ Tabela 5. – Table 5. Nadaljevanje – Continued Šifra Primarna Vse S t a r o s t i KS MKB lokacija Spol starosti A g e CR ICD Primary Sex All code site ages 0 – 5 – 10 – 15 – 20 – 25 – 30 – 35 – 40 – 45 – 50 – 55 – 60 – 65 – 70 – 75 – 80 + 0 – 74 C64 Ledvica razen meha M 13,4 – 4,0 – – – – – 1,3 5,1 8,4 27,3 30,4 34,1 52,0 53,6 89,3 50,9 1,1 Kidney, except renal pelvis Ž 4,9 4,6 – – – – – 1,4 1,3 2,6 3,9 1,4 11,0 9,1 11,2 9,9 26,7 18,4 0,3 C65 Ledvični meh M 0,9 – – – – – – – – – 2,4 – – – – 8,9 10,5 14,5 0,1 Renal pelvis Ž 0,5 – – – – – – – – – – – 1,8 – 5,6 2,0 – – 0,0 C66 Sečevod M 0,4 – – – – – – – – – – 1,4 – 2,0 – 3,0 5,3 – 0,0 Ureter Ž – – – – – – – – – – – – – – – – – – – C67 Sečni mehur M 13,9 – – – – – – 1,4 1,3 1,3 10,8 9,6 13,3 28,1 77,9 74,5 126,0 101,8 1,1 Bladder Ž 4,9 – – – – – – – – 4,0 – 1,4 1,8 3,7 7,5 21,8 31,5 39,4 0,2 Drugi in neopredeljeni sečni organi M 0,1 – – – – – – – – – – – – – 2,4 – – – 0,0 C68 Other and unspecified Ž – – – – – – – – – – – – – – – – – – – urinary organs C69 Oko in očesni adneksi M 0,9 – – – – – – – – 1,3 1,2 1,4 3,8 2,0 4,7 3,0 – – 0,1 Eye and adnexa Ž 0,8 – – – – – – 1,4 – – – 1,4 – – 1,9 2,0 4,9 5,3 0,0 C70 Meninge M 0,1 – – – – – – – – – – – – – – 3,0 – – 0,0 Meninges Ž 0,5 – – – – – – – – – 1,3 2,9 – 1,8 1,9 – – – 0,0 C71 Možgani M 6,9 6,5 – 3,4 3,0 – 1,3 1,4 3,8 3,8 9,6 9,6 20,9 14,0 21,3 17,9 10,5 14,5 0,6 Brain Ž 5,9 6,9 2,1 – 1,6 1,4 4,1 1,4 5,2 1,3 2,6 13,0 5,5 12,8 13,1 15,8 17,0 5,3 0,4 Hrbtni mozeg, možganski živci in drugi deli CŽS M 0,1 – – – – – – – – – – – – 2,0 – – – – 0,0 C72 Spinal cord, cranial nerves Ž 0,1 – – – – – – – – – – – – – 1,9 – – – 0,0 and other parts of CNS C73 Ščitnica M 2,3 – – – – 1,3 1,3 2,7 2,5 3,8 – 4,1 1,9 4,0 4,7 6,0 10,5 7,3 0,2 Thyroid gland Ž 7,4 – – 3,6 3,1 5,5 6,9 5,7 6,5 6,6 7,7 18,7 7,4 11,0 13,1 13,8 9,7 2,6 0,5 C74 Nadledvična žleza M 0,2 – – – – – – – – – – – 1,9 – – 3,0 – – 0,0 Adrenal gland Ž 0,4 2,3 – – – – – – – 1,3 – – – – – 4,0 – – 0,0 C75 Druge endokrine žleze in sorodne strukture M 0,2 – – – – 1,3 – – – 1,3 – – – – – – – – 0,0 Other endocrine glands Ž – – – – – – – – – – – – – – – – – – – and related structures Druga in slabo opredeljena mesta M 0,6 2,2 – – 1,5 – – – – – – – – – – 3,0 – 21,8 0,0C76 Other and ill-defined sites Ž 1,4 – – – – – – – – – – 1,4 – 5,5 – 4,0 14,6 5,3 0,1 C77 Metastaza in neopredeljena maligna neoplazma bezgavk M 3,0 – – – – – – – – – 3,6 6,8 9,5 2,0 16,5 14,9 10,5 7,3 0,3 Metastasis and unspecified Ž 1,8 – – – – – – – 1,3 – – 4,3 1,8 1,8 5,6 – 7,3 15,8 0,1 malignant neoplasm of lymph nodes C a ncer Incid ence in Slovenia 2002 47 Institute of O ncolog y Ljub lja na , C a ncer Reg istry of Slovenia nadaljevanje / cont’d ➝ Tabela 5. – Table 5. Nadaljevanje – Continued Šifra Primarna Vse S t a r o s t i KS MKB lokacija Spol starosti A g e CR ICD Primary Sex All code site ages 0 – 5 – 10 – 15 – 20 – 25 – 30 – 35 – 40 – 45 – 50 – 55 – 60 – 65 – 70 – 75 – 80 + 0 – 74 Metastaze dihal in prebavil M 6,7 – – – – – – – – – 1,2 4,1 5,7 16,1 21,3 56,6 42,0 101,8 0,5 Metastases of respiratory C78 and digestive organs Ž 5,7 – – – – – – – – 2,6 1,3 2,9 3,7 1,8 9,3 19,8 36,4 52,5 0,2 C79 Metastaze, drugje M 1,6 – – – – – – – – – 1,2 5,5 1,9 8,0 2,4 6,0 10,5 7,3 0,1 Metastases of other sites Ž 1,7 – – – – – – – – – 1,3 – – 3,7 – 7,9 12,1 13,1 0,1 Maligna neoplazma brez opredeljenega mesta M 4,3 – – – – – – – – 1,3 – 4,1 5,7 12,0 11,8 32,8 42,0 36,4 0,3 C80 Malignant neoplasm Ž 3,2 – – – – – – – – – 1,3 2,9 3,7 3,7 5,6 11,9 21,8 21,0 0,1 without specification of site C81 Hodgkinova bolezen M 1,8 – 4,0 1,7 4,5 3,9 2,6 1,4 1,3 – 1,2 – 3,8 2,0 – – 5,3 – 0,1 Hodgkin's disease Ž 2,5 – – 3,6 4,7 8,3 5,5 1,4 3,9 – 1,3 – – 1,8 1,9 2,0 2,4 2,6 0,2 Folikularni ne-Hodgkinov limfom M 2,2 – – – – – – – 1,3 – 7,2 4,1 3,8 4,0 – 11,9 5,3 14,5 0,2 C82 Follicular non-Hodgkin's Ž 1,5 – – – – – 1,4 – 1,3 – – 4,3 5,5 3,7 – 4,0 2,4 5,3 0,1 lymphoma C83 Difuzni ne-Hodgkinov limfom M 7,0 2,2 – – – 3,9 1,3 1,4 1,3 2,5 8,4 5,5 17,1 18,1 21,3 8,9 63,0 43,6 0,5 Diffuse non-Hodgkin's lymphoma Ž 5,4 – – 1,8 – – 1,4 – 1,3 1,3 3,9 5,8 5,5 7,3 14,9 21,8 26,7 18,4 0,3 Limfomi celic T in kožni limfom celic T M 1,0 – 2,0 – – – – 2,7 1,3 1,3 1,2 – 1,9 – 2,4 3,0 5,3 – 0,1 C84 Peripheral and cutaneous Ž 0,7 – – 1,8 1,6 – – – 1,3 – 1,3 1,4 – – 3,7 – – – 0,1 T-cell lymphomas C85 Druge in neopredeljene vrste ne-Hodgkinovega limfoma M 1,8 – 2,0 – 1,5 – – – – – – 2,7 – 2,0 2,4 17,9 15,8 21,8 0,1 Other and unspecified types Ž 1,9 – – – – – – – – – – – 1,8 – 3,7 13,8 4,9 18,4 0,1 of non-Hodgkin's lymphoma Maligne imunoproliferativne bolezni M 0,1 – – – – – – – – – – – 1,9 – – – – – 0,0 C88 Malignant immunoproliferative Ž – – – – – – – – – – – – – – – – – – – diseases C90 Difuzni plazmocitom in maligne neoplazme plazmocitov M 2,8 – – – – – – – 1,3 – 2,4 2,7 3,8 4,0 16,5 11,9 15,8 29,1 0,2 Multiple myeloma and Ž 3,4 – – – – – – – – – 1,3 4,3 3,7 5,5 5,6 15,8 26,7 10,5 0,2 malignant plasma cell neoplasms C91.0 Limfatična levkemija, akutna M 0,9 8,6 – – 1,5 – – 1,4 – – 2,4 – – 2,0 – – – – 0,1 Lymphoblastic leukaemia, acute Ž 1,2 13,9 2,1 – – – 1,4 1,4 – – – – – 3,7 1,9 – – – 0,1 C91.1 - Limfatična levkemija, druga M 3,6 – – – – – – – 1,3 1,3 1,2 1,4 1,9 4,0 16,5 26,8 15,8 65,4 0,3 C91.9 Lymphoid leukaemia, other Ž 2,9 – – – – – 1,4 – – 1,3 1,3 1,4 3,7 5,5 7,5 7,9 12,1 21,0 0,2 48 Incid enca ra ka v Sloveniji 2002 O nkološki inštitut Ljub lja na , Reg ister ra ka za Slovenijo Tabela 5. – Table 5. Nadaljevanje – Continued Šifra Primarna Vse S t a r o s t i KS MKB lokacija Spol starosti A g e CR ICD Primary Sex All code site ages 0 – 5 – 10 – 15 – 20 – 25 – 30 – 35 – 40 – 45 – 50 – 55 – 60 – 65 – 70 – 75 – 80 + 0 – 74 C92 Mieloična levkemija M 3,6 – – – 3,0 – 1,3 2,7 3,8 – 4,8 4,1 3,8 4,0 14,2 11,9 15,8 21,8 0,3 Myeloid leukaemia Ž 3,1 – – 1,8 1,6 – – 2,8 1,3 – 5,1 2,9 1,8 7,3 11,2 5,9 9,7 7,9 0,2 C93 Monocitna levkemija M 0,3 – – – – 1,3 – – – 1,3 – – – 2,0 – – – – 0,0 Monocytic leukaemia Ž 0,1 – – – – – – – – – 1,3 – – – – – – – 0,0 C94 Druge opredeljene levkemije M 0,1 – – – – – – – – – – 1,4 – – – – – – 0,0 Other leukaemias Ž – – – – – – – – – – – – – – – – – – – of specified cells C95 Levkemija z neopredeljenim celičnim tipom M 0,2 – – – – – – – 1,3 – – – – – – – – 7,3 0,0 Leukaemia, unspecified cell type Ž 0,3 – – – – – – 1,4 – – – – – – 1,9 – – 2,6 0,0 Druge in neopredeljene maligne neoplazme limfatičnega, krvotvornega ali sorodnega tkiva M 3,3 – – – – – 1,3 1,4 – – 1,2 4,1 1,9 6,0 9,4 20,9 36,8 29,1 0,2C96 Other and unspecified malignant Ž 4,0 – – – – 1,4 1,4 1,4 3,9 2,6 1,3 5,8 1,8 – 5,6 15,8 26,7 13,1 0,2 neoplasms of lymphoid, haematopoietic and related tissue Zgoraj neupoštevani Not included above D03 Melanom, in situ M 1,5 – – – – – 1,3 – – 2,5 2,4 1,4 3,8 2,0 4,7 8,9 5,3 – 0,1 Melanoma, in situ Ž 0,9 – – – – – 1,4 – – – – 4,3 – – – 5,9 4,9 – 0,1 D05 Dojka, in situ M – – – – – – – – – – – – – – – – – – – Breast, in situ Ž 7,0 – – – – – – 1,4 1,3 6,6 25,7 14,4 18,4 16,4 11,2 11,9 2,4 5,3 0,5 D06 Maternični vrat, in situ (CIN III) M – – – – – – – – – – – – – – – – – – – Cervix uteri, in situ (CIN III) Ž 88,4 – – – 3,1 64,7 247,1 275,4 253,6 167,2 118,3 41,8 20,3 14,6 14,9 9,9 2,4 5,3 6,2 D09.0 Karcinom in situ mehurja M 5,7 – – – – 1,3 1,3 1,4 – 1,3 3,6 8,2 11,4 10,0 21,3 41,7 31,5 21,8 0,5 Bladder, in situ Ž 0,9 – – – – – – – – – 1,3 1,4 1,8 1,8 1,9 – 7,3 2,6 0,0 D32.0 Meninge, benigna neoplazma M 1,5 – – – – 2,6 1,3 – 1,3 1,3 – 1,4 1,9 8,0 4,7 6,0 – – 0,1 Benign neoplasm of meninges Ž 5,1 – – – – – 2,8 – 6,5 5,3 5,1 8,6 9,2 9,1 13,1 13,8 12,1 5,3 0,4 D33.0 - Možgani, benigna neoplazma M – – – – – – – – – – – – – – – – – – – D33.2 Benign neoplasm of brain Ž 0,1 – – – – – – – – – – – 1,8 – – – – – 0,0 D39.1 Jajčnik, neopl. negotovega značaja M – – – – – – – – – – – – – – – – – – – Ovary, neopl. Ž 3,0 – – – – 1,4 – 1,4 3,9 1,3 6,4 5,8 1,8 11,0 11,2 2,0 – 5,3 0,2 of uncertain behavior D43.0 - Možgani, neopredeljeno M 0,4 – – – – – – – – – – 2,7 – 2,0 – 3,0 – – 0,0 D43.2 Brain, uncertain or unknown Ž 0,9 – – 1,8 – – – – – – – – – 1,8 1,9 2,0 2,4 10,5 0,0 C a ncer Incid ence in Slovenia 2002 49 Institute of O ncolog y Ljub lja na , C a ncer Reg istry of Slovenia 50 Incidenca raka v Sloveniji 2002 Onkološki inštitut Ljubljana, Register raka za Slovenijo Tabela 6a. Število novih primerov raka po statističnih regijah, po najpogostejših lokacijah in spolu - Slovenija 2002 Table 6a. Number of new cancer cases by statistical regions, by most frequent sites and sex - Slovenia 2002 Statistična Spol Skupaj Lokacija (šifre MKB-10) Druga regija C00-C96 C16 C18 C19 C20 C34 C44 C50 C53 C54 C61 Other D06* Statistical region Sex All sites Site (ICD-10 codes) Slovenija, skupaj M 4689 270 355 62 251 787 610 14 – – 541 1799 – Slovenia, total Ž 4667 173 295 38 175 258 715 1026 187 299 – 1501 901 Pomurska M 344 26 24 4 24 57 40 0 – – 53 116 – Ž 284 19 27 1 12 11 65 40 9 16 – 84 25 Podravska M 670 47 53 10 45 117 70 3 – – 70 255 – Ž 666 25 45 6 31 29 93 159 29 42 – 207 83 Koroška M 169 7 15 2 5 29 23 1 – – 13 74 – Ž 139 11 7 3 8 5 22 33 5 5 – 40 15 Savinjska M 466 30 40 8 26 76 39 1 – – 37 209 – Ž 513 26 32 7 22 30 59 105 28 40 – 164 157 Zasavska M 114 7 13 1 5 24 12 0 – – 8 44 – Ž 105 5 2 1 6 7 13 25 3 7 – 36 6 Spodnjeposavska M 167 16 16 4 6 36 12 0 – – 15 62 – Ž 144 6 6 3 7 9 12 30 9 15 – 47 31 Jugovzhodna Slovenija M 305 18 29 10 22 57 26 2 – – 21 120 – Ž 280 9 20 2 8 18 46 66 9 19 – 83 51 Osrednjeslovenska M 1250 57 86 17 53 192 200 4 – – 187 454 – Ž 1320 33 83 8 50 78 211 307 54 66 – 430 320 Gorenjska M 520 29 28 2 24 78 90 1 – – 68 200 – Ž 508 18 36 1 16 31 88 97 18 37 – 166 86 Notranjsko-kraška M 115 4 3 0 8 25 10 0 – – 17 48 – Ž 124 2 4 1 2 6 21 38 4 9 – 37 13 Goriška M 257 13 19 4 14 54 32 2 – – 13 106 – Ž 300 10 14 3 6 15 38 71 7 24 – 112 39 Obalno-kraška M 312 16 29 0 19 42 56 0 – – 39 111 – Ž 284 9 19 2 7 19 47 55 12 19 – 95 75 Opis šifer MKB Description of the ICD code * Neupoštevano v skupnem številu: D06 - Maternični vrat, in situ (CIN III) Not included in All sites: D06 - Cervix uteri, in situ (CIN III) C16 Želodec Stomach C18 Debelo črevo Colon C19 Rektosigmoidna zveza Rectosigmoid junction C20 Rektum Rectum C34 Sapnica in pljuča Bronchus and lung C44 Druge maligne neoplazme kože Skin, other malignomas C50 Dojka Breast C53 Maternični vrat Cervix uteri C54 Maternično telo Corpus uteri C61 Prostata Prostate D06 Maternični vrat, CIN III Cervix uteri, in situ Institute of Oncology Ljubljana, Cancer Registry of Slovenia Tabela 6b. Starostno standardizirana* incidenca raka po statističnih regijah, po najpogostejših lokacijah in spolu - Slovenija 2002 Table 6b. Age standardised* cancer incidence rate by statistical regions, by most frequent sites and sex - Slovenia 2002 Statistična Spol Skupaj Lokacija (šifre MKB-10) Druga regija C00-C96 C16 C18 C19 C20 C34 C44 C50 C53 C54 C61 Other D06** Statistical region Sex All sites Site (ICD-10 codes) Slovenija, skupaj M 472,0 27,0 36,1 5,9 25,2 79,0 60,4 1,3 – – 55,4 181,5 – Slovenia, total Ž 465,3 17,6 29,1 4,1 17,6 26,7 72,0 100,6 18,3 29,3 – 150,0 88,4 Pomurska M 559,9 38,8 40,1 3,4 39,5 98,6 64,0 0,0 – – 87,1 188,5 – Ž 447,3 32,3 39,2 4,6 18,8 18,4 99,5 62,8 14,4 24,4 – 132,9 40,2 Podravska M 423,2 29,5 35,1 6,4 28,8 71,1 45,2 1,9 – – 45,5 159,8 – Ž 399,7 15,0 25,7 3,7 18,5 19,1 55,3 94,3 17,4 25,1 – 125,6 50,5 Koroška M 473,2 20,8 39,6 5,7 14,5 82,4 65,5 3,1 – – 37,3 204,5 – Ž 413,0 32,2 23,7 8,8 24,6 14,1 66,0 94,9 13,8 14,2 – 120,7 39,4 Savinjska M 381,8 25,4 33,2 5,1 19,9 62,4 32,0 0,8 – – 31,5 171,4 – Ž 414,7 21,1 25,9 7,2 19,6 24,7 48,7 82,9 21,7 31,9 – 131,1 118,5 Zasavska M 478,7 30,3 55,8 4,1 21,7 98,5 52,4 0,0 – – 34,1 181,8 – Ž 440,8 19,9 8,5 3,9 24,6 32,6 51,4 101,9 12,8 28,5 – 156,7 27,2 Spodnjeposavska M 465,6 44,8 45,9 11,9 17,0 100,6 31,0 0,0 – – 41,8 172,7 – Ž 400,9 16,3 15,7 8,2 18,8 25,2 34,6 81,9 25,5 42,0 – 132,7 89,3 Jugovzhodna Slovenija M 475,7 26,0 45,8 16,1 34,1 87,5 38,8 3,2 – – 35,0 189,0 – Ž 423,0 14,6 30,0 3,0 12,4 27,1 70,3 100,0 13,2 28,2 – 124,2 74,2 Osrednjeslovenska M 511,3 23,3 35,0 7,1 21,7 79,2 78,8 1,3 – – 77,9 187,0 – Ž 534,1 13,7 33,4 3,2 20,1 31,6 89,0 121,3 21,0 26,2 – 174,5 124,2 Gorenjska M 530,8 29,7 27,6 2,0 25,2 77,7 90,2 1,0 – – 71,0 206,5 – Ž 532,7 19,2 38,7 1,0 16,4 35,5 92,6 98,5 18,1 37,6 – 174,9 85,7 Notranjsko-kraška M 425,3 14,1 11,2 0,0 30,3 90,7 37,4 0,0 – – 63,7 178,0 – Ž 479,2 7,6 14,2 4,0 7,8 27,4 75,2 149,2 16,3 35,6 – 141,9 51,7 Goriška M 401,1 19,8 29,7 6,6 20,5 84,4 48,5 3,1 – – 20,7 167,8 – Ž 456,9 15,5 20,5 4,4 9,9 26,1 55,5 110,1 11,0 36,6 – 167,4 66,8 Obalno-kraška M 533,9 27,8 49,4 0,0 33,2 73,2 94,2 0,0 – – 65,0 191,1 – Ž 514,1 16,1 34,2 3,6 12,9 33,5 85,6 98,0 21,5 34,0 – 174,7 140,5 * Standard - prebivalstvo Slovenije po popisu 2002 Standard - population of Slovenia according to census 2002 Opis šifer MKB Description of the ICD code C16 Želodec Stomach C18 Debelo črevo Colon C19 Rektosigmoidna zveza Rectosigmoid junction C20 Rektum Rectum C34 Sapnica in pljuča Bronchus and lung C44 Druge maligne neoplazme kože Skin, other malignomas C50 Dojka Breast C53 Maternični vrat Cervix uteri C54 Maternično telo Corpus uteri C61 Prostata Prostate D06 Maternični vrat, CIN III Cervix uteri, in situ Cancer Incidence in Slovenia 2002 51 ** Neupoštevano v skupnem številu: D06 - Maternični vrat, in situ (CIN III) Not included in All sites: D06 - Cervix uteri, in situ (CIN III) 52 Incidenca raka v Sloveniji 2002 Onkološki inštitut Ljubljana, Register raka za Slovenijo nadaljevanje / cont’d ➝ Tabela 7. Število novih primerov raka, ugotovljenih v bolnišnicah, ter število in odstotek mikroskopsko potrjenih primerov, po lokaciji in spolu - Slovenija 2002 Table 7. Total number of new cancer cases diagnosed in hospitals and number and percentage of microscopically confirmed cases - by site and sex - Slovenia 2002 Šifra Število novih Mikroskopsko MKB Primarna lokacija Spol primerov potrjeni primeri Število Odstotek* ICD Number of Microscopically code Primary site Sex new cases confirmed cases Number Per cent* C00 Vse lokacije M+Ž 9222 8597 93 – M 4617 4282 93 C96 All sites Ž 4605 4315 94 C00 Ustnica M 21 20 95 Lip Ž 12 12 C01 Baza jezika M 15 15 100 Base of tongue Ž – – C02 Jezik, drugi deli M 25 25 100 Tongue, other & unspecified parts Ž 3 3 C03 Dlesen M 4 4 Gum Ž 5 5 C04 Ustno dno M 33 32 97 Floor of mouth Ž 5 5 C05 Nebo M 10 10 Palate Ž 3 3 C06 Usta, drugi deli M 14 14 Mouth, other & unspecified parts Ž 6 6 C07 Parotidna žleza M 7 7 Parotid gland Ž 5 5 C08 Druge in neopredeljene velike žleze slinavke M – – Other & unspecified major salivary glands Ž 2 2 C09 Tonzila M 30 30 100 Tonsil Ž 5 5 C10 Orofarinks M 34 34 100 Oropharynx Ž 4 3 C11 Nazofarinks M 5 5 Nasopharynx Ž 8 8 C12 Piriformni sinus M 25 25 100 Pyriform sinus Ž 2 2 C13 Hipofarinks M 24 23 96 Hypopharynx Ž 1 1 C14 Druga in slabo opredeljena mesta na ustnici, v ustni votlini in farinksu M – – Other and ill-defined sites in the lip, Ž – – oral cavity and pharynx Institute of Oncology Ljubljana, Cancer Registry of Slovenia nadaljevanje / cont’d ➝ Cancer Incidence in Slovenia 2002 53 Tabela 7. – Table 7. Nadaljevanje – Continued Šifra Število novih Mikroskopsko MKB Primarna lokacija Spol primerov potrjeni primeri Število Odstotek* ICD Number of Microscopically code Primary site Sex new cases confirmed cases Number Per cent* C15 Požiralnik M 76 70 92 Oesophagus Ž 22 19 86 C16 Želodec M 263 254 97 Stomach Ž 168 153 91 C17 Tanko črevo M 11 11 Small intestine Ž 5 4 C18 Debelo črevo M 345 335 97 Colon Ž 291 278 96 C19 Rektosigmoidna zveza M 62 61 98 Rectosigmoid junction Ž 37 34 92 C20 Rektum M 249 246 99 Rectum Ž 170 162 95 C21 Anus in analni kanal M 3 3 Anus and anal canal Ž 8 8 C22 Jetra in intrahepatični vodi M 93 57 61 Liver and intrahepatic bile ducts Ž 34 28 82 C23 Žolčnik M 12 7 Gallbladder Ž 44 30 68 C24 Drugi in neopredeljeni deli biliarnega trakta M 35 28 80 Billiary tract, other and unspecified parts Ž 40 21 53 C25 Trebušna slinavka M 109 61 56 Pancreas Ž 129 66 51 C26 Druga in slabo opredeljena mesta v prebavnih organih M – – Other and ill-defined digestive organs Ž 5 4 C30 Nosna votlina in srednje uho M 2 2 Nasal cavity and middle ear Ž 3 3 C31 Obnosni sinusi M 5 4 Accessory sinuses Ž 4 4 C32 Grlo M 97 97 100 Larynx Ž 11 11 C33 Sapnik M 3 3 Trachea Ž 2 2 C34 Sapnica in pljuča M 775 717 93 Bronchus and lung Ž 255 230 90 C37 Timus M 1 1 Thymus Ž – – C38 Srce, mediastinum, plevra M 2 2 Heart, mediastinum, pleura Ž 1 – 54 Incidenca raka v Sloveniji 2002 Onkološki inštitut Ljubljana, Register raka za Slovenijo nadaljevanje / cont’d ➝ Tabela 7. – Table 7. Nadaljevanje – Continued Šifra Število novih Mikroskopsko MKB Primarna lokacija Spol primerov potrjeni primeri Število Odstotek* ICD Number of Microscopically code Primary site Sex new cases confirmed cases Number Per cent* C39 Druga in slabo opredeljena mesta v dihalih in prsnih organih M – – Other and ill-defined sites in the respiratory Ž – – system and intrathoracic organs C40 Kosti, sklepni hrustanec udov M 4 4 Bone and articular cartilage of limbs Ž 5 5 C41 Kosti, sklepni hrustanec, drugje M 5 5 Bone and articular cartilage Ž 3 3of other and unspecified parts C43 Maligni melanom kože M 115 115 100 Malignant melanoma of skin Ž 154 154 100 C44 Druge maligne neoplazme kože M 610 601 99 Skin, other malignomas Ž 714 704 99 C45 Mezoteliom M 22 22 100 Mesothelioma Ž 9 9 C46 Kaposijev sarkom M – – Kaposi's sarcoma Ž – – C47 Periferni živci in avtonomno živčevje M 4 4 Peripheral nerves and autonomic nervous system Ž 1 1 C48 Retro- in peritonej M 11 10 Retro- and peritoneum Ž 3 3 C49 Drugo vezivno in mehko tkivo M 21 21 100 Other connective and soft tissue Ž 20 19 95 C50 Dojka M 14 13 Breast Ž 1016 992 98 C51 Žensko zunanje spolovilo M – – Vulva Ž 41 41 100 C52 Nožnica M – – Vagina Ž 17 17 100 C53 Maternični vrat M – – Cervix uteri Ž 187 187 100 C54 Maternično telo M – – Corpus uteri Ž 299 298 100 C55 Maternica, neopredeljeno M – – Uterus, unspecified Ž 7 7 C56 Jajčnik M – – Ovary Ž 167 163 98 C57 Drugi in neopredeljeni ženski spolni organi M – – Other and unspecified parts of female genital organs Ž 11 10 Institute of Oncology Ljubljana, Cancer Registry of Slovenia nadaljevanje / cont’d ➝ Cancer Incidence in Slovenia 2002 55 Tabela 7. – Table 7. Nadaljevanje – Continued Šifra Število novih Mikroskopsko MKB Primarna lokacija Spol primerov potrjeni primeri Število Odstotek* ICD Number of Microscopically code Primary site Sex new cases confirmed cases Number Per cent* C58 Posteljica M – – Placenta Ž – – C60 Penis M 4 3 Penis Ž – – C61 Prostata M 524 470 90 Prostate Ž – – C62 Modo M 78 78 100 Testis Ž – – C63 Drugi in neopredeljeni moški spolni organi M 3 3 Other and unspecified male genital organs Ž – – C64 Ledvica razen meha M 131 114 87 Kidney, except renal pelvis Ž 50 40 80 C65 Ledvični meh M 9 9 Renal pelvis Ž 5 5 C66 Sečevod M 4 4 Ureter Ž – – C67 Sečni mehur M 134 129 96 Bladder Ž 49 48 98 C68 Drugi in neopredeljeni sečni organi M 1 1 Other and unspecified urinary organs Ž – – C69 Oko in očesni adneksi M 9 6 Eye and adnexa Ž 8 7 C70 Meninge M 1 1 Meninges Ž 5 5 C71 Možgani M 66 61 92 Brain Ž 60 46 77 C72 Hrbtni mozeg, možganski živci in drugi deli CŽS M 1 – Spinal cord, cranial nerves and other parts of CNS Ž 1 – C73 Ščitnica M 22 22 100 Thyroid gland Ž 75 75 100 C74 Nadledvična žleza M 2 2 Adrenal gland Ž 4 3 C75 Druge endokrine žleze in sorodne strukture M 2 2 Other endocrine glands and related structures Ž – – C76 Druga in slabo opredeljena mesta M 6 4 Other and ill-defined sites Ž 14 8 C77 Metastaza in neopredeljena maligna neoplazma bezgavk M 29 29 100 Metastasis and unspecified Ž 18 17 94 malignant neoplasm of lymph nodes 56 Incidenca raka v Sloveniji 2002 Onkološki inštitut Ljubljana, Register raka za Slovenijo nadaljevanje / cont’d ➝ Tabela 7. – Table 7. Nadaljevanje – Continued Šifra Število novih Mikroskopsko MKB Primarna lokacija Spol primerov potrjeni primeri Število Odstotek* ICD Number of Microscopically code Primary site Sex new cases confirmed cases Number Per cent* C78 Metastaze dihal in prebavil M 62 30 48 Metastases of respiratory and digestive organs Ž 55 30 55 C79 Metastaze, drugje M 16 10 63 Metastases of other sites Ž 15 7 47 C80 Maligna neoplazma brez opredeljenega mesta M 37 26 70 Malignant neoplasm without specification of site Ž 31 23 74 C81 Hodgkinova bolezen M 18 18 100 Hodgkin's disease Ž 25 25 100 C82 Folikularni ne-Hodgkinov limfom M 21 21 100 Follicular non-Hodgkin's lymphoma Ž 15 15 100 C83 Difuzni ne-Hodgkinov limfom M 68 68 100 Diffuse non-Hodgkin's lymphoma Ž 55 55 100 C84 Limfomi celic T in kožni limfom celic T M 10 10 Peripheral and cutaneous T-cell lymphomas Ž 7 7 C85 Druge in neopredeljene vrste ne-Hodgkinovega limfoma M 18 18 100 Other and unspecified types of non-Hodgkin's lymphoma Ž 18 18 100 C88 Maligne imunoproliferativne bolezni M 1 1 Malignant immunoproliferative diseases Ž – – C90 Difuzni plazmocitom in maligne neoplazme plazmocitov M 27 27 100 Multiple myeloma and malignant plasma cell neoplasms Ž 33 33 100 C91.0 Limfatična levkemija, akutna M 9 9 Lymphoblastic leukaemia, acute Ž 12 12 C91.1 - Limfatična levkemija, druga M 35 35 100 C91.9 Lymphoid leukaemia, other Ž 29 29 100 C92 Mieloična levkemija M 35 35 100 Myeloid leukaemia Ž 32 32 100 C93 Monocitna levkemija M 3 3 Monocytic leukaemia Ž 1 1 C94 Druge opredeljene levkemije M 1 1 Other leukaemias of specified cells Ž – – C95 Levkemija z neopredeljenim celičnim tipom M 2 2 Leukaemia, unspecified cell type Ž 3 3 C96 Druge in neopredeljene maligne neoplazme limfatičnega, krvotvornega ali sorodnega tkiva M 32 32 100 Other and unspecified malignant neoplasms Ž 41 41 100 of lymphoid, haematopoietic and related tissue Tabela 7. – Table 7. Nadaljevanje – Continued Šifra Število novih Mikroskopsko MKB Primarna lokacija Spol primerov potrjeni primeri Število Odstotek* ICD Number of Microscopically code Primary site Sex new cases confirmed cases Number Per cent* Zgoraj neupoštevani Not included above D03 Melanom, in situ M 15 15 100 Melanoma, in situ Ž 9 9 D05 Dojka, in situ M – – Breast, in situ Ž 71 71 100 D06 Maternični vrat, in situ (CIN III) M – – Cervix uteri, in situ (CIN III) Ž 901 901 100 D09.0 Karcinom in situ mehurja M 56 56 100 Bladder, in situ Ž 9 9 D32.0 Meninge, benigna neoplazma M 15 15 100 Benign neoplasm of meninges Ž 52 50 96 D33.0 Možgani, benigna neoplazma M – – - D33.2 Benign neopasm of brain Ž 1 1 D39.1 Jajčnik, neopl. negotovega značaja M – – Ovary, neopl. of uncertain behavior Ž 31 31 100 D43.0 Možgani, neopredeljeno M 4 1 -D43.2 Brain, uncertain or unknown Ž 9 1 * Odstotki niso računani pri številih pod 15 Percentages are not calculated for less than 15 cases Institute of Oncology Ljubljana, Cancer Registry of Slovenia Cancer Incidence in Slovenia 2002 57 58 Incidenca raka v Sloveniji 2002 Onkološki inštitut Ljubljana, Register raka za Slovenijo nadaljevanje / cont’d ➝ Tabela 8. Število histološko (in citološko) potrjenih novih primerov raka po histološki vrsti in lokaciji - Slovenija 2002 Table 8. Number of histologically (and cytologically) confirmed new cancer cases by histologic type and site - Slovenia 2002 Histološka vrsta Skupaj L o k a c i j a ( š i f r e M K B - 1 0 ) Histologic type All sites S i t e ( I C D - 1 0 c o d e s ) C00 C01 C02 C03 C04 C05 C06 C07 C08 C09 Vse vrste/ All Types 7798 799 30 2 14 1 25 3 9 – 36 1 13 – 20 – 11 1 2 – 34 1 Small cell carcinoma 127 68 – – – – – – – – – – – – – – – – – – – – Non-small cell carcinoma 32 29 – – – – – – – – – – – – – – – – – – – – Squamous cell carcinoma 1085 143 29 2 14 1 24 3 9 – 34 1 12 – 19 – – – – – 33 1 Basal cell carcinoma 1052 25 – – – – – – – – 1 – – – – – – – – – – – Transitional cel carcinoma 181 1 – – – – – – – – – – – – – – – – – – – – Adenocarcinoma 3828 228 – – – – – – – – 1 – 1 – – – 6 – 2 – – – Other specified carcinomas 134 20 – – – – – – – – – – – – 1 – 4 – – – – – Carcinoma, unspecified 212 186 1 – – – 1 – – – – – – – – – 1 1 – – 1 – Malignant thymoma 1 – – – – – – – – – – – – – – – – – – – – – Malignant paraganglioma/ pheochromocytoma – – – – – – – – – – – – – – – – – – – – – – Malignant melanoma 286 6 – – – – – – – – – – – – – – – – – – – – Fibrosarcoma 5 – – – – – – – – – – – – – – – – – – – – – Fibrohistiocytic sarcoma 9 1 – – – – – – – – – – – – – – – – – – – – Liposarcoma 12 – – – – – – – – – – – – – – – – – – – – – Leiomyosarcoma 25 – – – – – – – – – – – – – – – – – – – – – Rhabdomyosarcoma 2 – – – – – – – – – – – – – – – – – – – – – Synovial sarcoma 5 – – – – – – – – – – – – – – – – – – – – – Angiosarcoma 2 – – – – – – – – – – – – – – – – – – – – – Kaposi sarcoma – – – – – – – – – – – – – – – – – – – – – – Osteosarcoma 7 – – – – – – – – – – – – – – – – – – – – – Chondrosarcoma 7 1 – – – – – – – – – – – – – – – – – – – – Ewing sarcoma/PNET 2 – – – – – – – – – – – – – – – – – – – – – Other specified sarcomas 2 – – – – – – – – – – – – – – – – – – – – – Sarcoma, unspecified 9 3 – – – – – – – – – – – – – – – – – – – – Malignant complex mixed and stromal tumors 39 – – – – – – – – – – – – – – – – – – – – – Malignat fibroepithelial tumors 2 – – – – – – – – – – – – – – – – – – – – – Malignant mesothelioma 29 2 – – – – – – – – – – – – – – – – – – – – Malignant gonadal stromal tumors – – – – – – – – – – – – – – – – – – – – – – Dysgerminoma and seminoma 41 1 – – – – – – – – – – – – – – – – – – – – Other malignant germ cell tumors 38 1 – – – – – – – – – – – – – – – – – – – – Malignant trophoblastic tumors 5 – – – – – – – – – – – – – – – – – – – – – Malignant gliomas 104 – – – – – – – – – – – – – – – – – – – – – Malignant neuroepithelial tumors 3 2 – – – – – – – – – – – – – – – – – – – – Malignant meningioma 6 – – – – – – – – – – – – – – – – – – – – – Malignant nerve sheath tumors 3 – – – – – – – – – – – – – – – – – – – – – Non Hodgkin lymphoma 188 25 – – – – – – – – – – – – – – – – – – – – Hodgkin lymphoma 40 3 – – – – – – – – – – – – – – – – – – – – Plasma cell tumors 43 17 – – – – – – – – – – – – – – – – – – – – Chronic lymphoid leukemia 50 8 – – – – – – – – – – – – – – – – – – – – Leukemia except chronic lymphoid 90 14 – – – – – – – – – – – – – – – – – – – – Other lymphoreticular neoplasms – – – – – – – – – – – – – – – – – – – – – – Chronic myeloproliferative diseases 38 – – – – – – – – – – – – – – – – – – – – – Myelodysplastic syndromes 31 4 – – – – – – – – – – – – – – – – – – – – Other specified malignant tumors 4 1 – – – – – – – – – – – – – – – – – – – – Malignant tumor, unspecified 19 10 – – – – – – – – – – – – – – – – – – – – nadaljevanje / cont’d ➝ Cancer Incidence in Slovenia 2002 59 Institute of Oncology Ljubljana, Cancer Registry of Slovenia Tabela 8. – Table 8. Nadaljevanje – Continued Histološka vrsta Skupaj L o k a c i j a ( š i f r e M K B - 1 0 ) Histologic type All sites S i t e ( I C D - 1 0 c o d e s ) C10 C11 C12 C13 C14 C15 C16 C17 C18 C19 Vse vrste/ All Types 7798 799 37 – 13 – 27 – 24 – – – 84 5 397 10 14 1 606 7 95 – Small cell carcinoma 127 68 – – – – – – – – – – – – 1 – – – 1 – – – Non-small cell carcinoma 32 29 – – – – – – – – – – – – – – – – – – – – Squamous cell carcinoma 1085 143 36 – 7 – 26 – 23 – – – 68 1 3 – – – – – – – Basal cell carcinoma 1052 25 – – – – – – – – – – – – – – – – – – – – Transitional cel carcinoma 181 1 – – – – – – – – – – – – – – – – – – – – Adenocarcinoma 3828 228 1 – 2 – – – – – – – 12 1 367 5 10 1 583 2 92 – Other specified carcinomas 134 20 – – 1 – – – – – – – 1 – – – – – 1 – – – Carcinoma, unspecified 212 186 – – 2 – 1 – 1 – – – 2 3 17 3 – – 16 5 3 – Malignant thymoma 1 – – – – – – – – – – – – – – – – – – – – – Malignant paraganglioma /pheochromocytoma – – – – – – – – – – – – – – – – – – – – – – Malignant melanoma 286 6 – – – – – – – – – – – – – – – – 1 – – – Fibrosarcoma 5 – – – – – – – – – – – – – – – – – – – – – Fibrohistiocytic sarcoma 9 1 – – – – – – – – – – – – – – – – – – – – Liposarcoma 12 – – – – – – – – – – – – – – – – – 1 – – – Leiomyosarcoma 25 – – – – – – – – – – – – – – – 2 – – – – – Rhabdomyosarcoma 2 – – – 1 – – – – – – – – – – – – – – – – – Synovial sarcoma 5 – – – – – – – – – – – – – – – – – – – – – Angiosarcoma 2 – – – – – – – – – – – – – – – – – – – – – Kaposi sarcoma – – – – – – – – – – – – – – – – – – – – – – Osteosarcoma 7 – – – – – – – – – – – – – – – – – – – – – Chondrosarcoma 7 1 – – – – – – – – – – – – – – – – – – – – Ewing sarcoma/PNET 2 – – – – – – – – – – – – – – – – – – – – – Other specified sarcomas 2 – – – – – – – – – – – – – – – – – – – – – Sarcoma, unspecified 9 3 – – – – – – – – – – – – 1 – 1 – – – – – Malignant complex mixed and stromal tumors 39 – – – – – – – – – – – – – 6 – 1 – – – – – Malignat fibroepithelial tumors 2 – – – – – – – – – – – – – – – – – – – – – Malignant mesothelioma 29 2 – – – – – – – – – – – – – – – – – – – – Malignant gonadal stromal tumors – – – – – – – – – – – – – – – – – – – – – – Dysgerminoma and seminoma 41 1 – – – – – – – – – – – – – – – – – – – – Other malignant germ cell tumors 38 1 – – – – – – – – – – – – – – – – – – – – Malignant trophoblastic tumors 5 – – – – – – – – – – – – – – – – – 1 – – – Malignant gliomas 104 – – – – – – – – – – – – – – – – – – – – – Malignant neuroepithelial tumors 3 2 – – – – – – – – – – – – – – – – – – – – Malignant meningioma 6 – – – – – – – – – – – – – – – – – – – – – Malignant nerve sheath tumors 3 – – – – – – – – – – – – – – – – – – – – – Non Hodgkin lymphoma 188 25 – – – – – – – – – – – – – – – – – – – – Hodgkin lymphoma 40 3 – – – – – – – – – – – – – – – – – – – – Plasma cell tumors 43 17 – – – – – – – – – – – – – – – – – – – – Chronic lymphoid leukemia 50 8 – – – – – – – – – – – – – – – – – – – – Leukemia except chronic lymphoid 90 14 – – – – – – – – – – – – – – – – – – – – Other lymphoreticular neoplasms – – – – – – – – – – – – – – – – – – – – – – Chronic myeloproliferative diseases 38 – – – – – – – – – – – – – – – – – – – – – Myelodysplastic syndromes 31 4 – – – – – – – – – – – – – – – – – – – – Other specified malignant tumors 4 1 – – – – – – – – – – – – – – – – – – – – Malignant tumor, unspecified 19 10 – – – – – – – – – – 1 – 2 2 – – 2 – – – 60 Incidenca raka v Sloveniji 2002 Onkološki inštitut Ljubljana, Register raka za Slovenijo nadaljevanje / cont’d ➝ Tabela 8. – table 8. Nadaljevanje – continued Histološka vrsta Skupaj L o k a c i j a ( š i f r e M K B - 1 0 ) Histologic type All sites S i t e ( I C D - 1 0 c o d e s ) C20 C21 C22 C23 C24 C25 C26 C30 C31 C32 Vse vrste/ All Types 7798 799 408 – 11 – 67 18 33 4 47 2 104 23 4 – 5 – 8 – 108 – Small cell carcinoma 127 68 – – – – – – 1 – – – – – – – 1 – – – – – Non-small cell carcinoma 32 29 – – – – – – – – – – – – – – – – – – – – Squamous cell carcinoma 1085 143 – – 5 – – – – – – – – – – – 2 – 4 – 104 – Basal cell carcinoma 1052 25 – – – – – – – – – – – – – – – – – – – – Transitional cel carcinoma 181 1 – – 1 – – – – – – – – – – – – – – – – – Adenocarcinoma 3828 228 392 – 5 – 67 16 27 3 45 1 88 16 4 – 1 – 3 – – – Other specified carcinomas 134 20 – – – – – – – – – – 6 – – – – – – – 1 – Carcinoma, unspecified 212 186 14 – – – – 1 4 1 2 1 8 6 – – 1 – 1 – 2 – Malignant thymoma 1 – – – – – – – – – – – – – – – – – – – – – Malignant paraganglioma/ pheochromocytoma – – – – – – – – – – – – – – – – – – – – – – Malignant melanoma 286 6 1 – – – – – – – – – – – – – – – – – – – Fibrosarcoma 5 – – – – – – – – – – – – – – – – – – – – – Fibrohistiocytic sarcoma 9 1 – – – – – – – – – – – – – – – – – – – – Liposarcoma 12 – – – – – – – – – – – – – – – – – – – – – Leiomyosarcoma 25 – 1 – – – – – – – – – – – – – – – – – 1 – Rhabdomyosarcoma 2 – – – – – – – – – – – – – – – – – – – – – Synovial sarcoma 5 – – – – – – – – – – – – – – – – – – – – – Angiosarcoma 2 – – – – – – – – – – – – – – – – – – – – – Kaposi sarcoma – – – – – – – – – – – – – – – – – – – – – – Osteosarcoma 7 – – – – – – – – – – – – – – – – – – – – – Chondrosarcoma 7 1 – – – – – – – – – – – – – – – – – – – – Ewing sarcoma/PNET 2 – – – – – – – – – – – – – – – – – – – – – Other specified sarcomas 2 – – – – – – – – – – – – – – – – – – – – – Sarcoma, unspecified 9 3 – – – – – – – – – – – – – – – – – – – – Malignant complex mixed and stromal tumors 39 – – – – – – – – – – – 1 – – – – – – – – – Malignat fibroepithelial tumors 2 – – – – – – – – – – – – – – – – – – – – – Malignant mesothelioma 29 2 – – – – – – – – – – – – – – – – – – – – Malignant gonadal stromal tumors – – – – – – – – – – – – – – – – – – – – – – Dysgerminoma and seminoma 41 1 – – – – – – – – – – – – – – – – – – – – Other malignant germ cell tumors 38 1 – – – – – – – – – – – – – – – – – – – – Malignant trophoblastic tumors 5 – – – – – – – – – – – – – – – – – – – – – Malignant gliomas 104 – – – – – – – – – – – – – – – – – – – – – Malignant neuroepithelial tumors 3 2 – – – – – – – – – – – – – – – – – – – – Malignant meningioma 6 – – – – – – – – – – – – – – – – – – – – – Malignant nerve sheath tumors 3 – – – – – – – – – – – – – – – – – – – – – Non Hodgkin lymphoma 188 25 – – – – – – – – – – – – – – – – – – – – Hodgkin lymphoma 40 3 – – – – – – – – – – – – – – – – – – – – Plasma cell tumors 43 17 – – – – – – – – – – – – – – – – – – – – Chronic lymphoid leukemia 50 8 – – – – – – – – – – – – – – – – – – – – Leukemia except chronic lymphoid 90 14 – – – – – – – – – – – – – – – – – – – – Other lymphoreticular neoplasms – – – – – – – – – – – – – – – – – – – – – – Chronic myeloproliferative diseases 38 – – – – – – – – – – – – – – – – – – – – – Myelodysplastic syndromes 31 4 – – – – – – – – – – – – – – – – – – – – Other specified malignant tumors 4 1 – – – – – – – – – – – – – – – – – – – – Malignant tumor, unspecified 19 10 – – – – – 1 1 – – – 1 1 – – – – – – – – nadaljevanje / cont’d ➝ Cancer Incidence in Slovenia 2002 61 Institute of Oncology Ljubljana, Cancer Registry of Slovenia Tabela 8. – Table 8. Nadaljevanje – Continued Histološka vrsta Skupaj L o k a c i j a ( š i f r e M K B - 1 0 ) Histologic type All sites S i t e ( I C D - 1 0 c o d e s ) C33 C34 C37 C38 C39 C40 C41 C43 C44 C45 Vse vrste/ All Types 7798 799 1 4 615 332 1 – 2 – – – 9 – 7 1 265 4 1270 35 29 2 Small cell carcinoma 127 68 – 2 118 63 – – – – – – – – – – – – – – – – Non-small cell carcinoma 32 29 – – 32 28 – – – – – – – – – – – – – – – – Squamous cell carcinoma 1085 143 1 1 210 107 – – – – – – – – – – – – 202 6 – – Basal cell carcinoma 1052 25 – – – – – – – – – – – – – – – – 1048 25 – – Transitional cel carcinoma 181 1 – – – – – – – – – – – – – – – – – – – – Adenocarcinoma 3828 228 – – 193 103 – – – – – – – – – – – – 9 – – – Other specified carcinomas 134 20 – – 45 18 – – – – – – – – – – – – – – – – Carcinoma, unspecified 212 186 – 1 15 11 – – – – – – – – – – – – 3 4 – – Malignant thymoma 1 – – – – – 1 – – – – – – – – – – – – – – – Malignant paraganglioma/ pheochromocytoma – – – – – – – – – – – – – – – – – – – – – – Malignant melanoma 286 6 – – – – – – – – – – – – – – 265 4 – – – – Fibrosarcoma 5 – – – – – – – – – – – – – – – – – – – – – Fibrohistiocytic sarcoma 9 1 – – – – – – – – – – – – – – – – 4 – – – Liposarcoma 12 – – – – – – – – – – – – – – – – – – – – – Leiomyosarcoma 25 – – – – – – – – – – – – – – – – – 1 – – – Rhabdomyosarcoma 2 – – – – – – – – – – – – – – – – – – – – – Synovial sarcoma 5 – – – – – – – – – – – – – – – – – – – – – Angiosarcoma 2 – – – 1 – – – – – – – – – – – – – – – – – Kaposi sarcoma – – – – – – – – – – – – – – – – – – – – – – Osteosarcoma 7 – – – – – – – – – – – 5 – 1 – – – – – – – Chondrosarcoma 7 1 – – – – – – – – – – 4 – 3 1 – – – – – – Ewing sarcoma/PNET 2 – – – – – – – – – – – – – 2 – – – – – – – Other specified sarcomas 2 – – – – – – – – – – – – – – – – – – – – – Sarcoma, unspecified 9 3 – – – – – – – – – – – – 1 – – – – – – – Malignant complex mixed and stromal tumors 39 – – – 1 – – – – – – – – – – – – – 1 – – – Malignat fibroepithelial tumors 2 – – – – – – – – – – – – – – – – – – – – – Malignant mesothelioma 29 2 – – – – – – – – – – – – – – – – – – 29 2 Malignant gonadal stromal tumors – – – – – – – – – – – – – – – – – – – – – – Dysgerminoma and seminoma 41 1 – – – – – – 1 – – – – – – – – – – – – – Other malignant germ cell tumors 38 1 – – – – – – – – – – – – – – – – – – – – Malignant trophoblastic tumors 5 – – – – – – – – – – – – – – – – – – – – – Malignant gliomas 104 – – – – – – – – – – – – – – – – – – – – – Malignant neuroepithelial tumors 3 2 – – – – – – – – – – – – – – – – – – – – Malignant meningioma 6 – – – – – – – – – – – – – – – – – – – – – Malignant nerve sheath tumors 3 – – – – – – – – – – – – – – – – – – – – – Non Hodgkin lymphoma 188 25 – – – – – – – – – – – – – – – – – – – – Hodgkin lymphoma 40 3 – – – – – – – – – – – – – – – – – – – – Plasma cell tumors 43 17 – – – – – – – – – – – – – – – – – – – – Chronic lymphoid leukemia 50 8 – – – – – – – – – – – – – – – – – – – – Leukemia except chronic lymphoid 90 14 – – – – – – – – – – – – – – – – – – – – Other lymphoreticular neoplasms – – – – – – – – – – – – – – – – – – – – – – Chronic myeloproliferative diseases 38 – – – – – – – – – – – – – – – – – – – – – Myelodysplastic syndromes 31 4 – – – – – – – – – – – – – – – – – – – – Other specified malignant tumors 4 1 – – – – – – – – – – – – – – – – – – – – Malignant tumor, unspecified 19 10 – – – 2 – – 1 – – – – – – – – – 2 – – – 62 Incidenca raka v Sloveniji 2002 nadaljevanje / cont’d ➝ Tabela 8. – Table 8. Nadaljevanje – Continued Histološka vrsta Skupaj L o k a c i j a ( š i f r e M K B - 1 0 ) Histologic type All sites S i t e ( I C D - 1 0 c o d e s ) C46 C47 C48 C49 C50 C51 C52 C53 C54 C55 Vse vrste/ All Types 7798 799 – – 4 1 12 1 35 5 876 129 41 – 16 1 186 1 297 1 7 – Small cell carcinoma 127 68 – – – – – – – – – – – – – – – – – – – – Non-small cell carcinoma 32 29 – – – – – – – – – – – – – – – – – – – – Squamous cell carcinoma 1085 143 – – – – – – – – – – 34 – 13 1 148 1 – – – – Basal cell carcinoma 1052 25 – – – – – – – – – – 3 – – – – – – – – – Transitional cel carcinoma 181 1 – – – – – – – – – – – – – – – – – – – – Adenocarcinoma 3828 228 – – – – – – – – 850 19 2 – 1 – 22 – 236 1 – – Other specified carcinomas 134 20 – – – – – – – – 6 – – – 1 – 13 – 45 – – – Carcinoma, unspecified 212 186 – – – – – – – – 15 110 1 – 1 – 3 – 1 – – – Malignant thymoma 1 – – – – – – – – – – – – – – – – – – – – – Malignant paraganglioma /pheochromocytoma – – – – – – – – – – – – – – – – – – – – – – Malignant melanoma 286 6 – – – – – – – – – – 1 – – – – – – – – – Fibrosarcoma 5 – – – – – 1 – 4 – – – – – – – – – – – – – Fibrohistiocytic sarcoma 9 1 – – – – 1 – 4 1 – – – – – – – – – – – – Liposarcoma 12 – – – – – 5 – 4 – 1 – – – – – – – – – – – Leiomyosarcoma 25 – – – – – 1 – 11 – – – – – – – – – 1 – 5 – Rhabdomyosarcoma 2 – – – – – – – – – – – – – – – – – – – – – Synovial sarcoma 5 – – – – – – – 5 – – – – – – – – – – – – – Angiosarcoma 2 – – – – – – – – – 1 – – – – – – – – – – – Kaposi sarcoma – – – – – – – – – – – – – – – – – – – – – – Osteosarcoma 7 – – – – – – – 1 – – – – – – – – – – – – – Chondrosarcoma 7 1 – – – – – – – – – – – – – – – – – – – – Ewing sarcoma/PNET 2 – – – – – – – – – – – – – – – – – – – – – Other specified sarcomas 2 – – – – – – – 1 – – – – – – – – – – – – – Sarcoma, unspecified 9 3 – – – – 2 – 1 2 1 – – – – – – – – – 1 – Malignant complex mixed and stromal tumors 39 – – – – – 1 – – – 1 – – – – – – – 14 – 1 – Malignat fibroepithelial tumors 2 – – – – – – – – – 1 – – – – – – – – – – – Malignant mesothelioma 29 2 – – – – – – – – – – – – – – – – – – – – Malignant gonadal stromal tumors – – – – – – – – – – – – – – – – – – – – – – Dysgerminoma and seminoma 41 1 – – – – – 1 – – – – – – – – – – – – – – Other malignant germ cell tumors 38 1 – – – – 1 – – – – – – – – – – – – – – – Malignant trophoblastic tumors 5 – – – – – – – – – – – – – – – – – – – – – Malignant gliomas 104 – – – – – – – – – – – – – – – – – – – – – Malignant neuroepithelial tumors 3 2 – – 1 1 – – – – – – – – – – – – – – – – Malignant meningioma 6 – – – – – – – – – – – – – – – – – – – – – Malignant nerve sheath tumors 3 – – – 3 – – – – – – – – – – – – – – – – – Non Hodgkin lymphoma 188 25 – – – – – – – – – – – – – – – – – – – – Hodgkin lymphoma 40 3 – – – – – – – – – – – – – – – – – – – – Plasma cell tumors 43 17 – – – – – – – – – – – – – – – – – – – – Chronic lymphoid leukemia 50 8 – – – – – – – – – – – – – – – – – – – – Leukemia except chronic lymphoid 90 14 – – – – – – – – – – – – – – – – – – – – Other lymphoreticular neoplasms – – – – – – – – – – – – – – – – – – – – – – Chronic myeloproliferative diseases 38 – – – – – – – – – – – – – – – – – – – – – Myelodysplastic syndromes 31 4 – – – – – – – – – – – – – – – – – – – – Other specified malignant tumors 4 1 – – – – – – 3 1 – – – – – – – – – – – – Malignant tumor, unspecified 19 10 – – – – – – 1 1 – – – – – – – – – – – – Onkološki inštitut Ljubljana, Register raka za Slovenijo nadaljevanje / cont’d ➝ Cancer Incidence in Slovenia 2002 63 Institute of Oncology Ljubljana, Cancer Registry of Slovenia Tabela 8. – Table 8. Nadaljevanje – Continued Histološka vrsta Skupaj L o k a c i j a ( š i f r e M K B - 1 0 ) Histologic type All sites S i t e ( I C D - 1 0 c o d e s ) C56 C57 C58 C60 C61 C62 C63 C64 C65 C66 Vse vrste/ All Types 7798 799 152 11 10 – – – 3 – 459 11 77 1 3 – 142 12 13 1 4 – Small cell carcinoma 127 68 – – – – – – – – – – – – – – – – – – – – Non-small cell carcinoma 32 29 – – – – – – – – – – – – – – – – – – – – Squamous cell carcinoma 1085 143 – – – – – – 3 – – – – – 1 – – – – – – – Basal cell carcinoma 1052 25 – – – – – – – – – – – – – – – – – – – – Transitional cel carcinoma 181 1 1 – 1 – – – – – 1 – – – – – – – 13 1 4 – Adenocarcinoma 3828 228 133 8 8 – – – – – 378 2 1 – – – 134 10 – – – – Other specified carcinomas 134 20 2 – – – – – – – – – – – – – 1 – – – – – Carcinoma, unspecified 212 186 5 3 1 – – – – – 79 9 – – – – – 1 – – – – Malignant thymoma 1 – – – – – – – – – – – – – – – – – – – – – Malignant paraganglioma /pheochromocytoma – – – – – – – – – – – – – – – – – – – – – – Malignant melanoma 286 6 – – – – – – – – – – – – – – – – – – – – Fibrosarcoma 5 – – – – – – – – – – – – – – – – – – – – – Fibrohistiocytic sarcoma 9 1 – – – – – – – – – – – – – – – – – – – – Liposarcoma 12 – – – – – – – – – – – – – 1 – – – – – – – Leiomyosarcoma 25 – – – – – – – – – – – – – – – – – – – – – Rhabdomyosarcoma 2 – – – – – – – – – – – – – 1 – – – – – – – Synovial sarcoma 5 – – – – – – – – – – – – – – – – – – – – – Angiosarcoma 2 – – – – – – – – – – – – – – – – – – – – – Kaposi sarcoma – – – – – – – – – – – – – – – – – – – – – – Osteosarcoma 7 – – – – – – – – – – – – – – – – – – – – – Chondrosarcoma 7 1 – – – – – – – – – – – – – – – – – – – – Ewing sarcoma/PNET 2 – – – – – – – – – – – – – – – – – – – – – Other specified sarcomas 2 – – – – – – – – – – – – – – – – – – – – – Sarcoma, unspecified 9 3 – – – – – – – – – – – – – – – – – – – – Malignant complex mixed and stromal tumors 39 – 7 – – – – – – – – – – – – – 4 – – – – – Malignat fibroepithelial tumors 2 – 1 – – – – – – – – – – – – – – – – – – – Malignant mesothelioma 29 2 – – – – – – – – – – – – – – – – – – – – Malignant gonadal stromal tumors – – – – – – – – – – – – – – – – – – – – – – Dysgerminoma and seminoma 41 1 – – – – – – – – – – 39 – – – – – – – – – Other malignant germ cell tumors 38 1 3 – – – – – – – – – 33 1 – – – – – – – – Malignant trophoblastic tumors 5 – – – – – – – – – – – 4 – – – – – – – – – Malignant gliomas 104 – – – – – – – – – – – – – – – – – – – – – Malignant neuroepithelial tumors 3 2 – – – – – – – – – – – – – – – – – – – – Malignant meningioma 6 – – – – – – – – – – – – – – – – – – – – – Malignant nerve sheath tumors 3 – – – – – – – – – – – – – – – – – – – – – Non Hodgkin lymphoma 188 25 – – – – – – – – – – – – – – – – – – – – Hodgkin lymphoma 40 3 – – – – – – – – – – – – – – – – – – – – Plasma cell tumors 43 17 – – – – – – – – – – – – – – – – – – – – Chronic lymphoid leukemia 50 8 – – – – – – – – – – – – – – – – – – – – Leukemia except chronic lymphoid 90 14 – – – – – – – – – – – – – – – – – – – – Other lymphoreticular neoplasms – – – – – – – – – – – – – – – – – – – – – – Chronic myeloproliferative diseases 38 – – – – – – – – – – – – – – – – – – – – – Myelodysplastic syndromes 31 4 – – – – – – – – – – – – – – – – – – – – Other specified malignant tumors 4 1 – – – – – – – – – – – – – – – – – – – – Malignant tumor, unspecified 19 10 – – – – – – – – 1 – – – – – 3 1 – – – – 64 Incidenca raka v Sloveniji 2002 nadaljevanje / cont’d ➝ Onkološki inštitut Ljubljana, Register raka za Slovenijo Tabela 8. – Table 8. Nadaljevanje – Continued Histološka vrsta Skupaj L o k a c i j a ( š i f r e M K B - 1 0 ) Histologic type All sites S i t e ( I C D - 1 0 c o d e s ) C67 C68 C69 C70 C71 C72 C73 C74 C75 C76 Vse vrste/ All Types 7798 799 176 1 1 – 13 – 6 – 107 – – – 94 3 4 1 2 – 9 3 Small cell carcinoma 127 68 1 – – – – – – – – – – – – – – – – – – – Non-small cell carcinoma 32 29 – – – – – – – – – – – – – – – – – – – – Squamous cell carcinoma 1085 143 6 1 – – 1 – – – – – – – – – – – – – – – Basal cell carcinoma 1052 25 – – – – – – – – – – – – – – – – – – – – Transitional cel carcinoma 181 1 159 – 1 – – – – – – – – – – – – – – – – – Adenocarcinoma 3828 228 4 – – – – – – – – – – – 93 – 3 – – – 5 3 Other specified carcinomas 134 20 3 – – – – – – – – – – – 1 1 – – – – 1 – Carcinoma, unspecified 212 186 2 – – – – – – – – – – – – 2 1 – – – – – Malignant thymoma 1 – – – – – – – – – – – – – – – – – – – – – Malignant paraganglioma/ pheochromocytoma – – – – – – – – – – – – – – – – – – – – – – Malignant melanoma 286 6 – – – – 12 – – – – – – – – – – – – – – – Fibrosarcoma 5 – – – – – – – – – – – – – – – – – – – – – Fibrohistiocytic sarcoma 9 1 – – – – – – – – – – – – – – – – – – – – Liposarcoma 12 – – – – – – – – – – – – – – – – – – – – – Leiomyosarcoma 25 – 1 – – – – – – – – – – – – – – – – – – – Rhabdomyosarcoma 2 – – – – – – – – – – – – – – – – – – – – – Synovial sarcoma 5 – – – – – – – – – – – – – – – – – – – – – Angiosarcoma 2 – – – – – – – – – – – – – – – – – – – – – Kaposi sarcoma – – – – – – – – – – – – – – – – – – – – – – Osteosarcoma 7 – – – – – – – – – – – – – – – – – – – – – Chondrosarcoma 7 1 – – – – – – – – – – – – – – – – – – – – Ewing sarcoma/PNET 2 – – – – – – – – – – – – – – – – – – – – – Other specified sarcomas 2 – – – – – – – – – – – – – – – – – – – 1 – Sarcoma, unspecified 9 3 – – – – – – – – – – – – – – – – – – – – Malignant complex mixed and stromal tumors 39 – – – – – – – – – – – – – – – – – – – 1 – Malignat fibroepithelial tumors 2 – – – – – – – – – – – – – – – – – – – – – Malignant mesothelioma 29 2 – – – – – – – – – – – – – – – – – – – – Malignant gonadal stromal tumors – – – – – – – – – – – – – – – – – – – – – – Dysgerminoma and seminoma 41 1 – – – – – – – – – – – – – – – – 1 – – – Other malignant germ cell tumors 38 1 – – – – – – – – – – – – – – – – – – 1 – Malignant trophoblastic tumors 5 – – – – – – – – – – – – – – – – – – – – – Malignant gliomas 104 – – – – – – – – – 104 – – – – – – – – – – – Malignant neuroepithelial tumors 3 2 – – – – – – – – 2 – – – – – – 1 – – – – Malignant meningioma 6 – – – – – – – 6 – – – – – – – – – – – – – Malignant nerve sheath tumors 3 – – – – – – – – – – – – – – – – – – – – – Non Hodgkin lymphoma 188 25 – – – – – – – – – – – – – – – – – – – – Hodgkin lymphoma 40 3 – – – – – – – – – – – – – – – – – – – – Plasma cell tumors 43 17 – – – – – – – – – – – – – – – – – – – – Chronic lymphoid leukemia 50 8 – – – – – – – – – – – – – – – – – – – – Leukemia except chronic lymphoid 90 14 – – – – – – – – – – – – – – – – – – – – Other lymphoreticular neoplasms – – – – – – – – – – – – – – – – – – – – – – Chronic myeloproliferative diseases 38 – – – – – – – – – – – – – – – – – – – – – Myelodysplastic syndromes 31 4 – – – – – – – – – – – – – – – – – – – – Other specified malignant tumors 4 1 – – – – – – – – – – – – – – – – 1 – – – Malignant tumor, unspecified 19 10 – – – – – – – – 1 – – – – – – – – – – – nadaljevanje / cont’d ➝ Cancer Incidence in Slovenia 2002 65 Institute of Oncology Ljubljana, Cancer Registry of Slovenia Tabela 8. – Table 8. Nadaljevanje – Continued Histološka vrsta Skupaj L o k a c i j a ( š i f r e M K B - 1 0 ) Histologic type All sites S i t e ( I C D - 1 0 c o d e s ) C77 C78 C79 C80 C81 C82 C83 C84 C85 C88 Vse vrste/ All Types 7798 799 21 25 28 32 12 5 23 26 40 3 34 2 109 14 17 – 27 9 1 – Small cell carcinoma 127 68 – 2 – 1 2 – 2 – – – – – – – – – – – – – Non-small cell carcinoma 32 29 – – – – – – – 1 – – – – – – – – – – – – Squamous cell carcinoma 1085 143 10 14 1 1 2 – 1 2 – – – – – – – – – – – – Basal cell carcinoma 1052 25 – – – – – – – – – – – – – – – – – – – – Transitional cel carcinoma 181 1 – – – – – – – – – – – – – – – – – – – – Adenocarcinoma 3828 228 6 4 23 15 5 4 13 14 – – – – – – – – – – – – Other specified carcinomas 134 20 1 – – – – – – 1 – – – – – – – – – – – – Carcinoma, unspecified 212 186 4 5 2 11 – 1 1 7 – – – – – – – – – – – – Malignant thymoma 1 – – – – – – – – – – – – – – – – – – – – – Malignant paraganglioma/ pheochromocytoma – – – – – – – – – – – – – – – – – – – – – – Malignant melanoma 286 6 – – 1 1 1 – 4 1 – – – – – – – – – – – – Fibrosarcoma 5 – – – – – – – – – – – – – – – – – – – – – Fibrohistiocytic sarcoma 9 1 – – – – – – – – – – – – – – – – – – – – Liposarcoma 12 – – – – – – – – – – – – – – – – – – – – – Leiomyosarcoma 25 – – – – – 1 – – – – – – – – – – – – – – – Rhabdomyosarcoma 2 – – – – – – – – – – – – – – – – – – – – – Synovial sarcoma 5 – – – – – – – – – – – – – – – – – – – – – Angiosarcoma 2 – – – – – – – – – – – – – – – – – – – – – Kaposi sarcoma – – – – – – – – – – – – – – – – – – – – – – Osteosarcoma 7 – – – – – – – – – – – – – – – – – – – – – Chondrosarcoma 7 1 – – – – – – – – – – – – – – – – – – – – Ewing sarcoma/PNET 2 – – – – – – – – – – – – – – – – – – – – – Other specified sarcomas 2 – – – – – – – – – – – – – – – – – – – – – Sarcoma, unspecified 9 3 – – – 1 – – 1 – – – – – – – – – – – – – Malignant complex mixed and stromal tumors 39 – – – – – – – – – – – – – – – – – – – – – Malignat fibroepithelial tumors 2 – – – – – – – – – – – – – – – – – – – – – Malignant mesothelioma 29 2 – – – – – – – – – – – – – – – – – – – – Malignant gonadal stromal tumors – – – – – – – – – – – – – – – – – – – – – – Dysgerminoma and seminoma 41 1 – – – – – – – – – – – – – – – – – – – – Other malignant germ cell tumors 38 1 – – – – – – – – – – – – – – – – – – – – Malignant trophoblastic tumors 5 – – – – – – – – – – – – – – – – – – – – – Malignant gliomas 104 – – – – – – – – – – – – – – – – – – – – – Malignant neuroepithelial tumors 3 2 – – – – – – – – – – – – – – – – – – – – Malignant meningioma 6 – – – – – – – – – – – – – – – – – – – – – Malignant nerve sheath tumors 3 – – – – – – – – – – – – – – – – – – – – – Non Hodgkin lymphoma 188 25 – – – – – – – – – – 34 2 109 14 17 – 27 9 1 – Hodgkin lymphoma 40 3 – – – – – – – – 40 3 – – – – – – – – – – Plasma cell tumors 43 17 – – – – – – – – – – – – – – – – – – – – Chronic lymphoid leukemia 50 8 – – – – – – – – – – – – – – – – – – – – Leukemia except chronic lymphoid 90 14 – – – – – – – – – – – – – – – – – – – – Other lymphoreticular neoplasms – – – – – – – – – – – – – – – – – – – – – – Chronic myeloproliferative diseases 38 – – – – – – – – – – – – – – – – – – – – – Myelodysplastic syndromes 31 4 – – – – – – – – – – – – – – – – – – – – Other specified malignant tumors 4 1 – – – – – – – – – – – – – – – – – – – – Malignant tumor, unspecified 19 10 – – 1 2 1 – 1 – – – – – – – – – – – – – 66 Incidenca raka v Sloveniji 2002 Onkološki inštitut Ljubljana, Register raka za Slovenijo Tabela 8. – Table 8. Nadaljevanje – Continued Histološka vrsta Skupaj L o k a c i j a ( š i f r e M K B - 1 0 ) Histologic type All sites S i t e ( I C D - 1 0 c o d e s ) C90 C91 C92 C93 C94 C95 C96 Vse vrste/ All Types 7798 799 43 17 74 11 58 9 4 – 1 – 3 2 69 4 Small cell carcinoma 127 68 – – – – – – – – – – – – – – Non-small cell carcinoma 32 29 – – – – – – – – – – – – – – Squamous cell carcinoma 1085 143 – – – – – – – – – – – – – – Basal cell carcinoma 1052 25 – – – – – – – – – – – – – – Transitional cel carcinoma 181 1 – – – – – – – – – – – – – – Adenocarcinoma 3828 228 – – – – – – – – – – – – – – Other specified carcinomas 134 20 – – – – – – – – – – – – – – Carcinoma, unspecified 212 186 – – – – – – – – – – – – – – Malignant thymoma 1 – – – – – – – – – – – – – – – Malignant paraganglioma/ pheochromocytoma – – – – – – – – – – – – – – – – Malignant melanoma 286 6 – – – – – – – – – – – – – – Fibrosarcoma 5 – – – – – – – – – – – – – – – Fibrohistiocytic sarcoma 9 1 – – – – – – – – – – – – – – Liposarcoma 12 – – – – – – – – – – – – – – – Leiomyosarcoma 25 – – – – – – – – – – – – – – – Rhabdomyosarcoma 2 – – – – – – – – – – – – – – – Synovial sarcoma 5 – – – – – – – – – – – – – – – Angiosarcoma 2 – – – – – – – – – – – – – – – Kaposi sarcoma – – – – – – – – – – – – – – – – Osteosarcoma 7 – – – – – – – – – – – – – – – Chondrosarcoma 7 1 – – – – – – – – – – – – – – Ewing sarcoma/PNET 2 – – – – – – – – – – – – – – – Other specified sarcomas 2 – – – – – – – – – – – – – – – Sarcoma, unspecified 9 3 – – – – – – – – – – – – – – Malignant complex mixed and stromal tumors 39 – – – – – – – – – – – – – – – Malignat fibroepithelial tumors 2 – – – – – – – – – – – – – – – Malignant mesothelioma 29 2 – – – – – – – – – – – – – – Malignant gonadal stromal tumors – – – – – – – – – – – – – – – – Dysgerminoma and seminoma 41 1 – – – – – – – – – – – – – – Other malignant germ cell tumors 38 1 – – – – – – – – – – – – – – Malignant trophoblastic tumors 5 – – – – – – – – – – – – – – – Malignant gliomas 104 – – – – – – – – – – – – – – – Malignant neuroepithelial tumors 3 2 – – – – – – – – – – – – – – Malignant meningioma 6 – – – – – – – – – – – – – – – Malignant nerve sheath tumors 3 – – – – – – – – – – – – – – – Non Hodgkin lymphoma 188 25 – – – – – – – – – – – – – – Hodgkin lymphoma 40 3 – – – – – – – – – – – – – – Plasma cell tumors 43 17 43 17 – – – – – – – – – – – – Chronic lymphoid leukemia 50 8 – – 50 8 – – – – – – – – – – Leukemia except chronic lymphoid 90 14 – – 24 3 58 9 4 – 1 – 3 2 – – Other lymphoreticular neoplasms – – – – – – – – – – – – – – – – Chronic myeloproliferative diseases 38 – – – – – – – – – – – – – 38 – Myelodysplastic syndromes 31 4 – – – – – – – – – – – – 31 4 Other specified malignant tumors 4 1 – – – – – – – – – – – – – – Malignant tumor, unspecified 19 10 – – – – – – – – – – – – – – nadaljevanje / cont’d ➝ Cancer Incidence in Slovenia 2002 67 Institute of Oncology Ljubljana, Cancer Registry of Slovenia Tabela 9. Število primerov ne-Hodgkinovih limfomov* po lokaciji, spolu in starosti Slovenija 2002 Table 9. Total number of non-Hodgkin's malignant lymphomas* by site, sex, and age - Slovenia 2002 Šifra Vse S t a r o s t i MKB-8 Lokacija Spol starosti A g e ICD-8 Site Sex All code ages 0– 5– 10– 15– 20– 25– 30– 35– 40– 45– 50– 55– 60– 65– 70– 75– 80+ Skupaj 212 1 2 2 2 3 3 3 6 4 18 17 19 18 23 34 31 26 Vse lokacije Total Moški 117 1 2 – 1 3 1 3 3 3 14 9 12 12 11 14 17 11 All sites Male Ženske 95 – – 2 1 – 2 – 3 1 4 8 7 6 12 20 14 15 Female 141 Jezik M 1 – – – – – – – – – – – – – 1 – – –Tongue Ž – – – – – – – – – – – – – – – – – – 142 Slinavke M 2 – – – – – – – – – 1 – – – – – 1 –Salivary glands Ž 3 – – – – – – – – – – – 2 1 – – – – 143 Dlesni M – – – – – – – – – – – – – – – – – –Gum Ž 1 – – – – – – – – – – – – – – – – 1 145 Usta, drugo M – – – – – – – – – – – – – – – – – –Mouh, other parts Ž 1 – – – – – – – – – – – – – – – – 1 146 Orofarinks M 4 – – – – – – – – – 1 – 1 1 – – 1 –Oropharynx Ž 2 – – – – – – – – – – – – – – – 1 1 147 Epifarinks M 1 – – – – – – 1 – – – – – – – – – –Epipharynx Ž – – – – – – – – – – – – – – – – – – 151 Želodec M 15 – – – – – – – – – 2 2 2 2 1 1 3 2Stomach Ž 10 – – – – – – – – – – – 1 1 – 6 1 1 152 Tanko črevo M 3 – – – – – – – 1 – 1 – 1 – – – – –Small intestine Ž 1 – – – – – – – – – – – – – – – 1 – 153 Debelo črevo M 2 – – – – – – – – – – – – – 1 – – 1Colon Ž 2 – – – – – – – – – – – – – 1 – – 1 155 Jetra M 2 – – – – – – – – 1 – – – – – 1 – –Liver Ž – – – – – – – – – – – – – – – – – – 159 Prebavila, drugo M 1 – – – – – – – – – – – – 1 – – – –Digestive organs, other Ž – – – – – – – – – – – – – – – – – – 162 Sapnik, sapnica, pljuča M 1 – 1 – – – – – – – – – – – – – – –Trachea, bronchus, lung Ž – – – – – – – – – – – – – – – – – – 170 Kosti M 1 – – – – 1 – – – – – – – – – – – –Bone Ž 2 – – – – – – – – – – 1 – – – – – 1 171 Mehka tkiva M 1 – – – – – – – – – – – – – – – 1 –Soft tissues Ž – – – – – – – – – – – – – – – – – – 173 Koža, drugi malignomi M 2 – – – – – – – – – 1 – – – – 1 – –Skin, other malignancies Ž 3 – – – – – – – – – – 1 – – 2 – – – 174 Dojka M – – – – – – – – – – – – – – – – – –Breast Ž 4 – – – – – – – – – – – 1 1 1 1 – – 189 Ledvica, sečevod, drugo M 1 – – – – – – – – – 1 – – – – – – –Kidney, ureter, etc. Ž – – – – – – – – – – – – – – – – – – 190 Oko M 2 – – – – – – – – – 1 – – – – 1 – –Eye Ž – – – – – – – – – – – – – – – – – – 191 Možgani M 3 – 1 – – – – – – – – – 1 1 – – – –Brain Ž 4 – – – – – – – – – – – 1 – – 2 1 – 193 Ščitnica M – – – – – – – – – – – – – – – – – –Thyroid Ž 1 – – – – – – – – – – – – – – 1 – – 202 Bezgavke M 75 1 – – 1 2 1 2 2 2 6 7 7 7 8 10 11 8Lymph nodes Ž 61 – – 2 1 – 2 – 3 1 4 6 2 3 8 10 10 9 * Vključeni so samo citološko in histološko potrjeni primeri All cases included have been verified citologically and histologically Tabela 10. Število novih primerov raka po bolnišnicah ugotovitve diagnoze ter število in odstotek* primerov, napotenih na Onkološki inštitut Ljubljana (OI) - Slovenija 2002 Table 10. Number of new cancer cases diagnosed by reporting hospitals, and number and percentage* ¸ of cases referred to the Institute of Oncology Ljubljana (IO) - Slovenia 2002 Bolnišnice Število novih Napoteni na OI primerov Število Odstotek* Hospitals Number of new Referred to the IO cases Number Percent* Skupaj 9222 4508 49Total Onkološki inštitut, Ljubljana 713 713 100 Institute of Oncology Ljubljana Klinični center Ljubljana 2771 1172 42 Medical center Ljubljana SPS Interna klinika 600 207 35 Klinični oddelek za gastroenterologijo 264 83 31 Drugi klinični oddelki 336 124 37 SPS Kirurška klinika 1511 526 35 Klinični oddelek za abdominalno kirurgijo 393 152 39 Klinični oddelek za nevrokirurgijo 103 68 66 Klinični oddelek za maksilofacialno in oralno kirurgijo 51 40 78 Klinični oddelek za plastično kirurgijo in opekline 515 64 12 Klinični oddelek za torakalno kirurgijo 109 57 52 Klinični oddelek za urologijo 335 141 42 Drugi klinični oddelki 5 4 SPS Ginekološka klinika 231 137 59 SPS Nevrološka klinika 28 16 57 SPS Pediatrična klinika 37 29 78 Dermatovenerološka klinika 62 25 40 Klinika za infekcijske bolezni in vročinska stanja 22 14 64 Klinika za otorinolaringologijo in cervikofacialno kirurgijo 229 193 84 Očesna klinika 32 7 22 Ortopedska klinika 19 18 95 68 Incidenca raka v Sloveniji 2002 nadaljevanje / cont’d ➝ Onkološki inštitut Ljubljana, Register raka za Slovenijo Tabela 10. – Table 10. Nadaljevanje – Continued Bolnišnice Število novih Napoteni na OI primerov Število Odstotek* Hospitals Number of new Referred to the IO cases Number Percent* Splošne in specialistične bolnišnice 5069 2347 46 General and special hospitals Splošna bolnišnica Brežice 100 52 52 Splošna bolnišnica Celje 635 363 57 Bolnišnica Golnik 453 322 71 Splošna bolnišnica Jesenice 224 90 40 Splošna bolnišnica Izola 278 127 46 Splošna bolnišnica Maribor 1335 534 40 Splošna bolnišnica Murska Sobota 439 157 36 Splošna bolnišnica dr. Franc Derganc Nova Gorica 384 162 42 Splošna bolnišnica Novo mesto 428 195 46 Splošna bolnišnica dr. Jožeta Potrča Ptuj 92 45 49 Splošna bolnišnica Slovenj Gradec 349 84 24 Splošna bolnišnica Trbovlje 71 39 55 Bolnišnica za ginekologijo in porodništvo Kranj 55 33 60 Bolnišnica Topolšica 136 97 71 Bolnišnica za ginekologijo in porodništvo Postojna 37 19 51 Bolnica Sežana 47 22 47 Ortopedska bolnica Valdoltra 5 5 Psihiatrična klinika Ljubljana – – Psihiatrična bolnišnica Begunje – – Psihiatrična bolnišnica Idrija 1 1 Zasebne ordinacije 536 179 33 Private clinics Drugi zdravstveni zavodi 133 97 73 Other health institutions * Odstotki niso računani pri številih pod 15 Percentages are not calculated for less than 15 cases Cancer Incidence in Slovenia 2002 69 Institute of Oncology Ljubljana, Cancer Registry of Slovenia 70 Incidenca raka v Sloveniji 2002 nadaljevanje / cont’d ➝ Onkološki inštitut Ljubljana, Register raka za Slovenijo Tabela 11. Število in odstotek* novih primerov raka, ugotovljenih v bolnišnicah, po stadiju, lokaciji in spolu - Slovenija 2002 Table 11. Number and percentage* of new cancer cases reported by hospitals by stage, site and sex - Slovenia 2002 S t a d i j Šifra Primarna Spol Število Lokaliziran Reg. razširitev Odd. razširitev Neznan MKB lokacija primerov Število Odstotek* Število Odstotek* Število Odstotek* Število Odstotek* S t a g e ICD Primary Sex Number Localized Regional Remote Unknown code site of cases Number Percent* Number Percent* Number Percent* Number Percent* C00 Vse lokacije M+Ž 9222 4082 44 2697 29 2056 22 387 4 – M 4617 1864 40 1411 31 1108 24 234 5 C96 All sites Ž 4605 2218 48 1286 28 948 21 153 3 C00 Ustnica M 21 18 86 2 10 1 5 – –Lip Ž 12 12 – – – C01 Baza jezika M 15 2 13 12 80 1 7 – –Base of tongue Ž – – – – – C02 Jezik, drugi deli M 25 6 24 19 76 – – – –Tongue, other & unspecified parts Ž 3 2 1 – – C03 Dlesen M 4 1 3 – –Gum Ž 5 3 2 – – C04 Ustno dno M 33 14 42 18 55 – – 1 3Floor of mouth Ž 5 1 4 – – C05 Nebo M 10 4 6 – –Palate Ž 3 1 2 – – C06 Usta, drugi deli M 14 4 10 – –Mouth, other & unspecified parts Ž 6 1 5 – – C07 Parotidna žleza M 7 3 4 – –Parotid gland Ž 5 3 2 – – C08 Druge in neopredeljene velike žleze slinavke M – – – – – Other & unspecified major Ž 2 1 1 – – salivary glands C09 Tonzila M 30 6 20 21 70 2 7 1 3Tonsil Ž 5 2 3 – – C10 Orofarinks M 34 2 6 31 91 1 3 – –Oropharynx Ž 4 2 1 1 – C11 Nazofarinks M 5 – 5 – –Nasopharynx Ž 8 2 6 – – C12 Piriformni sinus M 25 4 16 20 80 1 4 – –Pyriform sinus Ž 2 1 1 – – C13 Hipofarinks M 24 2 8 20 83 1 4 1 4Hypopharynx Ž 1 – 1 – – C14 Druga in slabo opredeljena mesta na ustnici, v ustni votlini in farinksu M – – – – – Other and ill-defined sites in the lip, Ž – – – – – oral cavity and pharynx C15 Požiralnik M 76 13 17 27 36 27 36 9 12Oesophagus Ž 22 5 23 9 41 3 14 5 23 C16 Želodec M 263 52 20 108 41 84 32 19 7Stomach Ž 168 47 28 53 32 43 26 25 15 C17 Tanko črevo M 11 3 7 1 –Small intestine Ž 5 1 1 2 1 C18 Debelo črevo M 345 40 12 214 62 82 24 9 3Colon Ž 291 34 12 179 62 67 23 11 4 C19 Rektosigmoidna zveza M 62 10 16 28 45 21 34 3 5Rectosigmoid junction Ž 37 5 14 19 51 10 27 3 8 nadaljevanje / cont’d ➝ Cancer Incidence in Slovenia 2002 71 Institute of Oncology Ljubljana, Cancer Registry of Slovenia Tabela 11. – Table 11. Nadaljevanje – Continued S t a d i j Šifra Primarna Spol Število Lokaliziran Reg. razširitev Odd. razširitev Neznan MKB lokacija primerov Število Odstotek* Število Odstotek* Število Odstotek* Število Odstotek* S t a g e ICD Primary Sex Number Localized Regional Remote Unknown code site of cases Number Percent* Number Percent* Number Percent* Number Percent* C20 Rektum M 249 58 23 136 55 45 18 10 4Rectum Ž 170 30 18 89 52 43 25 8 5 C21 Anus in analni kanal M 3 1 2 – –Anus and anal canal Ž 8 2 1 2 3 C22 Jetra in intrahepatični vodi M 93 39 42 14 15 33 35 7 8Liver and intrahepatic bile ducts Ž 34 10 29 11 32 9 26 4 12 C23 Žolčnik M 12 – 5 5 2Gallbladder Ž 44 3 7 18 41 21 48 2 5 C24 Drugi in neopredeljeni deli biliarnega trakta M 35 4 11 21 60 6 17 4 11 Billiary tract, other Ž 40 11 28 14 35 9 23 6 15 and unspecified parts C25 Trebušna slinavka M 109 11 10 39 36 52 48 7 6Pancreas Ž 129 16 12 43 33 58 45 12 9 C26 Druga in slabo opredeljena mesta v prebavnih organih M – – – – – Other and ill-defined Ž 5 1 1 3 – digestive organs C30 Nosna votlina in srednje uho M 2 1 1 – –Nasal cavity and middle ear Ž 3 3 – – – C31 Obnosni sinusi M 5 – 4 – 1Accessory sinuses Ž 4 – 4 – – C32 Grlo M 97 52 54 44 45 1 1 – –Larynx Ž 11 1 9 1 – C33 Sapnik M 3 – 2 1 –Trachea Ž 2 – 1 1 – C34 Sapnica in pljuča M 775 148 19 310 40 295 38 22 3Bronchus and lung Ž 255 53 21 101 40 98 38 3 1 C37 Timus M 1 – 1 – –Thymus Ž – – – – – C38 Srce, mediastinum, plevra M 2 – – 1 1Heart, mediastinum, pleura Ž 1 1 – – – C39 Druga in slabo opredeljena mesta v dihalih in prsnih organih M – – – – – Other and ill-defined sites in the respi- Ž – – – – – ratory system and intrathoracic organs C40 Kosti, sklepni hrustanec udov M 4 2 1 – 1Bone and articular cartilage of limbs Ž 5 2 2 – 1 C41 Kosti, sklepni hrustanec, drugje M 5 1 3 1 –Bone and articular cartilage Ž 3 1 – 1 1of other and unspecified parts C43 Maligni melanom kože M 115 76 66 19 17 15 13 5 4Malignant melanoma of skin Ž 154 118 77 27 18 6 4 3 2 C44 Druge maligne neoplazme kože M 610 603 99 7 1 – – – –Skin, other malignomas Ž 714 700 98 12 2 2 – – – C45 Mezoteliom M 22 9 41 12 55 1 5 – –Mesothelioma Ž 9 3 3 1 2 C46 Kaposijev sarkom M – – – – –Kaposi's sarcoma Ž – – – – – 72 Incidenca raka v Sloveniji 2002 nadaljevanje / cont’d ➝ Onkološki inštitut Ljubljana, Register raka za Slovenijo Tabela 11. – Table 11. Nadaljevanje – Continued S t a d i j Šifra Primarna Spol Število Lokaliziran Reg. razširitev Odd. razširitev Neznan MKB lokacija primerov Število Odstotek* Število Odstotek* Število Odstotek* Število Odstotek* S t a g e ICD Primary Sex Number Localized Regional Remote Unknown code site of cases Number Percent* Number Percent* Number Percent* Number Percent* C47 Periferni živci in avtonomno živčevje M 4 2 – 1 1Peripheral nerves and Ž 1 1 – – –autonomic nervous system C48 Retro- in peritonej M 11 1 8 1 1Retro- and peritoneum Ž 3 1 2 – – C49 Drugo vezivno in mehko tkivo M 21 8 38 8 38 5 24 – –Other connective and soft tissue Ž 20 7 35 12 60 1 5 – – C50 Dojka M 14 4 7 2 1Breast Ž 1016 526 52 418 41 66 6 6 1 C51 Žensko zunanje spolovilo M – – – – –Vulva Ž 41 29 71 10 24 – – 2 5 C52 Nožnica M – – – – –Vagina Ž 17 8 47 8 47 – – 1 6 C53 Maternični vrat M – – – – –Cervix uteri Ž 187 125 67 53 28 7 4 2 1 C54 Maternično telo M – – – – –Corpus uteri Ž 299 213 71 60 20 20 7 6 2 C55 Maternica, neopredeljeno M – – – – –Uterus, unspecified Ž 7 2 1 4 – C56 Jajčnik M – – – – –Ovary Ž 167 22 13 15 9 127 76 3 2 C57 Drugi in neopredeljeni ženski spolni organi M – – – – – Other and unspecified parts of Ž 11 2 2 7 – female genital organs C58 Posteljica M – – – – –Placenta Ž – – – – – C60 Penis M 4 3 – 1 –Penis Ž – – – – – C61 Prostata M 524 331 63 83 16 53 10 57 11Prostate Ž – – – – – C62 Modo M 78 47 60 25 32 6 8 – –Testis Ž – – – – – Drugi in neopredeljeni moški spolni organi M 3 2 – 1 – C63 Other and unspecified male Ž – – – – – genital organs C64 Ledvica razen meha M 131 69 53 18 14 33 25 11 8Kidney, except renal pelvis Ž 50 26 52 8 16 13 26 3 6 C65 Ledvični meh M 9 2 4 2 1Renal pelvis Ž 5 1 1 3 – C66 Sečevod M 4 3 1 – –Ureter Ž – – – – – C67 Sečni mehur M 134 86 64 32 24 8 6 8 6Bladder Ž 49 34 69 12 24 1 2 2 4 C68 Drugi in neopredeljeni sečni organi M 1 – 1 – –Other and unspecified urinary organs Ž – – – – – C69 Oko in očesni adneksi M 9 7 2 – –Eye and adnexa Ž 8 6 2 – – C70 Meninge M 1 1 – – –Meninges Ž 5 4 – 1 – C71 Možgani M 66 65 98 1 2 – – – –Brain Ž 60 55 92 5 8 – – – – Tabela 11. – Table 11. Nadaljevanje – Continued S t a d i j Šifra Primarna Spol Število Lokaliziran Reg. razširitev Odd. razširitev Neznan MKB lokacija primerov Število Odstotek* Število Odstotek* Število Odstotek* Število Odstotek* S t a g e ICD Primary Sex Number Localized Regional Remote Unknown code site of cases Number Percent* Number Percent* Number Percent* Number Percent* C72 Hrbtni mozeg, možganski živci in drugi deli CŽS M 1 1 – – – Spinal cord, cranial nerves Ž 1 1 – – – and other parts of CNS C73 Ščitnica M 22 12 55 7 32 2 9 1 5Thyroid gland Ž 75 56 75 16 21 3 4 – – C74 Nadledvična žleza M 2 – – 1 1Adrenal gland Ž 4 1 – 3 – Druge endokrine žleze in sorodne strukture M 2 1 1 – –C75 Other endocrine glands Ž – – – – – and related structures C76 Druga in slabo opredeljena mesta M 6 – 1 3 2Other and ill-defined sites Ž 14 – 3 8 3 Metastaza in neopredeljena maligna neoplazma bezgavk M 29 – – – – – – 29 100C77 Metastasis and unspecified Ž 18 – – – – – – 18 100 malignant neoplasm of lymph nodes C78 Metastaze dihal in prebavil M 62 – – – – 62 100 – –Metastases of respiratory Ž 55 – – – – 55 100 – –and digestive organs C79 Metastaze, drugje M 16 – – – – 16 100 – –Metastases of other sites Ž 15 – – – – 15 100 – – C80 Maligna neoplazma brez opredeljenega mesta M 37 – – – – 37 100 – – Malignant neoplasm without Ž 31 – – – – 31 100 – – specification of site S t a d i j ( A n n – A r b o r ) Šifra Primarna Spol Število I II III + IV Neznan MKB lokacija primerov Število Odstotek* Število Odstotek* Število Odstotek* Število Odstotek* S t a g e ICD Primary Sex Number I II III + IV Unknown code site of cases Number Percent* Number Percent* Number Percent* Number Percent* C81 Hodgkinova bolezen M 18 2 11 11 61 5 28 – –Hodgkin's disease Ž 25 2 8 12 48 10 40 1 4 C82- Ne-Hodgkinov limfom M 117 27 67 25 63 48 118 17 53 C85 Ne-Hodgkin's lymphoma Ž 95 18 79 20 54 41 113 16 53 * Odstotki niso računani pri številih pod 15 Percentages are not calculated for less than 15 cases Cancer Incidence in Slovenia 2002 73 Institute of Oncology Ljubljana, Cancer Registry of Slovenia 74 Incidenca raka v Sloveniji 2002 nadaljevanje / cont’d ➝ Onkološki inštitut Ljubljana, Register raka za Slovenijo Tabela 12. Število umrlih za rakom po lokaciji, spolu in starosti - Slovenija 2002* Table 12. Number of cancer deaths by site, sex and age - Slovenia 2002* Šifra Primarna Vse S t a r o s t i MKB lokacija Spol starosti A g e ICD Primary Sex All code site ages 0– 5– 10– 15– 20– 25– 30– 35– 40– 45– 50– 55– 60– 65– 70– 75– 80– 85+ Skupaj 4978 4 4 1 7 12 10 22 41 80 191 307 355 537 757 876 794 558 422 Vse lokacije Total Moški 2809 4 2 1 5 9 5 12 19 41 109 184 225 374 483 531 399 233 173 All sites Male Ženske 2169 0 2 0 2 3 5 10 22 39 82 123 130 163 274 345 395 325 249 Female C00 Ustnica M 1 – – – – – – – – – – 1 – – – – – – –Lip Ž 2 – – – – – – – – – – 1 – – – 1 – – – C01 Baza jezika M 3 – – – – – – – – – 1 – – 1 – – – – 1Base of tongue Ž – – – – – – – – – – – – – – – – – – – C02 Jezik, drugi deli M 13 – – – – – – – – 1 3 1 – 3 2 3 – – – Tongue, other & unspecified parts Ž 1 – – – – – – – – – – – – – – – 1 – – C03 Dlesen M 1 – – – – – – – – – – – – – – – 1 – –Gum Ž – – – – – – – – – – – – – – – – – – – C04 Ustno dno M 14 – – – – – – – – 1 3 2 1 2 2 1 2 – –Floor of mouth Ž 2 – – – – – – – – – – 1 – – – – 1 – – C06 Usta, drugi deli M 9 – – – – – – – – 1 1 – 1 3 – 2 1 – –Mouth, other & unspecified parts Ž 1 – – – – – – – – – – – – – 1 – – – – C07 Parotidna žleza M – – – – – – – – – – – – – – – – – – –Parotid gland Ž 2 – – – – – – – – – – – – – – 1 1 – – C09 Tonzila M 1 – – – – – – – – – – – – – – – 1 – –Tonsil Ž – – – – – – – – – – – – – – – – – – – C10 Orofarinks M 42 – – – – – – – 1 – 10 4 8 8 6 3 1 1 –Oropharynx Ž 5 – – – – – – – – – 1 2 – 2 – – – – – C11 Nazofarinks M 5 – – – – – – – 1 1 – – – 1 1 – 1 – –Nasopharynx Ž 1 – – – – – – – – – – – – – 1 – – – – C12 Piriformni sinus M 1 – – – – – – – – – – – 1 – – – – – –Pyriform sinus Ž – – – – – – – – – – – – – – – – – – – C13 Hipofarinks M 30 – – – – – – – – 2 3 6 5 5 4 3 – 2 –Hypopharynx Ž 5 – – – – – – – – – 1 – 2 – – 1 – – 1 Druga in slabo oprede- ljena mesta na ustnici, C14 v ustni votlini in farinksu M 6 – – – – – – – – – 1 1 – – 1 3 – – –Other and ill-defined Ž 2 – – – – – – – – – – – 1 – – – – 1 – sites in the lip, oral cavity and pharynx C15 Požiralnik M 88 – – – – – – – 1 2 7 4 8 15 19 18 11 2 1Oesophagus Ž 20 – – – – – – – – – 1 1 – – 2 6 1 6 3 C16 Želodec M 244 – – – – – – 1 – 3 7 17 19 32 40 39 44 21 21Stomach Ž 140 – – – – – 1 3 – 4 1 4 5 8 17 24 30 17 26 C17 Tanko črevo M 8 – – – – – – – – – 1 1 – – 1 3 1 1 –Small intestine Ž 4 – – – – – – – – – – – – – 1 – – 2 1 C18 Debelo črevo M 209 – – – – – – – 1 1 4 10 18 25 36 39 30 30 15Colon Ž 159 – – – – – – – – 2 1 4 7 7 23 26 33 34 22 C19 Rektosigmoidna zveza M 40 – – – – – – – – 1 – – 3 4 8 11 5 5 3Rectosigmoid junction Ž 31 – – – – – – – 1 1 – 1 2 – 1 4 5 9 7 C20 Rektum M 129 – – – – – – – 1 – 1 7 3 22 25 23 22 15 10Rectum Ž 98 – – – – – – – – 2 1 5 5 7 17 13 22 16 10 C21 Anus in analni kanal M 2 – – – – – – – – – – – 1 – – – – 1 –Anus and anal canal Ž 4 – – – – – – – – – – – – – 1 – 2 – 1 C22 Jetra in intrahepatični vodi M 89 – – – – – – – – 2 1 2 11 13 11 27 13 8 1 Liver and intrahepatic bile ducts Ž 57 – – – – – – – – – 1 1 3 4 6 11 14 8 9 C23 Žolčnik M 24 – – – – – – – – 1 – 3 3 1 5 6 4 – 1Gallbladder Ž 34 – – – – – – – – – – – 3 4 3 6 4 9 5 nadaljevanje / cont’d ➝ Cancer Incidence in Slovenia 2002 75 Institute of Oncology Ljubljana, Cancer Registry of Slovenia Tabela 12. – Table 12. Nadaljevanje – Continued Šifra Primarna Vse S t a r o s t i MKB lokacija Spol starosti A g e ICD Primary Sex All code site ages 0– 5– 10– 15– 20– 25– 30– 35– 40– 45– 50– 55– 60– 65– 70– 75– 80– 85+ Drugi in neopredeljeni deli biliarnega trakta M 21 – – – – – – – – – 1 5 – 1 6 4 2 1 1C24 Billiary tract, other and Ž 26 – – – – – – – – – – 2 2 1 3 3 4 3 8 unspecified parts C25 Trebušna slinavka M 121 – – – – 1 – 1 3 1 4 11 12 15 16 25 15 11 6Pancreas Ž 126 – – – – – – – – 2 6 2 7 7 11 28 26 24 13 C26 Druga in slabo opredeljena mesta v prebavnih organih M 7 – – – – – – – – – – 1 – 2 – 1 1 1 1 Other and ill-defined Ž 10 – – – – – – – – – – – – – – 1 2 2 5 digestive organs Nosna votlina in srednje uho M 1 – – – – – – – – – – – – – – 1 – – –C30 Nasal cavity and Ž – – – – – – – – – – – – – – – – – – – middle ear C31 Obnosni sinusi M 5 – – – – – – – – – 1 1 1 – – 2 – – –Accessory sinuses Ž 5 – – – – – – – – – – 1 1 – 1 – 1 1 – C32 Grlo M 47 – – – – – – – – 1 5 4 1 5 15 7 5 3 1Larynx Ž 5 – – – – – – – – – – 1 – – 1 1 – 1 1 C33 Sapnik M 1 – – – – – – – – – – – – 1 – – – – –Trachea Ž 1 – – – – – – – – – – – – – – 1 – – – C34 Sapnica in pljuča M 715 – – – – – – 3 2 10 24 57 80 112 141 137 103 28 18ronchus and lung Ž 231 – – – – – 1 1 2 2 20 21 20 21 37 36 36 26 8 C37 Timus M 1 – – – – – – – – – – – – – 1 – – – –Thymus Ž – – – – – – – – – – – – – – – – – – – Srce, mediastinum, plevra M 10 – – – – 1 – – – 1 – – 1 2 3 1 – – 1C38 Heart, mediastinum, Ž 4 – – – – – – – – – – – – – – 1 – 2 1 pleura Kosti, sklepni hrustanec udov M 1 – – – – – – – – – – – – – – 1 – – – C40 Bone and articular Ž 3 – – – – – 1 – 1 1 – – – – – – – – – cartilage of limbs Kosti, sklepni hrustanec, drugje Bone and articular M 5 – – – 1 2 – – – – – – 1 1 – – – – –C41 cartilage of other and Ž 6 – – – – – – – – – – – 1 1 1 2 1 – – unspecified parts C43 Maligni melanom kože M 54 – – – – – 1 – 1 3 2 6 2 10 10 8 5 3 3Malignant melanoma of skin Ž 30 – – – – – – 2 1 1 1 5 – 1 2 1 9 3 4 C44 Druge maligne neoplazme kože M 7 – – – – – – – – – – – – 1 – 2 3 – 1 Skin, other malignomas Ž 9 – – – – – – – – – – – – – 3 – 1 2 3 C45 Mezoteliom M 22 – – – – – – – – – 2 2 4 5 4 3 1 1 –Mesothelioma Ž 7 – – – – – – – – – – – – 1 1 3 1 1 – Periferni živci in avtonomno živčevje M 1 – – – – – 1 – – – – – – – – – – – – C47 Peripheral and autho- Ž 1 – – – – 1 – – – – – – – – – – – – – nomic nervous system C48 Retro- in peritonej M 5 – – – – – – – – – – 1 – – 1 1 1 – 1Retro- and peritoneum Ž 2 – – – – – – – – – – – – – – – 2 – – Drugo vezivno in mehko tkivo M 13 – 1 – 1 1 – 1 – 1 – – 3 2 – 1 – – 2 C49 Other connective and Ž 9 – – – – – – – – 1 – – – 1 1 1 4 1 – soft tissue C50 Dojka M 5 – – – – – – – – – 1 – – – 2 – 2 – –Breast Ž 425 – – – – – – – 10 8 23 36 37 42 53 65 65 48 38 C51 Žensko zunanje spolovilo M – – – – – – – – – – – – – – – – – – –Vulva Ž 15 – – – – – – – – – 2 – – – – 3 4 2 4 C52 Nožnica M – – – – – – – – – – – – – – – – – – –Vagina Ž 7 – – – – – – – – – 1 – – – – 1 1 2 2 C53 Maternični vrat M – – – – – – – – – – – – – – – – – – –Cervix uteri Ž 47 – – – – – 1 – 4 6 5 4 2 6 1 5 6 6 1 76 Incidenca raka v Sloveniji 2002 nadaljevanje / cont’d ➝ Onkološki inštitut Ljubljana, Register raka za Slovenijo Tabela 12. – Table 12. Nadaljevanje – Continued Šifra Primarna Vse S t a r o s t i MKB lokacija Spol starosti A g e ICD Primary Sex All code site ages 0– 5– 10– 15– 20– 25– 30– 35– 40– 45– 50– 55– 60– 65– 70– 75– 80– 85+ C54 Maternično telo M – – – – – – – – – – – – – – – – – – –Corpus uteri Ž 50 – – – – – – – – 3 2 1 1 6 7 8 10 9 3 C55 Maternica, neopredeljeno M – – – – – – – – – – – – – – – – – – – Uterus, unspecified Ž 51 – – – – – – – – – 1 1 3 5 8 11 8 8 6 C56 Jajčnik M – – – – – – – – – – – – – – – – – – –Ovary Ž 118 – – – – – – 1 1 2 4 13 10 13 17 19 16 14 8 Drugi in neopredeljeni ženski spolni organi M – – – – – – – – – – – – – – – – – – –C57 Other and unspecified parts Ž 9 – – – – – – – – – – 1 1 1 2 1 1 – 2 of female genital organs C60 Penis M 6 – – – – – – – – – – 1 – 1 1 1 – – 2Penis Ž – – – – – – – – – – – – – – – – – – – C61 Prostata M 277 – – – 1 – – – – – – 4 8 16 32 57 55 55 49Prostate Ž – – – – – – – – – – – – – – – – – – – C62 Modo M 2 – – – – – – 1 – – – – – – – 1 – – –Testis Ž – – – – – – – – – – – – – – – – – – – C64 Ledvica razen meha M 66 – – – – – – 1 1 1 5 7 2 7 14 12 12 2 2Kidney, except renal pelvis Ž 28 – – – – – – – – – 1 – – 2 4 4 9 4 4 C65 Ledvični meh M 1 – – – – – – – – – – – – – – – – – 1Renal pelvis Ž – – – – – – – – – – – – – – – – – – – C66 Sečevod M 2 – – – – – – – – – – – 1 1 – – – – –Ureter Ž – – – – – – – – – – – – – – – – – – – C67 Sečni mehur M 100 – – – – – – – – 1 2 2 5 11 21 23 13 9 13Bladder Ž 30 – – – – – – – – – – – – – 3 6 6 8 7 Drugi in neopredeljeni sečni organi M 1 – – – – – – – – – – – – – – – – – 1C68 Other and unspecified Ž 1 – – – – – – – – – – – – 1 – – – – – urinary organs C70 Meninge M 3 – – – – – – – – – 1 1 – 1 – – – – –Meninges Ž 3 – – – – – – 1 – – – – 1 – – – – 1 – C71 Možgani M 70 1 1 1 – 1 – 1 3 1 8 7 7 12 13 5 6 2 1Brain Ž 43 – 1 – 1 – 1 1 1 1 1 5 3 4 8 3 8 4 1 Hrbtni mozeg, možganski živci in drugi deli CŽS M 2 – – – – – – – – – 1 – – – 1 – – – –C72 Spinal cord, cranial nerves Ž 1 – – – – – – – – – – 1 – – – – – – – and other parts of CNS C73 Ščitnica M 8 – – – – 1 – – – 1 – – 1 – 1 2 1 1 –Thyroid gland Ž 12 – – – – – – – – – – – – – 1 3 5 2 1 C74 Nadledvična žleza M 1 – – – – – – – – – – – – – – – 1 – –Adrenal gland Ž 4 – 1 – – – – – – 1 – – – – 1 – – – 1 Druge endokrine žleze in sorodne strukture M – – – – – – – – – – – – – – – – – – –C75 Other endocrine glands Ž 3 – – – – – – – – – – – – 1 – – 1 1 – and related structures Druga in slabo opredeljena mesta M 7 – – – – – – – – – – – – 2 2 1 – 2 –C76 Other and ill-defined sites Ž 19 – – – – – – – – – – – 1 – – 2 3 8 5 Metastaza in neopredeljena maligna C77 neoplazma bezgavk M 1 – – – – – – – – – 1 – – – – – – – –Metastasis and Ž 1 – – – – – – – – – – 1 – – – – – – – unspecified malignant neoplasm of lymph nodes C78 Metastaze dihal in prebavil M 18 – – – – – – – – – 1 1 1 3 3 3 2 2 2Metastases of respiratory and digestive organs Ž 20 – – – – – – – – – – 1 – 1 1 6 6 2 3 nadaljevanje / cont’d ➝ Cancer Incidence in Slovenia 2002 77 Institute of Oncology Ljubljana, Cancer Registry of Slovenia Tabela 12. – Table 12. Nadaljevanje – Continued Šifra Primarna Vse S t a r o s t i MKB lokacija Spol starosti A g e ICD Primary Sex All code site ages 0– 5– 10– 15– 20– 25– 30– 35– 40– 45– 50– 55– 60– 65– 70– 75– 80– 85+ C79 Metastaze, drugje M 5 – – – – – – – – – – 1 1 1 1 1 – – –Metastases of other sites Ž 3 – – – – – – – – – – 1 1 – – 1 – – – Maligna neoplazma brez opredeljenega mesta M 51 – – – – – – – – 2 – 4 2 7 4 9 11 6 6 C80 Malignant neoplasm Ž 61 – – – – – – – – 1 1 2 4 1 8 8 12 13 11 without specification of site C81 Hodgkinova bolezen M 7 – – – 1 – 1 – 1 – 1 1 – – – 2 – – –Hodgkin's disease Ž 3 – – – – 1 – – – – 1 – – – – – – – 1 Folikularni ne-Hodgkinov limfom M 7 – – – 1 – – – – – – 1 – 1 2 1 – 1 –C82 Follicular non-Hodgkin's Ž 5 – – – – – – – – – – 1 1 1 – – 1 1 – lymphoma C83 Difuzni ne-Hodgkinov limfom M 12 1 – – – – – 1 – – – – – 3 1 2 4 – – Diffuse non-Hodgkin's Ž 8 – – – – – – – – – – – – – 1 1 2 2 2 lymphoma Limfomi celic T in kožni limfom celic T M 1 – – – – – – – – – 1 – – – – – – – –C84 Peripheral and cutaneous Ž 1 – – – – – – – – – – – – 1 – – – – – T-cell lymphomas C85 Druge in neopredeljene vrste ne-Hodgkinovega limfoma M 27 – – – – – – 1 1 1 2 1 – 7 4 5 5 – – Other and unspecified Ž 36 – – – – – – – 1 1 3 – 1 1 9 4 6 4 6 types of non-Hodgkin's lymphoma Maligne imunoprolife- rativne bolezni M – – – – – – – – – – – – – – – – – – –C88 Malignant immunopro- Ž 1 – – – – – – – – – – – – – – – – – 1 liferative diseases C90 Difuzni plazmocitom in maligne neoplazme plazmocitov M 26 – – – – – – – 1 – – – 1 2 7 8 2 5 – Multiple myeloma and Ž 46 – – – – – – – – – 1 – 1 4 7 13 9 8 3 malignant plasma cell neoplasms C91 Limfatična levkemija M 36 1 – – – 2 1 1 1 – 1 – 2 3 4 8 4 4 4Lymphoid leukaemia Ž 23 – – – – 1 – 1 – – – – 1 2 3 3 8 2 2 C92 Mieloična levkemija M 27 1 – – – – 1 – – 1 1 4 3 – 4 6 1 3 2Myeloid leukaemia Ž 24 – – – 1 – – – – – 2 1 1 2 4 3 4 3 3 C93 Monocitna levkemija M 2 – – – – – – – – – – – – – 2 – – – –Monocytic leukaemia Ž – – – – – – – – – – – – – – – – – – – C95 Levkemija z neopredeljenim celičnim tipom M 6 – – – – – – – – – – 1 – 1 1 1 – 2 – Leukaemia, unspecified Ž 2 – – – – – – – – – – – – 1 – – – – 1 cell type Druge in neopredeljene maligne neoplazme limfatičnega, krvotvornega in sorodnega tkiva M 1 – – – – – – – – – – – – – 1 – – – –C96 Other & unspecified Ž 2 – – – – – – – – – – – – – 2 – – – – malignant neoplasms of lymphoid, haemopoetic & related tissues C97 Maligne neoplazme na več neodvisnih (primarnih) mestih M 35 – – – – – – – – – 1 1 4 3 4 8 7 5 2 Malignant neoplasms Ž 24 – – – – – – – – – – 2 2 3 – 4 3 5 5 of independant (primary) multiple sites Tabela 12. – Table 12. Nadaljevanje – Continued Šifra Primarna Vse S t a r o s t i MKB lokacija Spol starosti A g e ICD Primary Sex All code site ages 0– 5– 10– 15– 20– 25– 30– 35– 40– 45– 50– 55– 60– 65– 70– 75– 80– 85+ Zgoraj neupoštevani Not included above Meninge, benigna neoplazma M 1 – – – – – – – – – – – – – – – – 1 –D32 Benign neoplasm Ž 4 – – – – – – – – – 1 – – – 2 – – 1 – of meninges D33 CŽS, benigna neoplazma M 2 – – – – – – – – – – – 1 – 1 – – – – Benign neoplasm of brain Ž 1 – – – – – – – – – – – – – 1 – – – – and other parts of CNS D43 CŽS, neopredeljeno M 4 – – – – – – – – – – 2 – 1 – – – – 1CNS, uncertain or unknown Ž 8 – – – – – – – 1 – – – – 1 – – 2 1 3 * Vir: Inštitut za varovanje zdravja Source: Institute of Public Health 78 Incidenca raka v Sloveniji 2002 Onkološki inštitut Ljubljana, Register raka za Slovenijo Cancer Incidence in Slovenia 2002 79 Institute of Oncology Ljubljana, Cancer Registry of Slovenia Tabela 13. Število vseh živih bolnikov z rakom po spolu in izbrani primarni lokaciji - Slovenija, 31. 12. 2002 Table 13. Prevalence of cancer patients by sex and selected primary site - Slovenia, December 31, 2002 Šifra Primarna MKB lokacija Skupaj Moški Ženske ICD Primary Total Males Females code site C00 – Vse lokacije Skupaj 53858 20846 33012 C96 All sites Total C00 Usta in žrelo 1677 1268 409 -C14 Mouth and pharynx C15 Požiralnik 111 85 26 Oesophagus C16 Želodec 1454 816 638 Stomach C18 Debelo črevo 2744 1376 1368 Colon C19 Rektum in rektosigmoidna zveza 2445 1295 1150 -C20 Rectum and rectosigmoid junction C22 Jetra in intrahepatični vodi 96 61 35 Liver and intrahepatic bile ducts C23 Žolčnik in žolčevodi 170 80 90 -C24 Gallbladder and billiary tract C25 Trebušna slinavka 149 70 79 Pancreas C32 Grlo 889 799 90 Larynx C33 Sapnik, sapnici in pljuča 1666 1265 404 -C34 Trachea, bronchus and lung C43 Maligni melanom kože 2124 817 1307 Malignant melanoma of skin C44 Druge maligne neoplazme kože 10989 4930 6059 Skin, other malignomas C48 Vezivno in mehko tkivo 501 245 256 -C49 Connective and soft tissue C50 Dojka 8923 58 8865 Breast C53 Maternični vrat 3401 – 3401 Cervix uteri C54 Maternično telo 3179 – 3179 Corpus uteri C56 Jajčnik 1212 – 1212 Ovary C61 Prostata 2188 2188 – Prostate C62 Modo 1196 1196 – Testis C64 Ledvica z ledvičnim mehom 1240 717 523 -C65 Kidney with renal pelvis C67 Sečni mehur 993 751 242 Bladder C70 Centralni in avtonomni živčni sistem 480 265 215 -C72 Central and autonomic nervous system C73 Ščitnica 949 209 740 Thyroid gland C81 Hodgkinova bolezen 697 368 329 Hodgkin's disease C82 ne-Hodgkinovi limfomi 1318 682 636 -C85 non-Hodgkin's lymphoma C90 Difuzni plazmocitom in maligne neoplazme plazmocitov 226 97 129 Multiple myeloma and malignant plasma cell neoplasms C91 Levkemije 951 482 469 -C95 Leukaemias 80 Incidenca raka v Sloveniji 2002 Onkološki inštitut Ljubljana, Register raka za Slovenijo IZBOR PUBLIKACIJ, ki so jih sodelavci Epidemiologije in Registra raka objavili v zadnjih petih letih (tudi v sodelovanju z drugimi raziskovalci) SELECTION OF PUBLICATIONS, published by the members of Epidemiology and Cancer Registry in the last five years (also in cooperation with other researchers) 2000 - Pompe Kirn V, Japelj B, Primic Žakelj M. Future trends in breast, cervical, lung, mouth and pharyngeal cancer incidence in Slovenia. Cancer Causes Control 2000; 11(4): 309-18. - Pompe Kirn V, Japelj B, Primic Žakelj M. Trend incidence pljučnega raka in kadilskih navad pri moških v Sloveniji. Zdrav Vestn 2000; 69(2): 97-9. - Pompe Kirn V, Japelj B. Trend incidence pljučnega raka in kadilskih navad pri ženskah v Sloveniji. Zdrav Vestn 2000; 69(10): 679-82. - Pompe Kirn V. Epidemiološke značilnosti raka glave in vratu v Sloveniji. In: Gale N, Žargi M, eds. Epithelial tumours of the head and neck. 31st memorial meeting for professor Janez Plečnik, Ljubljana 2000. Ljubljana: Institute of Pathology; Faculty of Medicine, 2000, 63-4. - Pompe Kirn V. Petdeset let dela Registra raka za Slovenijo. Onkologija 2000; 4(1): 39-42. - Pompe Kirn V. Pogostnost raka in preživetje bolnikov z rakom v Republiki Sloveniji. In: Velepič M, Skela Savič B, eds. Priročnik iz onkološke zdravstvene nege in onkologije. Ljubljana: Onkološki inštitut, 2000: 20-8. - Pompe Kirn V. Prehrana in rak. In: Štabuc B, ed. Prehrana in rak. 8. seminar »In memoriam dr. Dušana Reje«, Ljubljana 2000. Ljubljana: Zveza slovenskih društev za boj proti raku; Onkološki inštitut; Inštitut za varovanje zdravja; Rdeči križ Slovenije, 2000: 60-3. - Pompe Kirn V. Rak v Sloveniji. In: Bergant O, ed. Slovenija proti raku: desetletni program 2000-2010. Ljubljana: Zveza slovenskih društev za boj proti raku, 2000: 15-7. - Pompe Kirn V. Rak v Sloveniji. In: Lah A, ed. Zdravje in okolje: kakovost okolja in življenja konec 20. stoletja. Ljubljana: Svet za varstvo okolja Republike Slovenije, 2000: 61-4. - Primic Žakelj M. Dejavniki tveganja in preprečevanje raka. In: Velepič M, Skela Savič B, eds. Priročnik iz onkološke zdravstvene nege in onkologije. Ljubljana: Onkološki inštitut, 2000: 29-37. - Primic Žakelj M. Desetletni program boja proti raku: zdravstve- na osveščenost prebivalstva: pomemben prispevek v boju proti raku. In: Bergant O, ed. Slovenija proti raku: desetletni pro- gram 2000-2010. Ljubljana: Zveza slovenskih društev za boj proti raku, 2000: 18-26. - Primic Žakelj M. Priporočila o presejanju za raka v Evropski uniji. In: Lindtner J, Štabuc B, Bešić N et al, eds. Družinski zdravnik in rak. 15. onkološki vikend, Ljubljana 2000. Zbornik. Ljubljana: Kancerološko združenje Slovenskega zdravniškega društva; Zveza slovenskih društev za boj proti raku, 2000: 21-9. - Robertson C, Perone C, Primic Žakelj M, Pompe Kirn V, Boyle P. Breast cancer incidence rates in Slovenia 1971-1993. Int J Epidemiol 2000; 29(6): 969-74. - Vercelli M, Capocaccia R, Quaglia A, Casella C, Puppo A, Coebergh JWW and EUROCARE Working Group. Relative sur- vival in elderly European cancer patients: evidence for health care inequalities. Clin Rev Oncol Hematol 2000; 35(3): 161-79. 2001 - Boffetta P, Saellsten G, Pompe Kirn V et al. Mortality from car- diovascular diseases and exposure to inorganic mercury. Occup Environ Med 2001; 58(7): 461-6. - Capocaccia R, Gatta G, Magnani C, Stiller C, Coebergh JW, eds. Childhood cancer survival in Europe 1978-1992: the EURO- CARE Study. Milano: European School of Oncology, 2001. (Eur J Cancer 2001; 37 (6): 671-816. - Collaborative Group on Hormonal Factors in Breast Cancer. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58209 women with breast cancer and 101986 women without the disease. Lancet 2001; 358(9291): 1389-99. - Debeljak A, Triller N, Pompe Kirn V et al. Smernice za internistično obravnavo bolnika s pljučnim rakom: uradno stal- išče Združenja pulmologov Slovenije, ki bo sprejeto na letni konferenci decembra 2001. Zdrav Vestn 2001; 70(12): 751-70. - Ećimović P, Pompe Kirn V. Incidenca raka v Sloveniji 1998 – novo letno poročilo Registra raka za Slovenijo. Onkologija 2001; 5(1): 45. - Pompe Kirn V, Japelj B, Primic Žakelj M, Šircelj M. Kaj je vpliva- lo na incidenco raka dojk v Sloveniji in kako bo z zbolevnostjo v tem desetletju. Zdrav Vestn 2001; 70(6): 341-5. - Primic Žakelj M, Pompe Kirn V, Čeh F. Najpomembnejši dejavniki tveganja raka. In: Več znanja - manj raka: didaktični komplet za učitelje. Ljubljana: Zavod Republike Slovenije za šol- stvo, 2001: 11-6. - Primic Žakelj M, Pompe Kirn V, Škrlec F, Šelb J. Can we rely on cancer mortality data? Checking the validity of cervical can- cer mortality data for Slovenia. Radiol Oncol 2001; 35(4): 243-47. - Primic Žakelj M. Epidemiology of breast cancer in the XXI cen- tury. Evidence based management of breast cancer, Sarajevo 2001. Sarajevo: European School of Oncology, 2001. - Pompe Kirn V. Kajenje in rak pri ženskah. In: Štabuc B, ed. Kajenje in rak pri ženskah. 9. seminar »In memoriam dr.Dušana Reje«, Ljubljana 2001. Ljubljana: Zveza slovenskih društev za boj proti raku; Onkološki inštitut; Inštitut za varovanje zdravja RS; Rdeči križ Slovenije 2001: 16-20. - Robertson C, Van Den Donk M, Primic Žakelj M, MacFarlane T, Boyle P. The association between induced and spontaneous abortion and risk of breast cancer in Slovenian women aged 25-54. Breast 2001; 10(4): 291-4. - Sant M, Capocaccia R, Coleman MP et al. and the EUROCARE Working Group. Cancer survival increases in Europe, but inter- national differences remain wide. Eur J Cancer 2001; 37(13): 1659-67. - Uršič Vrščaj M, Bebar S, Primic Žakelj M. Hormone replacement therapy after invasive ovarian serous cystadenocarcinoma treatment: the effect on survival. Menopause 2001; 8(1): 70-5. Cancer Incidence in Slovenia 2002 81 Institute of Oncology Ljubljana, Cancer Registry of Slovenia 2002 - Capocaccia R, Colonna M, Corazziari I et al. and the EURO- PREVAL Working Group. Measuring cancer prevalence in Europe: the EUROPREVAL project. Ann Oncol 2002; 13(6): 831-9. - Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet 2002; 360(9328): 187-95. - Debeljak A, Triller N, Pompe Kirn V et al. Strokovna izhodišča za internistično obravnavo bolnika s pljučnim rakom. Zdrav Vestn 2002; 71(6): 385-90. - Ećimović P, Pompe Kirn V. Second primary cancers in laryn- geal cancer patients in Slovenia, 1961-1996. Eur J Cancer 2002; 38(9): 1254-60. - Lambert R, Guilloux A, Pompe Kirn V et al. Incidence and mor- tality from stomach cancer in Japan, Slovenia and the USA. Int J Cancer 2002; 97(6): 811-8. - Micheli A, Mugno E, Krogh V et al. and the EUROPREVAL Working Group. Cancer prevalence in European registry areas. Ann Oncol 2002; 13(6): 840-65. - Pompe Kirn V. Epidemiological features of laryngeal cancer in Slovenia. Zdrav Vestn 2002; 71: Suppl 3: 59-63. - Pompe Kirn V. Rak v Sloveniji - število in preživetje bolnikov. In: Frankič D, ed. Prepoznavanje in zdravljenje raka. Strokovno izpopolnjevanje magistrov farmacije v letu 2002, Ljubljana 2002. Ljubljana: Lekarniška zbornica Slovenije, 2002: 5-8. - Pompe Kirn V.: Preživetje bolnikov z rakom v Sloveniji - novosti iz Registra raka za Slovenijo za obdobje 1988-1997. Onkologija 2002; 6(1): 28-31. - Primic Žakelj M. Rak danes in rak šest desetletij nazaj. In: Skela Savič B, ed. Razvoj onkologije in onkološke zdravstvene nege. Kakovost v zdravstveni negi. 29. strokovni seminar, Ljubljana 2002. Zbornik. Ljubljana: Sekcija medicinskih sester v onkologi- ji pri Zbornici zdravstvene nege Slovenije - Zvezi društev medi- cinskih sester in zdravstvenih tehnikov Slovenije, 2002: 19-24. - Uršič Vrščaj M, Primic Žakelj M, Kirar Fazarinc I. Epidemiologija raka materničnega vratu v Sloveniji in v svetu ter nacionalni program ZORA. In: Možina A, ed. Zgodnja detekcija raka materničnega vratu : kolposkopski tečaj, Ljubljana 2002. Zbornik predavanj. Ljubljana: Klinični center - Ginekološka klini- ka, 2002: 5-7. 2003 - Benedičič Pilih A. Trend incidence in preživetja bolnikov s kožnim malignim melanomom v Sloveniji v obdobju 1980-1999 glede na izbrane napovedne dejavnike preživetja. Magistrsko delo. Ljubljana: Univerza v Ljubljani, 2003. - Benedičič Pilih A, Pompe Kirn V, Kokol P, Povalej P, Arzenšek J. Kožni melanom v Sloveniji in potreba po preventivi. In: Miljković J, ed. Dermatološki dnevi. Strokovno izpopolnjevanje iz der- matologije z mednarodno udeležbo, Maribor 2003. Maribor: Splošna bolnišnica, 2003: 27-37. - Berrino F, Capocaccia R, Gatta G et al, eds. Survival of cancer patients in Europe: the EUROCARE-3 study. Ann Oncol 2003: 14(Suppl 5). - Lutz JM, Francisci S, Pompe Kirn V et al and EUROPREVAL Working Group. Cancer prevalence in Central Europe: the EUROPREVAL study. Ann Oncol 2003; 14(2): 313-22. - Pompe Kirn V. Rak v številkah: da bi ga bolje razumeli in lažje obvladovali. Okno 2003; 17(1): 27-9. - Pompe-Kirn V, Zakotnik B, Zadnik V. Preživetje bolnikov z rakom v Sloveniji 1983-1997. Ljubljana: Onkološki inštitut, Register raka za Slovenijo, 2003. - Primic Žakelj M, Arko D, Rener M, Žgajnar J. Rak dojk v Sloveniji: epidemiologija in presejanje. Zdrav Vestn 2003; 72: Suppl 2: ,II- 179-II-181. - Primic Žakelj M, Zadnik V. Epidemiologija raka dojk. In: Takač I, Arko D, eds. 30 let Centra za bolezni dojk v Mariboru. Simpozij z mednarodno udeležbo, Maribor 2003. Zbornik predavanj. Maribor: Splošna bolnišnica, 2003, 15-27. - Primic Žakelj M, Zadnik V. Rak dojk: razširjenost in nevarnostni dejavniki.In: Štabuc B, ed. Več znanja o raku, manj smrti. Seminar, Strunjan 2003. Ljubljana; Koper: Zveza slovenskih društev za boj proti raku; Obalno društvo za boj proti raku, 2003: 55-63. - Primic Žakelj M, Zadnik V. Staranje prebivalstva in rak. In: Skela Savič B, ed. Starost in rak. 30 strokovni seminar, Ljubljana 2003. Ljubljana: Sekcija medicinskih sester v onkologiji pri Zbornici zdravstvene nege - Zvezi društev medicinskih sester in zdravstvenih tehnikov Slovenije, 2003: 5-11. - Uršič Vrščaj M, Primic Žakelj M, Kirar Fazarinc I. Epidemiologija raka materničnega vratu v Sloveniji in v svetu ter nacionalni program ZORA. In: Možina A, ed. Zgodnja detekcija raka materničnega vratu in kolposkopski tečaj in Praktična kol- poskopija in ambulantno zdravljenje prekanceroze, Ljubljana 2003. Zbornik predavanj. Ljubljana: Klinični center; Ginekološka klinika; Združenje za ginekološko onkologijo, kolposkopijo in cervikalno patologijo, 2003: 92-5. - Zadnik V, Šelb J. Osnovni vzroki smrti s kazalniki umrljivosti v Sloveniji v letu 2001. - Zdrav Vestn 2003; 72(7-8): 429-4. 2004 - Benedičič Pilih A, Pompe Kirn V, Kokol P, Povalej P. Kožni melanom v Sloveniji in potreba po preventivi. In: Bešić N, Anderluh F, Benedik J et al, eds. Novosti v onkologiji in smernice za obravnavo bolnic z rakom dojk in bolnikov z malignim melanomom. 17. onkološki vikend. Laško: Kancerološko združenje Slovenskega zdravniškega društva, 2004: 107-9. - de Vries E, Boniol M, Dore JF, Coebergh JW, Pompe Kirn V and Eurocare Working Group. Lower incidence rates but thicker melanomas in Eastern Europe before 1992: a comparison with Western Europe. Eur J Cancer 2004; 40: 1045-52. - Ećimović P. Drugi primarni raki pri bolnikih s kadilskimi raki v Sloveniji v obdobju 1961-2000 ter njihov vpliv na preživetje. Doktorsko delo. Ljubljana: Univerza v Ljubljani, 2004. - Jazbec J, Ećimović P, Jereb B. Second neoplasms after treat- ment of childhood cancer in Slovenia. Pediatr Blood Cancer 2004; 42: 574-81. - Kirar Fazarinc I, Primic Žakelj M. Stanje na področju presejanja raka dojk in vzpostavitev organiziranega programa v Sloveniji. Radiol Oncol 2004; 38: Suppl 1: S21-5. - Kirar Fazarinc I, Primic Žakelj M. Izvajanje Državnega programa ZORA in kazalci organiziranega presejanja raka materničnega vratu v Sloveniji. In: Bešić N, Anderluh F, Benedik J et al, eds. Novosti v onkologiji in smernice za obravnavo bolnic z rakom dojk in bolnikov z malignim melanomom. 17. onkološki vikend. Laško: Kancerološko združenje Slovenskega zdravniškega društva, 2004: 105-6. - Noričič G, Repše S, Pompe-Kirn V. Rezultati zdravljenja raka debelega črevesa in danke v Sloveniji - analiza leta 1997. Gastroenterolog 2004; 8: Suppl 2: 287-9. - Pompe-Kirn V, Zadnik V. Analiza incidence raka na območju UE Idrija. In: Osredkar J. Vpliv elementarnega živega srebra na peroksidacijo lipidov in funkcijsko sposobnost posameznih tarčnih organov pri prebivalcih mesta Idrije in delavcih rudni- ka. Zaključno poročilo o rezultatih raziskovalnega projekta v letu 2004. Ljubljana, 2004. - Primic Žakelj M. Smernice za zgodnje odkrivanje raka. In: Skela Savič B, Logonder M, Lokar K, eds. Ukrepajmo danes, da bomo živeli jutri. 31. strokovni seminar Sekcije medicinskih sester v onkologiji. Moravske toplice: Zbornica zdravstvene nege Slovenije-ZDMSZTS, 2004: 28-33. - Primic Žakelj M, Kirar Fazarinc I. Cervical cancer screening – a Slovenian experience. In: Better health outcomes through pub- lic health approaches in primary health care. Fourth interna- tional forum on common access to health care. Brdo pri Kranju: Ministry of Health, 2004: 1-5. - Primic Žakelj M, Ravnihar B and Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and abor- tion: collaborative reanalysis of data from 53 epidemiological studies, including 83000 women with breast cancer from 16 countries. Lancet 2004; 363: 1007-16. - Primic Žakelj M, Zadnik V. Kajenje in rak v Sloveniji. In: Štabuc B, Primic Žakelj M, Zdešar A, eds. Kajenje in rak. 12. seminar »In memoriam dr. Dušana Reje«. Ljubljana: Zveza slovenskih društev za boj proti raku, Onkološki inštitut, Inštitut za varovanje zdravja RS, Rdeči križ Slovenije, 2004: 36-42. - Primic Žakelj M, Zadnik V. Epidemiologija raka dojk v svetu in v Sloveniji. Radiol Oncol 2004; 38: Suppl 1: S1-S7. - Primic Žakelj M, Zadnik V, Škrlec F. Nekaj osnovnih podatkov in zanimivosti iz novega letnega poročila Registra raka za Slovenijo. Onkologija 2004; 8: 22-4. - Tyczynski JE, Bray F, Pompe Kirn V et al. Lung cancer mortality patterns in selected Central Eastern and Southern European countries. Int J Cancer 2004; 109: 598-610. - Tyczynski JE, Pleško I, Primic Žakelj M et al. Breast cancer mor- tality patterns and time trends in 10 new EU member states: mortality declining in young women, but still increasing in the elderly. Int J Cancer 2004; 112: 1056-64. - Zadnik V, Primic Žakelj M. Vpliv dejavnikov tveganja in genetske nagnjenosti na pojavljanje raka dojk pri mladih ženskah. In: Bešić N, Anderluh F, Benedik J et al, eds. Novosti v onkologiji in smernice za obravnavo bolnic z rakom dojk in bol- nikov z malignim melanomom. 17. onkološki vikend. Laško: Kancerološko združenje Slovenskega zdravniškega društva, 2004: 114-5. 82 Incidenca raka v Sloveniji 2002 Onkološki inštitut Ljubljana, Register raka za Slovenijo Cancer Incidence in Slovenia 2002 83 Institute of Oncology Ljubljana, Cancer Registry of Slovenia 84 Incidenca raka v Sloveniji 2002 Onkološki inštitut Ljubljana, Register raka za Slovenijo